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1. Introduction 
 Nanoparticle research has greatly expanded over the past several decades. A 
significant factor in this increase is development of numerous potential biological 
applications of nanoparticles, ranging from imaging [1-3] to biochemical sensing [4, 
5], tumor targeting [6] and drug delivery [7-9]. The combination of inorganic and 
biochemical building blocks let to a wide variety of novel hybrid systems with 
unexpected properties. Functional groups found in biological systems provide a wide 
range of potential interactions with nanoparticle surface, which can easily interfere 
with biomolecule structure and function. While there is a huge part of work detailing 
the use of nanoparticles in biological settings, there are few studies exploring their 
affects on biomolecular structure and function. Thus, effective use of bio-nano 
systems requires also a detailed understanding of biomolecule-nanoparticle 
interactions on their interface.  
 The modification of peptides, proteins and other complex molecules with 
specific anchoring groups facilitates the binding to nanoparticles via a site-specific 
linkage, introducing chemical functionalities that can provide recognition or affinity 
interactions between the biomolecules and antibodies or cell receptors. This 
approach has been widely used to design nanoparticle conjugates to be used in 
different applications. 
 In this PhD thesis we focus our attention on the synthesis of gold 
nanoparticles modified with different organic molecules with biological activity. The 
manuscript is organized as follows. Chapter I contains some general data on gold 
nanoparticle properties, synthesis approaches and their application in order to 
familiarize the reader with the topic. Materials and methods, used in present work, 
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are briefly described in Chapter II. While Chapter III is dedicated to the studies of 
gold nanoparticles modified with nucleic acid components, such as nucleobases, 
nucleosides and nucleotides. Besides the synthesis details, and nanoparticle 
characterisation, a thorough study on the binding between the nanoparticles and the 
compounds, carried out by NMR and FTIR methods, is reported. Novel results are 
obtained on the binding sites and conformational changes occurred under interaction 
with gold nanoparticle surface. Moreover, preliminary results on biological studies of 
the nanoconjugates in U87 cancer cells are shown. The following Chapter IV 
contains the results on the study of gold nanoparticles modified with an RGD-peptide, 
designed for the targeting of integrin receptors in U87 cancer cells. The mechanism 
of the nanoconjugates uptake into the cells is studied by confocal and TEM 
microscopy, showing some interesting novel results. Finally, Chapter V is dedicated 
to the design and synthesis of gold nanoparticles functionalized by Halo Tag specific 
ligands. Different synthesis approaches described and the properties of final 
conjugates are compared in order to find out the best synthesis conditions. The 
biological studies using microinjection method are in progress in order to evaluate the 
activity of the nanoconjugates and study their behaviour in cancer cells.  
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2. Gold nanoparticles: general aspects 
 Metal nanoparticles have a long history in terms of preparation, 
characterization, and application. Understanding the properties of noble metal 
nanoparticles and exploring their application potential are two major driving forces 
behind the synthesis of a large variety of nanomaterials. Many properties of 
nanoparticles arise from their large surface-area-to-volume ratio and the spatial 
confinement of electrons, phonons, and electric fields in and around the particles. 
These may cause deviations from the usual bulk atomic arrangements, such as 
higher reactivity; different elastic, tensile, and magnetic properties; increased 
conductivity; or increased tendency to reflect and refract light [10].  
 The SI prefix “nano” means a billionth (10−9) part of a meter, or about one 
hundred thousandth the thickness of a sheet of paper. The nanoscale, defined by the 
US National Nanotechnology Initiative, is a range from 1 to 100 nm, including 
particles which are naturally occurring, such as particles in smoke, volcanic ash, sea 
spray, and from anthropogenic sources. In terms of biology, the nanoscale is the size 
range of important cellular components, such as DNA (double-stranded DNA is about 
2.5 nm in diameter), proteins (hemoglobin is about 5 nm in diameter), cell walls, cell 
membranes, and compartments [11].  
The ‘‘soluble’’ gold, which we now call colloid gold, was developed around the 
5th or 4th century B.C. and has been used technologically due to its optical properties, 
in particular for staining glass [12]. The modern era of gold nanoparticles synthesis 
began over 150 years ago with the work of Michael Faraday, who was possibly the 
first to observe that colloidal gold solutions have properties that differ from bulk gold 
[13]. 
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Gold nanoparticles (AuNPs) possess distinct physical and chemical attributes 
that make them excellent tools for biological and medical applications. First, AuNPs 
can be synthesized in a straightforward manner and can be made highly stable. 
Second, they possess unique optoelectronic properties. Third, they provide high 
surface-to-volume ratio with excellent biocompatibility, using appropriate ligands. 
Finally, AuNPs offer a suitable platform for multifunctionalization with a wide range of 
organic or biological ligands for the selective binding and detection of small 
molecules and biological targets [14]. 
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3. Optical properties of gold nanoparticles 
 AuNPs, like any noble metal NPs, feature surface plasmon resonance band 
(SPR). The SPR is the result from the collective oscillation of the conduction 
electrons across the particle due to the resonant excitation by the incoming photons. 
For AuNPs, the resonance condition is satisfied at visible wavelengths, therefore 
attributing for its intense colour [15]. The SPR band intensity and wavelength 
depends on the factors affecting the electron charge density on the particle surface, 
such as particle size, shape, structure, composition and the dielectric constant of the 
surrounding medium, as theoretically described by Mie theory [16]. The SPR band of 
AuNPs with size smaller than 10 nm is largely damped due to the phase changes 
resulting from the increased rate of electron-surface collisions compared to larger 
particles. Increasing particle size red-shifts the SPR wavelength and also increases 
the intensity [17]. The particles shape also determines the position of SPR: with a 
change from spheres to rods, the SPR band is split into two bands with a strong one 
in NIR region, corresponding to electron oscillations along the long axis, referred to 
longitudinal band, and a weak one in the visible region at a wavelength similar to that 
of gold nanospheres, referred to transverse band [18].  
Besides the shape factor for optical tuning in NIR region, structure variations 
can result in similar phenomena. For instance, the SPR band of gold nanoshells, 
composed of silica core and gold shell, strongly depends on the shell-to-core ratio, 
but remaining independent of the particle size, core and shell material and even 
surrounding medium [19]. While gold nanocages of about 50 nm edge width with few 
nanometers walls and holes show the SPR band around 800 nm, which can be tuned 
to NIR region, by controlling the amount of reagents [20]. 
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Figure 1. UV-vis spectra of gold nanoparticles in different sizes. 
 
Another parameter affecting the SPR band is the medium surrounding the particle. 
The fact that the position and intensity of the plasmonic band changes with structural 
rearrangements in ligand shell is being taken into consideration by the scientists 
when using ligand exchange and bioconjugation techniques to functionalize the 
nanoparticles. It is probably the most simple and useful approach to understand if 
exchange reaction took place [21]. Moreover, the SPR band can be highly indicative 
of nanoparticle stability: their aggregation can be monitored via colour change or 
variation in the SPR band position and shape. Due to their optical properties, AuNPs 
have been finding a plenty of applications, from biosensors [22-24] to photothermal 
therapy [25, 26]. 
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Figure 2. TEM images and extinction spectra of: a) 13 nm gold nanospheres; b) gold 
nanorods with different aspect ratios; c) gold nanostars; d) spiky gold nanoshells with 
spherical and rod cores; e) gold nanoprisms with different edge lengths. 
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4. Colloidal stability of gold nanoparticles 
 Particle size, surface composition, and density directly affect how a particle 
behaves in suspension. When particle size gets to about 100 nm, Brownian motion 
causes water molecules to collide with particles with high enough force-to-mass 
ratios to prevent them from settling under gravity, and a true colloidal suspension 
occurs [27]. The forces acting on particles in a colloidal solution mainly can be 
explained by the Derjaguin, Landau, Verwey, and Overbeek (DLVO) theory, which 
describes the attractive van der Waals forces and repulsive electrostatic forces 
affecting the nanoparticle stability (Derjaguin and Landau, 1941; Verwey and 
Overbeek, 1948). Classical DLVO theory models particles as infinitely flat solid 
surfaces with uniform surface charge densities. Furthermore, surface potential (i.e. 
zeta potential) is constant and uniform, and no chemical reactions occur between the 
solvent and the particles (i.e. solvent influences the solution dielectric constant only) 
[28-30]. This theory proposes that the nanoparticles are in an interactive regime 
where strong attractive forces between them can be prevented by an energy barrier 
resulting from electrostatic and/or steric repulsive forces.  
Nanoparticle stabilization includes the following kinds: electrostatic, steric and 
electrosteric. Electrostatic stabilization (Figure 3, A) bases on the electrical double 
layer repulsion between the particles. The generation of electrostatic repulsion 
between charged conjugates is the most common strategy to keep NPs separated in 
aqueous medium and, subsequently, stable under physiological conditions [31]. For 
this purpose, AuNPs can be modified by different capping ligands, such as citrate 
[32], peptides [33, 34], short polyethylene glycol molecules containing polar groups 
[35] and small charged molecules [36]. A characteristic feature of electrostatic 
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repulsion is its high sensitivity to the bulk ionic strength; the force of electrostatic 
repulsion diminishes significantly at high salt concentrations, when the electric double 
layer is highly suppressed. This explains why citrate-capped AuNPs are stabilized in 
water but undergo aggregation at elevated salt concentrations (e.g., 50 mM NaCl) 
[37]. 
Steric stabilization (Figure 3, B) is achieved by the coordination of sterically 
bulky organic molecules that act as protective shields on the metallic surface [38-40]. 
In this way, nanocores are separated from each other and agglomeration is 
prevented. Macromolecules grafted on colloid surfaces in a “good solvent”— that is, 
a solvent in which steric stabilization diminishes with decreasing solubility—impart a 
polymeric barrier that prevents colloids from coming too close, and van der Waals 
attractive forces can dominate. Essentially, the penetration of polymer chains on 
colloids when they approach each other results in a loss of polymer configurational 
entropy, which disfavours the aggregation process. Steric stabilization is much less 
sensitive towards ionic strength than electrostatic stabilization. Rather, the molecular 
weight of the macromolecule and surface graft density are more important factors. In 
general, thicker polymer layers and higher graft densities lead to more effective steric 
stabilization [41]. Polymers and proteins, like BSA (bovine serum albumin), are large 
enough to sterically stabilize nanoparticles [42].  
Electrosteric stabilization has become one of the most useful and effective 
method for keeping the nanoparticles stable in aqueous solution, recently (Figure 3, 
C). DNA (negatively charged polymer) modified AuNPs represent an excellent 
example of such systems. DNA-modified AuNPs with high DNA graft density remain 
stabilized even at very high salt concentrations (e.g., 300 mM MgCl2).  
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Steric factors are expected to play a major role in stabilizing AuNPs at salt 
concentrations in which the electrostatic repulsion is significantly diminished [41]. 
Peptides containing charged amino acid residues and PEG molecules with polar side 
groups such as –NH2 and –COOH, possess an excellent stabilization ability, keeping 
the particles from aggregation by electrosteric forces [43-45].  
 
 
 
 
 
Figure 3. Schematic representation of colloidal stabilization through: A) small charged 
molecules on the AuNP surface (electrostatic stabilization), B) surface grafted polymers (steric 
stabilization), and C) surface grafted charged polymers (electrosteric stabilization). 
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5. Synthesis of gold nanoparticles 
The generation of stable colloidal solution with particles of controlled size and 
shape requires a real synthetic strategy as well as a perfect knowledge of the 
intimate relationship existing between particle surface and stabilizing agent. The 
growth of gold nanoparticles persists as long as the crystallization sites are not 
blocked by the capping agent and as long as the gold (III) salt is available in the 
reaction medium. Stabilizing molecule should display a higher affinity for the particle 
surface than the solvent molecules, exhibit a high solubility in the reaction medium 
and induce mutual repulsions between particles to prevent the aggregation. 
Therefore, a prerequisite for stabilizing molecules is to possess at least one atom or 
a functional group exhibiting lone pair electrons that can ensure its binding to the 
gold surface [46] (Figure 4). 
 The range of capping agents used to stabilize and functionalize nanoparticles 
varies from unconventional ones, such as plants extracts (Aloe [47], Cinnamomum 
camphora [48] etc.), microorganisms and bacteria, to a more usual kinds, such as 
small organic molecules (amines [49], amino acids [50]). Polymers such as 
polypeptides [51-53], PEG with reactive functional groups [54-58] and proteins [59-
61] are superior compared with small organic molecules, as they can form a shell 
around the gold particles and can provide an excellent robustness against 
agglomeration in various extreme conditions.  
 The choice of the synthesis procedure is dependent on the needed particle 
size. Here, the most common methods to obtain spherical gold nanoparticles are 
reported.  
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Figure 4. a) Schematic representation of a nanoparticle stabilized by a stabilizing agent; 
b) A series of functional end-groups commonly used for capping agents. 
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5.1. Turkevich-Frens method 
 The method pioneered by J. Turkevich et al. in 1951 [62, 63] and refined by G. 
Frens in 1970s [64], is one of the most frequently applied methods. Generally, it is 
used to produce modestly monodisperse nanoparticles of around 10–20 nm in 
diameter operating in the aqueous phase. The method involves the reaction of boiling 
chloroauric acid solution with small amounts of warm sodium citrate solution. Citrate 
ions act as both a reducing agent and a capping agent leading to the formation of 
nanoparticles.  
 
 
 
 
 
Figure 5. A schematic representation of citrate-stabilized gold nanoparticles by 
Turkevich-Frens method. 
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5.2. Brust method 
 Discovered by Brust and Schiffrin in early 1990s, this method can be used to 
produce AuNPs in organic solvents that are normally not miscible with water [65, 66]. 
It involves the reaction in toluene of a chloroauric acid solution with 
tetraoctylammonium bromide (TOAB) solution and sodium borohydride as a 
stabilizing and a reducing agent, respectively. The sizes of as-prepared AuNPs are 
around 5–6 nm. Notably, the TOAB does not bind to the gold nanoparticles 
particularly strongly, so particle colloid tends to aggregate gradually over the course 
of approximately two weeks. To prevent this, a stronger binding agent such a thiol 
can be added, which binds to the gold surface covalently, leading to a stable particle 
colloidal solution . 
 
 
Figure 6. A schematic representation of thiol-stabilized gold nanoparticles by Brust-Schiffrin 
method. 
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5.3. Sodium borohydride reduction method 
 This “one-pot” method involves the reduction of a gold salt (NaAuCl4) by 
sodium borohydride in presence of stabilizing agents of different kinds, such as 
simple small or large organic molecules [67, 68], peptides [69] and even proteins 
[70]. Sodium borohydride is a strong reducing agent capable of producing small 
AuNPs at room temperature. The particle size is regulated by the amount of 
stabilizing agent involved in the reaction and normally varies between 4 and 25 nm. 
The synthesis can be also performed in an organic phase, such as methanol, 
working with the stabilizing molecules that are not soluble in water. 
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6. Biomolecule-functionalized gold nanoparticles 
Biological molecules have been immobilized on gold nanoparticles by a variety of 
techniques, including physical adsorption, electrostatic interaction, specific 
recognition and covalent coupling. Here, we discuss the most important approaches 
to obtain the gold bioconjugates.  
6.1. Functionalization by electrostatic adsorption 
 The biomolecules ranging from low-molecular-weight organic substrates to 
large protein/enzyme molecules can interact electrostatically with the anionic ligands 
such as carboxylic acids (citrate, tartrate, lipoic acid) stabilizing the nanoparticles. For 
example, setting up the pH of AuNPs prepared by citrate reduction slightly above the 
isoelectric point of the citrate ligand, allows effective binding between the positively 
charged amino acid side chains of the peptides and proteins and the negatively 
charged citrate groups on the nanoparticles [71, 72]. 
6.2. Functionalization by chemisorption of thiol-derivatized biomolecules 
 Strong chemisorptions of biomolecules on AuNPs can originate from the 
binding of thiol groups, for example, from cysteine residues in peptides and proteins 
[73-75]. DNA molecules functionalized with a steroid-disulfide derivative can readily 
bind to AuNPs and demonstrate higher adsorption stability because two sulphur 
atoms of the disulfide anchor group are involved in the attachment process [76, 77]. 
Enhanced binding of nucleic acids to metal nanoparticles may be accomplished by 
the use of oligonucleotides that include several adenosyl phosphothiolate residues at 
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their ends, thus enabling multi-point attachment to the NPs [78]. 
6.3. Functionalization by specific interactions 
 The AuNPs can be functionalized with groups such as low-molecular 
bifunctional linkers that have anchor groups for attachment to nanoparticle surface 
and functional groups for further covalent coupling to the target biomolecules. Anchor 
groups such as thiols, disulfides, or phosphane ligands are often used for the binding 
of the bifunctional linkers to AuNPs, being able to readily substitute weakly adsorbed 
molecules stabilizing the nanoparticles, or may be incorporated in the nanoparticle 
synthesis, resulting in a particle surface providing functional groups for further 
reactions [79-82]. A wide variety of terminal functional groups is available in different 
bifunctional linkers: amino, active ester, and maleimide groups are used for the 
covalent coupling of biological compounds by means of carbodiimide-mediated 
esterification and amidation, or reaction with thiol groups. Biotin-streptavidin 
interaction is another potential tool to be applied for AuNPs: the binding affinity 
between the two molecules is very high ((Ka 1013 M-1) and is considered one of the 
strongest receptor−ligand interactions found in nature. This high binding affinity, the 
symmetry of the biotin-binding pockets which are positioned in pairs at opposite 
faces of the protein, and the ease of functionalization of diverse biomolecules (e.g., 
antibodies, peptides, and nucleotides) with biotin make the streptavidin−biotin system 
extremely useful in a wide range of biotechnological applications [83]. Thus, applying 
this approach to the AuNPs and modifying the gold surface with streptavidin, plenty 
of biotin-containing biomolecules can be conjugated [84]. 
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Figure 7. Functionalization of gold nanoparticles: specific interactions and 
biomolecules monolayer on the particle surface. 
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7. Application of gold nanoparticles 
7.1. Gold nanoparticles as drug delivery systems 
AuNPs are found to be attractive platforms for the delivery of increasingly 
potent, selective, and multifunctional anti-cancer drug conjugates [85, 86]. Drug 
delivery systems (DDSs) can improve several crucial properties of ‘‘free’’ drugs, such 
as solubility, in vivo stability, pharmacokinetics, and biodistribution, enhancing their 
efficacy. Moreover, nanoparticles can provide effective carriers for biomolecules such 
as DNA, RNA, or proteins, protecting these materials from degradation and 
transporting them across the cell-membrane barrier. Thiol-PEGylated AuNPs 
functionalized by tumor therapeutic agents such as paclitaxel [86, 87], anthracycline 
[88], doxorubicin [89-94] were proved to be efficiently delivered into cancer cells. For 
successful delivery, carriers must: (a) form condensed complexes with biomolecules, 
(b) facilitate penetration of the cell membrane after complexation, and (c) unload their 
payloads inside of cells. Two approaches to serve this purpose are ‘‘passive’’ and 
‘‘active’’ targeting. Passive targeting relies on the homing of the carriers to infected 
tissues. On the other hand, active targeting relies on specific recognition of the 
ligands that are displayed on delivery vehicles by cell surface receptors. The ligand 
used for active targeting can be a small molecule, or a peptide or protein [95]. A key 
goal of delivery systems is to discharge their payloads specifically at the diseased 
tissue. The release could be triggered by internal (e.g. glutathione (GSH), or pH or 
external (e.g. light) stimuli. Significantly the internal stimuli operate in a biologically 
control manner, whereas the external stimuli provide spatio-temporal control over the 
release [96].  
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7.2. Gold nanoparticles for photothermal cancer therapy 
AuNPs can resonantly absorb and scatter incident light upon excitation of their 
surface plasmon oscillations typically in the visible range, with their absorption cross 
sections orders of magnitude larger than those of strongly absorbing organic 
molecules. In addition, photon energies that are absorbed by AuNPs can be 
efficiently converted into heat on a picosecond time scale, as a result of electron-
phonon and phonon-phonon processes. Thus, AuNPs can be a highly potent 
photothermal therapeutic agent, by exploiting their strong absorptions and efficient 
heat conversions [97-100].  
 Photothermal therapy using spherical AuNPs can be achieved with pulsed or 
cw (continuous wave) visible lasers due to the SPR absorption in the visible region 
and thus such treatment is suitable for shallow cancer (e.g. skin cancer). The first 
thorough study using pulsed laser and gold nanospheres was performed in 2003 by 
Lin and co-workers for selective and highly localized photothermolysis of targeted 
lymphocyte cells [101]. Lymphocytes incubated with AnNPs conjugated to antibodies 
were exposed to nanosecond laser pulses and showed cell death with 100 laser 
pulses. Adjacent cells just a few micrometers away without nanoparticles remained 
viable. Their numerical calculations showed that the peak temperature lasting for 
nanoseconds under a single pulse exceeds 2000 K with a heat fluid layer of 15 nm. 
The cell death is attributed mainly to the cavitation damage induced by the generated 
micro-scale bubbles around the nanoparticles. So far, the use of spherical AuNPs in 
such an application has not been made, first of all because of their limited tissue 
penetration, which confines their applicability mostly to melanoma. However, the 
AuNPs of different forms, such as core-shell nanoparticles with ferromagnetic  
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properties [102], nanorods [103], nanocages [104], nanostars [105] and even 
popcorn-shaped gold nanoparticles [106] are being tried to be used as photothermal 
therapy agents using different cancer cell lines. 
 
7.3. Cancer imaging 
As I have already mentioned in a previous section, the scattering properties of 
gold colloids depend on the size, shape and structure of the nanoparticles. Typically, 
particles of 30–100 nm diameters scatter intensely and can be easily detected by a 
commercial microscope under dark-field illumination conditions. In fact, 40 nm 
AuNPs can be easily detected by eye down to a particle concentration of 10-14 M. 
Likewise, the scattering from a 60 nm AuNPs is 105 stronger than the emission of a 
fluorescein molecule [107]. The high scattering cross-sections of AuNPs together 
with their superior photostability (as compared to organic dyes) make them extremely 
promising for cellular imaging.  
Standard clinical imaging modalities such as X-ray based computer 
tomography (CT), magnetic resonance imaging, and ultrasound are able to provide 
basic information regarding tumor location, size and spread. However, these 
methods are not efficient in detecting tumors and metastases smaller than 0.5 cm 
and they can barely distinguish between benign and cancerous tumors [108].  
Present CT contrast agents based on iodine containing molecules are 
effective in absorbing X-rays, however, they have a number of limitations: nonspecific 
targeting, because of their inability to be conjugated to most biological components or 
cancer markers; they allow only very short imaging times due to rapid clearance by 
the kidneys.  
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On the other hand, gold induces a strong X-ray attenuation, having unique 
physical, chemical, and biological properties, which make them an ideal candidate for 
CT contrast agents [109, 110].In addition, AuNPs provide a high degree of flexibility 
in terms of functional groups for coating and targeting and have also proved to be 
nontoxic and biocompatible in vivo. 
The feasibility of AuNPs for cancer imaging has been demonstrated in recent 
years. In the earlier attempts by Sokolov et al, the scattered light is collected in a 
reflection mode under single laser wavelength excitation using a confocal microscope 
or simply a laser pen [111]. An improvement of the cancer imaging based on the 
scattering properties of AuNPs was made by El-Sayed et al. using dark field 
microscopy in 2005 [112]. In this case, the nanoparticles are excited by the white 
light from a halogen lamp which is also the same lamp used for bright field imaging. 
As the nanoparticles scatter light most strongly at the wavelength of the SPR 
maximum, the nanoparticles appears in brilliant colour that depends on the size and 
shape of the particles [15]. Bischof et al. demonstrated the use of confocal Raman 
microscopy to measure the localization of AuNPs with nanoscale resolution. Raman 
laser interaction with AuNPs inside cells shown unique spectroscopic features 
corresponding to the different intracellular localizations of AuNPs, proving to be a 
potential technique for cancer cells imaging [113].  
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7.4. Cellular targeting 
The targeted delivery of nanoparticles to solid tumors is a key task in the 
development of cancer nanomedicine for in vivo molecular imaging and targeted 
therapy. “Passive” and “active” targeting are two approaches used for tumor 
targeting. Active targeting relies on specific recognition of the ligands that are 
displayed on nanoparticles by cell surface receptors, often followed by receptor-
mediate endocytosis and nanoparticle internalization [114]. Biomolecules of interest 
may include one or more of the following: peptides, proteins and antibodies; 
enzymes, oligonucleotides and aptamers; drugs or other biologically active small 
molecules; reporter molecules or contrast agents, e.g., radiolabels or fluorescent 
dyes. On the other hand, in the passive mode, nanoparticles without targeting ligands 
are accumulated and retained in the tumor interstitial space mainly through the 
enhanced permeability and retention effect [115, 116]. In both mechanisms, a 
common feature is that nanoparticles in the blood stream must first move across the 
tumor blood vessels (usually leaky vasculatures) and extravasate into the tumor 
interstitium or the perivascular region [117]. Albericio et al. functionalized AuNPs with 
both a targeting peptide and a drug peptide ligand with the aim to improve not only 
the selectivity of the conjugates via a higher capacity to enter the cells, but also their 
antitumor activity over the free drug via increase of its local concentration [118]. Nam 
et al. used cyclic RGD-PEGylated AuNPs with directly labeled radioactive iodine as 
molecular imaging probes for tumor sites, taking advantage that radioactive iodine 
has a sensitivity of 10-10-10-11 M for in vivo imaging, and finding out that the probes 
can target tumor sites via integrin receptor recognition only after 10 min from 
intravenous injection. Interestingly, TEM and radio-TLC analysis of urine samples 
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suggested the ability of these nanoparticles to go through renal filtration and be 
excreted from the body [119]. El-Sayed and co-workers in their recent paper report 
on the prostate cancer targeting: AuNPs conjugated with antiandrogen 
chemotherapeutics target membrane androgen receptor and androgen-sensing G 
protein-coupled receptor, involved in prostate cancer growth and progression [120]. 
Eck et al. applied antibody-conjugated AuNPs as contrast agent for X-ray computer 
tomography with the aim of tumor targeting: a heterobifunctional PEG ligand was 
used for stabilization, while an anti-mouse CD4 monoclonal antibody was coupled to 
the PEG molecules using a NHS/EDC coupling reactions for CD4-receptor 
recognition [121]. Finally, DNA- and RNA-conjugated AuNPs were found to be taken 
up by HeLa cells in serum-free culture by a process involving receptor-mediated 
endocytosis primarily mediated by scavenger receptors, a class of pattern-
recognition receptors [122]. Here we have nominated only most important examples 
of AuNPs application in biology and nanomedicine: this field is continuosly being 
developing and, hopefully, soon will bring to in vivo tests on humans. 
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1. Characterization challenges 
A rational characterization strategy for bioconjugated nanoparticles contains 
three elements: physicochemical characterization, in vitro assays, and in vivo 
studies. Each of these is essential to a comprehensive understanding of nanoparticle 
safety and efficacy. However, physicochemical characterization plays a key role in 
the interpretation of in vitro or in vivo biological data. While testing in vitro 
physiological models can give an initial estimate of formulation efficacy and toxicity. 
The approaches traditionally used for small molecules to ascertain their 
physicochemical properties, can be perfectly applied for nanoconjugates. Techniques 
like nuclear magnetic resonance (NMR), mass spectrometry, ultraviolet-visible (UV-
vis) spectroscopy, infrared spectroscopy (IR) can be run in a high-throughput fashion 
to analyze the molecule-nanoparticle interactions. The nanoconjugates properties, 
such as composition, purity, stability, influence biological activity, and may depend on 
parameters such as particle size, size distribution, surface area, surface charge, 
surface functionality, shape, and aggregation state. Additionally, since many 
nanoparticle concepts are multifunctional (with targeting, imaging, and therapeutic 
components), the stability and distribution of these components can have dramatic 
effects on nanoparticle biological activity as well.  
Physicochemical characterization of properties such as size, surface area, 
surface chemistry, and aggregation state can provide the basis for better 
understanding of structure–activity relationships. Determination of nanoparticle size 
in solution by dynamic light scattering (DLS), surface charge through zeta potential  
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measurements, core diameter by transmission electron microscopy (TEM) are some 
of the up-to-date methods widely used for characterization of nanoconjugates.  
Another important and challenging area of nanoparticle characterization is 
measurement under physiological conditions that resembles or mimics the physical 
state in vivo. Many properties of nanoparticles are environment and condition 
dependent; for example, the particle’s hydrodynamic size at physiological pH and 
ionic strength may differ from the size in water. Surface charge may also depend on 
the pH and ionic strength of the suspending solution. While in vitro characterization is 
performed to elucidate mechanisms and biocompatibility of nanomaterials, making 
use of numerous immortalized cell lines. 
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2. Core size and shape 
2.1. Transmission electron microscopy 
Transmission electron microscopy (TEM) remains the first choice for the 
investigation of size, dispersion and shape of NPs. TEM gives a photograph of the 
gold core, and by measuring each particle’s diameter the histogram of size 
distribution is obtained. Thus, the information about the dispersity of the sample can 
be calculated. 
In present work, TEM micrographs of AuNPs were obtained using an EFTEM 
Leo 912 AB instrument at an accelerating voltage of 100 kV. The samples were 
prepared by evaporating a drop of nanoparticles onto carbon-coated copper grid and 
allowing it to dry on the air. The histograms of the particle size distribution and the 
average particle diameter were obtained by measuring about 150-200 particles by 
using Measure IT Olympus Software. 
 
2.2. Analytical centrifugation 
Particle size, size distribution and extent of aggregation were analyzed by 
analytical centrifugation on a CPS disc centrifuge DC24000 (CPS Instruments Inc.). 
The CPS Disc Centrifuge separates particles by size using centrifugal sedimentation 
in a liquid medium. The sedimentation is stabilized by a slight density gradient within 
the liquid. The particles sediment within an optically clear, rotating disc. Approaching 
the outside edge of the disc, they scatter a portion of a light beam that passes 
through the disc. The change in light intensity is continuously recorded, and 
converted by the operating software into a particle size distribution.  
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As a gradient fluid, 8–24 wt% sucrose solution in Milli-Q water was used and 
filled successively in nine steps into the disc, starting with the dilution of highest 
density. For analysis, the disc rotation speed was set to 24 000 rpm. Calibration was 
performed using polyvinylchloride (PVC) particles (0.377 µm) as calibration standard 
(Analytik Ltd.). The colloids were sonicated before injection into the disc centrifuge. 
 
2.3. Dynamic Light Scattering 
Dynamic Light Scattering (DLS) is one of few techniques capable of 
determining the size of nanoparticles in solution, providing an accurate measure of 
nanoparticle hydrodynamic size. In DLS, the nanoparticle solution is illuminated by a 
monochromatic laser and its scattering intensity is recorded with a photon detector at 
a fixed or variable scattering angle with time. Generally, nanoparticle samples 
contain a distribution of sizes as a result of imperfections in synthesis and due to 
natural conformational variations in the large number of atoms involved. A metric for 
size variability is the polydispersity index (PI) equivalent to the relative variance of the 
distribution.  
DLS measurements were performed, using a 90 Plus Particle Size Analyzer 
from Brookhaven Instrument Corporation (Holtsville, NY) operating at 15 mW of a 
solid-state laser (λ = 661 nm), using a scattering angle of 90°. A disposable cuvette 
with 1 cm optical path length was used for the measurements. The cuvettes were 
cleaned with Milli-Q water and stored dry. The samples were prepared by dilution 
with Milli-Q water or 10mM NaCl in order to obtain the final concentration of AuNPs 
close to 100 µg/mL, followed by filtration with a 0.45 µm cellulose acetate syringe 
filter before loading into the cuvette in order to remove large interfering 
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particulate matter. Each sample was allowed to equilibrate for 4 min prior to starting 
measurement. Three to ten independent measurements of 60 s duration were 
performed, at 25°C. The calculations of hydrodynamic diameter were performed 
using Mie theory, considering absolute viscosity and refractive index values of the 
medium to be 0.911 cP and 1.334, respectively. 
 
2.4. UV-vis spectroscopy 
If a routinely sizing of nanoparticles is needed, UV-vis spectroscopy can be a 
useful tool in fast and real-time monitoring of AuNPs size, providing information about 
AuNPs aggregation and concentration [1]. Surface plasmon resonance originates an 
extinction spectrum which depends on the size, shape, and aggregation of AuNPs. 
The position of the plasmon resonance is affected by multiple factors, like 
environment dielectric properties [2-4], physical or chemical interactions on particles 
surface [5], surface charge [6], interparticles distance [7, 8], and aggregation [9].  
In present work, UV-visible spectra were recorded on a JASCO V530 
spectrometer using 1 cm path length quartz cuvettes and a solution obtained by 
diluting three times the original sols with Milli-Q water. Haiss and co-workers, 
analyzing the optical properties of spherical AuNPs of 3-120 nm diameters in 
aqueous solutions, proposed a method to calculate the particle diameter from UV-vis 
spectra, considering an analytical relation between the extinction efficiency and 
diameter, which allow the determination of the particle concentration [10]. Using a 
ratio of the absorbance of AuNPs at the surface plasma resonance peak (ASPR) to the 
absorbance at 450 nm (A450), the particle diameter and corresponding extinction 
coefficient can be detected.  
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Subsequently, the particle concentration can be calculated by dividing the value of 
A450 to the corresponding extinction coefficient (see Tables A5.1-3 in Appendix). 
2.5. Zeta-potential measurements 
In an ionic solution, nanoparticles with a net charge will have two surrounding 
layers: a layer of ions of opposite charge strongly bound to their surface, and a 
diffuse outer layer of loosely associated ions. These two layers are collectively called 
the electrical double layer. As the particle moves, a distinction is created between 
ions in the diffuse layer that move with the nanoparticle and ions that remain with the 
bulk dispersant. The electrostatic potential at this “slipping plane” boundary is called 
the zeta potential and is related to the surface charge of the nanoparticle. In zeta 
potential measurements, an electrical field is applied across the sample and the 
electrophoretic mobility of nanoparticles is measured by laser doppler velocimetry 
[11]. Nanoparticles with a zeta potential between −10 and +10 mV are considered 
approximately neutral, while nanoparticles with zeta potentials greater than +30 mV 
or less than −30 mV are considered strongly cationic and anionic, respectively [12].  
The zeta-potential was determined at 25°C using a 90 Plus Particle Size 
Analyzer from Brookhaven Instrument Corporation (Holtsville, NY) equipped with an 
AQ-809 electrode, operating at applied voltage of 120 V. The samples for 
measurements were prepared by dilution the concentrated nanoparticle sols in 10 
mM NaCl solution up to 0.01 mg/mL final concentration, with pH value of 7. A 
minimum of three runs and ten sub runs per sample were performed to establish 
measurement repeatability.  
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The Zeta-potential was automatically calculated from electrophoretic mobility based 
on the Smoluchowski theory. A viscosity of 0.891 cP, a dielectric constant of 78.6, 
and Henry function of 1.5 were used for the calculations.  
     Helmholtz-Smoluchowski equation, 
 
where Ue- electrophoretic mobility, εrs- relative permittivity of the electrolyte solution, 
ε0 –electric permittivity in vacuum, η-dynamic viscosity of the liquid, ζ-zeta-potential 
[12]. 
 
 
 
Figure 1. Electrical double layer on gold nanoparticle surface. 
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3. Characterization of organic shell 
 The organic shell of AuNPs can be investigated by a variety of techniques, as 
nuclear magnetic resonance (NMR) and infrared (IR) spectroscopies, and 
thermogravimetric analysis (TGA). The data obtained with most of these 
measurements represent average parameters because the materials examined are 
typically polydispersed samples. 
3.1. ATR-FTIR spectroscopy 
 FTIR spectroscopy is widely used for characterizing the secondary structure of 
proteins and peptides. Recently, FTIR spectroscopy has been used for studying the 
interactions between nanoparticles and organic molecules: both the binding sites and 
conformational changes [13-16].  
 ATR-FTIR analysis was performed on a Biorad FTS-40 spectrometer 
equipped with a Specac Golden Gate ATR platform with a diamond crystal. The 
spectra of free ligands were recorded in the solid state, while the AuNPs were 
analyzed throughout the formation of a colloidal thin film structured on the ATR 
crystal surface. 
3.2. NMR spectroscopy 
 NMR spectroscopy is another potential tool in studying the interactions 
between ligand shell and nanoparticle surface: shielding and/or deshielding of the 
proton resonances indicates an interaction or a conformational rearrangement in 
organic molecule bound to the gold surface. It is possible that a strong NMR signal 
broadening is observed in the spectra of gold nanoparticles.  
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This is the combined result of several factors: (1) the solid-like appearance of gold 
nanoparticles-the groups closest to the gold surface are more densely packed and 
thereby experience fast spin relaxation from dipolar interaction, similar to solid-state 
samples; (2) the distribution of chemical shifts-the site where the molecules are 
connected to the gold core has specific influence on the chemical shift of the 
neighboring groups, thereby causing a substantial broadening of the resonance for 
the groups closest to the site [17].  
 In present study, since the total amount of organic molecules on the particle 
surface is very low comparing to free organic substance, the samples for NMR 
analysis were prepared scaling up the molar amounts of every reagent in order to 
obtain a highly concentrated sol, for a better spectra resolution. The resulting sols  
were lyophilized, and redispersed in a H2O/D2O (90:10) mixture in case of peptides 
coated nanoparticles and in D2O in case of nucleic acid components, prior to 
analysis.  
 NMR spectra were collected at 25 °C using both Bruker Avance 400 MHz and 
a Varian UNITY INOVA 600 MHz spectrometer equipped with a cold probe. Proton 
resonances of free peptides were assigned using a standard protocol based on the 
comparison of 2D [1H, 1H] TOCSY [18] (mixing time: 70 ms) and 2D [1H, 1H] 
ROESY [19] (mixing times: 150 and 200 ms) experiments. 2D experiments for 
resonance assignments were generally recorded with 16 scans, 128-256 FIDs in t1, 
1024 or 2048 data points in t2. 
 NMR spectra of Au-peptides NPs were recorded with 1024 scans for 1D and 
256 scans for 2D experiments, respectively.  
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Water signal was suppressed by means of either the WATERGATE PFG18 or the 
DPFGSE (Double Pulsed Field Gradient Selective Echo) techniques. Proton 
resonances were referenced to the water signal at 4.75 ppm. The spectra were 
processed with the Varian software VNMRJ 1.1D and analyzed with NEASY as 
implemented in CARA.  
3.3. TGA analysis 
 Although it is an extremely valuable technique for surface characterization of 
nanoparticles, it is not commonly applied in the literature. The information one can 
retrieve from TGA measurements is bipartite. First of all, TGA allows us to determine 
the bonding strength of the ligand to the nanoparticles’ surface and its thermal 
stability. Typically, ligands that are bound more strongly desorb at higher 
temperatures. Second, TGA provides direct information about the quantity of organic 
components on the AuNP, by measuring the total mass loss under gradual heating of 
dry nanoparticles. The advantage of this technique is that it can be applied to any 
kind of hybrid organic-inorganic nanostructures, even when dealing with a very small 
amount of the organic material present on the nanoparticle surface. The ligand 
coverage can be calculated using the following equation 
 
, 
 
 
Chapter II  
 
 
54 
where N is the number of ligands on each particle, R is the mean radius of the 
AuNPs, ρ is the density of the nanoparticles (19.30 g/cm3), NA is Avogadro’s number, 
MM is the molar mass of the ligand molecules (g/mol) and ω is the mass loss in 
percent (%) [20.]  
TGA analyses were performed on Perkin-Elmer 7 HT thermo-balance. AuNPs 
were prepared scaling up the amounts of reagents in order to obtain about 10-3 mmol 
of organic molecules in the resulting sols. The sols were lyophilized and 
subsequently washed several times with mQ water and centrifuged at 2000 rpm for 5 
min. The resulting dark brown powders were used for TGA measurements. The 
samples were maintained at 120 °C, under isothermal conditions for 1 h to remove 
any residual water and then ramped at 5 °C/min to 900 °C. 
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4. Biological experiments 
U87 human glioblastoma and HeLa cervical cancer cell lines were used for 
biological experiments.  
4.1. Cell culture 
The U87 cells were cultured in 3 cm Petri dishes at 37 °C in a humidified 
atmosphere of 5% CO2 in Dulbecco’s Modified Eagle Medium (DMEM) cell culture 
media, supplemented with 10% heat-inactivated fetal calf serum, 1% penicillin-
streptomycin, and 2×10-3 M L-glutamine. Cells were typically grown to 80% 
confluence before splitting and re-seeding at 40–50% confluence the day before an 
uptake experiment. The uptake experiments were carried out at approximately 80% 
confluence. 
HeLa cells were cultured in 3 cm culture Petri dishes at 37 °C in a humidified 
atmosphere of 5% CO2 in Dulbecco’s Modified Eagle Medium (DMEM) cell culture 
media containing 10% heat-inactivated fetal bovine serum, 1% penicillin-
streptomycin, and 1% non-essential amino acid solution. Passages 5–25 were used 
for the experiments; cells were typically grown to 80% confluence before splitting and 
re-seeding at 40–50% confluence the day before an uptake experiment. The uptake 
experiments were carried out at approximately 80% confluence. 
4.2. TEM on the cells 
TEM can visualize internal subcellular structures from thin sliced cells. Since 
many biological molecules may not have a rigid structure or density capable of 
scattering high velocity electrons, the electrons simply pass through the molecules 
and are therefore not visible in the resulting images.  
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Embedding in epoxy resin can be used to render some biological molecules 
sufficiently structured to scatter electrons and be visible in TEM micrographs. TEM 
allows detection of nanoparticles in biological materials (tissue specimens or cell 
culture samples) and visualization of fine cellular structures (details of subcellular 
organelles such as mitochondria, endoplasmic reticula, Golgi, centrioles, 
microtubules, endosomes, and ribosomes). 
Figure 1 shows a schematic illustration of TEM samples preparation. To 
prepare the samples for epoxy resin embedding, immediately after incubation, the 
cells were fixed by addition of 4% para-formaldehyde/2.5% glutaraldehyde in 0.1 M 
phosphate buffer pH 7.4 (0.7 mL) for 1 h. Then the cells were rinsed with PBS buffer, 
postfixed using 1% aqueous solution of OsO4 (0.5 mL) for 1 h. Subsequently, the 
cells were washed with Milli-Q H2O, 30% ethanol solution, and stained with 0.5% 
uranyl acetate (0.5 mL, in 30% ethanol) for 1h (Caution, extremely toxic!). Cells were 
then gradually dehydrated using a series of ethanol solutions (30, 60, 70, 80, and 
100%) and embedded in epoxy resin. The resin was polymerized at 60 °C for 48h. 
Ultrathin sections (70–100 nm) were cut using a diamond knife on a Leica 
Ultramicrotome and mounted on Formvar-coated copper grids (200 mesh). The 
sections were then post stained with 5% uranyl acetate in 50% ethanol and 2% 
aqueous lead citrate solution and imaged with an FEI Tecnai Spirit TEM at 100 kV 
using AnalySIS software (Soft Imaging Systems). 
4.3. Confocal microscopy 
 Confocal microscopy is one of the most important cellular analysis techniques 
and has been used with considerable success in the real-time observation of cells. 
Normally, molecular fluorescent probes are employed to label the cells to be 
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observed [21]. However, AuNPs can be a promising tool as contrast agent for cellular 
labeling due to their optical properties [22]. 
 Confocal microscopy studies on the cells were performed by a Leica TCS-NT 
instrument using reflected-light optics at a magnification of 63× (1.53 NA Plan-
Apochromat). The samples were illuminated with a 488 nm Argon/Krypton laser, 
using an intensity of AOTF filter by 10%. A neutral filter RT 30/70 was used as beam 
splitter and placed at a 45° angle in the path of beam. 
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Figure 1. Schematic illustration of TEM cell sample preparation procedure. 
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1. Introduction 
 The interaction of DNA with metal nanoparticles has found diverse 
applications in the recent advancements of nanobiotechnology [1-12]. Of particular 
interest is the DNA-gold interaction which forms the basis of several diagnostics 
applications involving DNA detection employing such techniques as surface plasmon 
resonance spectroscopy (SERS), electrochemical, colorimetric detection, etc [13-17]. 
DNA molecule adsorbed on gold films, gold electrodes, or DNA coated with gold 
nanoparticles have been reported to have applications in the field of electronics, 
sensors, drug delivery, chips, imaging, etc [18, 19]. 
 The nucleobases are nitrogenous ring compounds consisting of either purine 
or pyrimidine derivatives. A purine is a fused-ring compound containig one 6-
membered ring attached to a 5-membered ring, whereas a pyrimidine consists of a 
single 6-membered ring structure (Figure 1). Adenine, guanine, thymine, and 
cytosine are the four main base constituents found in DNA. Nucleic acid sugar 
residues are attached to the associated base units in an N-glycosidic bond, involving 
N-1 nitrogen of pyrimidine bases or the N-9 nitrogen of purines directly linked to the 
C-1 carbon of the monosaccharide derivative to give a nucleoside (Figure 2). In DNA, 
the sugar group consists of a β-D-2-deoxyribose unit.  A nucleotide consists of a 
base and a sugar plus a phosphate group. In each nucleotide monomer of DNA, a 
phosphate group is attached to the C-5 hydroxyl of each sugar residue in an ester 
(anhydride) linkage.  
With the development of DNA microarray techniques there has been particular 
interest in understanding the nature of the interaction of the DNA molecules with the 
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Figure 1. The pyrimidine (a) and purine (b) ring structures common to nucleic acids. 
 
 
 
 
Figure 2. The formation of an N-glycosidic bond links the base unit of nucleic acids to the 
associated ribose derivative. 
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gold surface. To build a model of the complex DNA-gold interactions, one should first 
understand the interactions involving every single DNA fragment (adenine, guanine, 
thymine and cytosine) and AuNPs. The strength of the interactions appears to be 
very sequence-dependent [20-23].  
 
 
 
Figure 3a. Structural formula of nucleobases, nucleosides and nucleotides: adenine (1), 
guanine (2), cytosine (3). thymine (4), adenosine (5), guanosine (6), cytidine (7), thymidine (8), 
adenosine 5`-monophosphate (9), guanosine 5`-monophosphate (10), cytidine 5`-
monophosphate (11) and thymidine 5`-monophosphate (12). 
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Demers et al. have studied the interaction of nucleic acid bases and nucleosides with 
gold surfaces using the temperature-programmed desorption and reflection 
absorption Fourier transform infrared spectroscopic techniques. They have found that 
desorption from the gold surface takes place at lower temperature for pyrimidine 
bases (thymine and cytosine) than for purine bases (guanine and adenine) (Figure 
3a). Consequently, the measured desorption was revealed in the order 
thymine<cytosine<adenine<guanine. Kryachko and Remacle [24, 25] have 
investigated the interaction of small gold clusters with nucleic acid bases and base 
pairs at the density functional theory level. In these experiments, the interaction 
energies of small gold clusters with different sites of bases, proton affinity, and 
deprotonating affinity were evaluated, and, thus, the most probable site for binding 
with gold was determined. They have found that gold interacts with oxygen and 
nitrogen centres and revealed the presence of NH---Au hydrogen bonding. 
  
 
 
Figure 3b. Structural formula of 1-methylguanosine (1), inosine (2) and 8-bromoguanosine (3): 
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2. Synthesis of AuNPs 
2.1. Synthesis of nucleobase capped AuNPs 
The solutions were prepared freshly for each synthesis, except for sodium 
tetrachloroaurate (III), which was prepared as a 34.1 mM stock solution. Being 
nucleobases insoluble in water at room temperature, the stock solutions were 
prepared by dissolving in the 0.01 M NaOH, following by dilution with water up to 
necessary concentration. All the glass vessels and stirrers were washed with aqua 
regia (Caution! Extremely corrosive), and the solutions were filtered through 0.22 µm 
cellulose filter prior to use in order to avoid undesirable nucleation. 
The molar ratios between the reagents are reported in Table 1. In a typical 
reaction, to 5 mL of Milli-Q water, an aqueous solution of NaAuCl4 (2·10-3 mmol; 34.1 
mM) was added. Under vigorous stirring, an aqueous solution of adenine (6·10-6 
mmol, 3.95 mM), guanine (8·10-6 mmol, 0.909 mM), cytosine (1.8·10-5 mmol, 5.09 
mM) or thymine (8·10-6 mmol, 4.48 mM) was added. After 5 minutes, an aqueous 
solution of NaBH4 was added (4 µmol; 0.1M) and red sols were immediately formed. 
The obtained colloidal solutions were left under stirring several hours to complete the 
reaction. The particles were purified by dialysis overnight (Sigma-Aldrich Dialysis 
tubing cellulose membrane, cut off 12.400 MW) or by repeated centrifugation. 
 
2.2. Synthesis of nucleoside capped AuNPs 
The molar ratios between the reagents are reported in Table 2. In a tipical 
reaction, to 5 mL of Milli-Q water, an aqueous solution of NaAuCl4 (2·10-3 mmol; 34.1 
mM) was added. Under vigorous stirring, an aqueous solution of adenosine (9·10-6 
mmol, 2.53 mM), guanosine (1·10-5 mmol, 0.42 mM), cytidine (1·10-5 mmol, 2.77 
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mM), or thymidine (1.4·10-5 mmol, 2.3 mM ) was added. After 5 minutes, an aqueous 
solution of NaBH4 was added (4 µmol; 0.1M) and red sols were immediately formed. 
The obtained colloidal solutions were left under stirring several hours to complete the 
reaction. The particles were purified by dialysis overnight or by repeated 
centrifugation.  
 
Table 1. Molar ratios between Au (III), nucleobases and sodium borohydride used for 
the synthesis of AuNPs. 
 
Stabilising agent Au (III): nucleobase: NaBH4 
Adenine 1:0.001:1 
Guanine 1:0.006:2 
Cytosine 1:0.003:2 
Thymine 1:0.002:2 
 
 
Table 2. Molar ratios between Au (III), nucleosides and sodium borohydride used for the 
synthesis of AuNPs. 
 
Stabilising agent Au (III): nucleoside: NaBH4 
Adenosine 1:0.003:2 
Guanosine 1:0.005:2 
Cytidine 1:0.005:2 
Thymidine 1:0.007:2 
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2.3. Synthesis of nucleotide capped AuNPs 
The molar ratios between the reagents are reported in Table 3. In a typical 
reaction, to 5 mL of Milli-Q water, an aqueous solution of NaAuCl4 (2·10-3 mmol; 34.1 
mM) was added. Under vigorous stirring, an aqueous solution of adenosine 5`-
monophosphate (6·10-6 mmol, 1.1 mM), guanosine 5`-monophosphate (6·10-4 mmol, 
1.18 mM), cytidine 5`-monophosphate (1.25·10-6 mmol, 0.925 mM), or thymidine 5`-
monophosphate (2·10-5 mmol, 1.3 mM) was added. After 5 minutes, an aqueous 
solution of NaBH4 was added (4 µmol; 0.1M) and red sols were immediately formed. 
The obtained colloidal solutions were left under stirring several hours to complete the 
reaction. The particles were purified by dialysis overnight or by repeated 
centrifugation.  
 
2.4. Synthesis of AuNPs capped by guanosine derivatives 
1-methylguanosine and 8-bromoguanosine were synthesized as reported in 
ref. 25. The molar ratios between the reagents are reported in Table 4. In a tipical 
reaction, to 5 mL of Milli-Q water, an aqueous solution of NaAuCl4 (2·10-3 mmol; 34.1 
mM) was added. Under vigorous stirring, an aqueous solution of 1-methylguanosine 
(1·10-5 mmol, 0.272 mM), 8-bromoguanosine (2·10-5 mmol, 0.263 mM) or inosine 
(1·10-5 mmol, 0.69 mM) was added. After 5 minutes, an aqueous solution of NaBH4 
was added (4 µmol; 0.1M) and red sols were immediately formed. The obtained 
colloidal solutions were left under stirring for several hours to complete the reaction. 
The particles were purified by dialysis overnight.  
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Table 3. Molar ratios between Au (III), nucleotides and sodium borohydride used for the 
synthesis of AuNPs. 
 
Stabilising agent Au (III): nucleoside: NaBH4 
Adenosine 5`-monophosphate 1:0.003:2 
Guanosine 5`-monophosphate 1:0.3:2 
Cytidine 5`-monophosphate 1:0.08:2 
Thymidine 5`-monophosphate 1:0.01:2 
 
 
Table 4. Molar ratios between Au (III), guanosine derivatives and sodium borohydride 
used for the synthesis of AuNPs. 
 
Stabilizing agent Au (III): ligand: NaBH4 
Au-8-bromoguanosine 1:0.01:2 
Au-Inosine 1:0.005:2 
Au- 1-methylguanosine 1:0.005:2 
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3. Results and discussion 
We prepared small water-soluble AuNPs following “one-pot” approach, where 
a gold salt aqueous solution was reduced by sodium borohydride in the pгesence of 
purine and pyrimidine derivatives as capping ligands (Figure 2, 3). The molar ratios 
between the ligands, gold salt and sodium borohydride were varied in the preliminary 
experiments in order to find out the reaction conditions at which the resulting AuNPs 
possess a number of characteristics we were interested in, such as particle size and 
stability. These experiments were based on changing the molar amount of organic 
ligand to be added to the gold precursor, and following the reaction progress by UV-
vis spectroscopy. Both shape and position of SPR band, along with the colour of 
resulting colloidal dispersions were an indication of stability and certain particle size. 
Relying on these facts, we selected the ratios reported in Table 1-4 which were used 
in further experiments. 
Besides UV-vis spectroscopy used for preliminary studies of AuNPs stability, 
we employed Dynamic Light Scattering and Z-potential measurements in order to 
evaluate the particle electro-kinetic characteristics. The morphology was studied by 
TEM microscopy and the ligand shell interaction with gold was characterized by ATR-
FTIR, 1H- and 31P NMR spectroscopy.  
 As a result of gold nanoparticles formation, the characteristic SPR bands with 
the wavelengths varying between 516 and 531 nm, depending on the ligand used, 
were observed. The UV-vis spectra of functionalized AuNPs were constantly run from 
the moment of reducing agent addition until the absorbance of SPR band stopped 
growing. This indicated the completion of AuNPs formation.  
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The UV-vis spectra related to every kind of particles are reported in Figures 4-6, 
whereas SPR band values are reported in Table 5. 
 
Table 5. Comparison of SPR band values of AuNPs stabilized by nucleobases, 
nucleosides, nucleotides, and guanosine derivatives. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Au-ligand Plasmon band, nm 
Au-adenine 529 
Au-adenosine 525 
Au-adenosine 5`-monophosphate 531 
Au-guanine 524 
Au-guanosine 525 
Au-guanosine 5`-monophosphate 525 
Au-thymine 517 
Au-thymidine 516 
Au-thymidine 5`-monophosphate 517 
Au-cytosine 529 
Au-cytidine 527 
Au-cytidine 5`-monophosphate 523 
Au-8-bromoguanosine 519 
Au-inosine 519 
Au- 1-methylguanosine 519 
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 TEM results indicate the diameter of the particles to vary from 6 to 35 nm: 
the largest nanoparticles of 35 nm were obtained using adenosine 5`-
monophosphate as capping agent, while the smallest ones of 6 nm were produced 
both with guanosine 5`-monophosphate and cytidine and corresponding nucleotide, 
which indicates a dependence of the size from the ligand nature and its amount per 
nanoparticles. 
The shape of the nanoparticles was found nearly spherical, except for several 
cases when the nanoparticles had an ovate shape. TEM images and diagrams of 
mean particle diameter distributions are reported in Figure 7-9. Small nanoparticle 
agglomerates were detected in several TEM images, while the nanoparticles capped 
by guanosine derivatives were found to form chain-like structures likely due to charge 
loss (Figure 8, a-c).  
 One pot synthesis does allow obtaining the nanoparticles of quite small sizes, 
because of the reducing agent used to reduce gold ions to Au (0). Sodium 
borohydride is considered a strong reducing agent, able to quickly reduce metal ions 
to metal nanoparticles [26-28]. 
Dynamic Light Scattering studies supports TEM results, showing the presence 
of fractions with larger mean diameters (34-95 nm), arising from the formation of 
small particle agglomerates (Table 6). Despite the presence of agglomerates, they do 
not bring about any nanoparticle aggregation.  
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Figure 4. UV-vis spectra of a) adenine, b) guanine, c) cytosine, d) thymine, e) adenosine, f) 
guanosine, g) cytidine and h) thymidine: SPR band values were recorded every 15 min until 
their absorbance value was constant. 
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Figure 5. UV-vis spectra of a) adenosine 5`-monophosphate, b) guanosine 5`-monophosphate, 
c) cytidine 5`-monophosphate and d) thymidine 5`-monophosphate: SPR band values were 
recorded every 15 min until their absorbance value was constant. 
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Figure 6. UV-vis spectra of a) 1-methylguanosine, b) inosine and c) 8-bromoguanosinee: SPR 
band values were recorded every 30 min until their absorbance value was constant. 
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Table 6. Hydrodynamic diameter obtained by Dynamic Light Scattering and core diameter of 
nanoparticles obtained by TEM.  
Au-ligand Diameter (DLS), nm Diameter (TEM), nm 
Au-adenine 18 12 
Au-adenosine 19 (90) 16 
Au-adenosine 5`-monophosphate 39 35 
Au-guanine 19 (95) 16 
Au-guanosine 16 (64) 16 
Au-guanosine 5`-monophosphate 24 6 
Au-thymine 13 11 
Au-thymidine 32 16 
Au-thymidine 5`-monophosphate 12 (83) 10 
Au-cytosine 15 (84) 15 
Au-cytidine 15 (54) 6 
Au-cytidine 5`-monophosphate 9 (34) 6 
Au-8-bromoguanosine 27 13 
Au-inosine 28 10 
Au- 1-methylguanosine 23 13 
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Figure 7. TEM images and diameter distributions of: a) Au-adenine, b) Au-adenosine, c) Au-
adenosine 5`-monophosphate, d) Au-guanine, e) Au-guanosine and f) Au-guanosine 5`-
monophosphate NPs. 
To evaluate the particle charge and stability, we employed zeta-potential 
approach. Zeta potential measurements can be a convenient tool which allows 
chemical reactions to be quickly monitored on particles with minimal sample 
preparation [29]. Zeta-potential, being easily calculated from measured particle 
mobility, can be used to derive information concerning the particle surface charge, 
and, hence, chemical composition. The values obtained for each kind of particle, are 
reported in Table 7. For comparison, we report the zeta-potential value of “bare” 
nanoparticles, i.e. those without any specific ligand surrounding the nanoparticle.  
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Figure 8a. TEM images and diameter distributions of: a) Au-1-methylguanosine, b) Au-8-
bromoguanosine and c) Au-inosine NPs. 
 
Figure 8b. TEM images and diameter distributions of: a) Au-cytosine, b) Au-cytidine, c) Au-
cytidine 5`-monophosphate, d) Au-thymine, e) Au-thymidine and f) Au-thymidine 5`-
monophosphate NPs. 
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The “bare” nanoparticles were prepared by using the same amounts of gold 
salt and reducing agent used in a typical reaction, leaving out the ligand. Since the 
“bare” nanoparticles tend to quickly aggregate due to the absence of a stabilizing 
shell, the zeta-potential measurement was performed using a freshly formed sol. As-
prepared “bare” AuNPs shows a positive zeta-potential value of +11.04 mV. On the 
other hand, all the capped particles are negatively charged showing negative zeta-
potential values. Notably, the particles capped by nucleobases and nucleosides show 
similar zeta-potential values around -20-23 mV, indicating that sugar does not greatly 
contribute to the particle charge. On the other hand, the particles capped by 
nucleotides show very negative values close to -50 mV, indicating a contribution of 
the phosphate moiety in the stabilization of the AuNPs. The only exception is Au-
adenosine 5`-monophosphate NPs, which show a zeta-potential close to the zero, 
that, probably, is explained by the charge loss during the measurements. 
 The electro-kinetic characteristics of some nucleosides and nucleotides have 
been studied elsewhere [30, 31]. Brook et al. have discovered that, under given 
reaction conditions, the AuNPs capped by adenosine phosphates are stable and 
possess negative zeta-potentials, while AuNPs functionalized by nucleosides (e.g. 
adenosine or inosine) undergo aggregation caused by surface charge loss. In our 
case the adenosine 5`-monophosphate capped AuNPs seem to undergo a charge 
loss under electric field applied, having the zeta potential close to the zero. While 
inosine-AuNPs do show a charge loss under electron beam effect (Figure 8, c). The 
zeta-potential values of the AuNPs capped by “thymine-family” molecules followed 
the order Au–thymine< Au–thymidine< Au-thymidine 5`-monophosphate increasing 
along with the AuNPs hydrodynamic diameter.  
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The rise in the zeta-potential value can be associated with the formation of small 
nanoparticle arrangements, causing a light scattering increase and a mobility bias by 
the largest particles in the poly-dispersed sample [32]. Nevertheless, it is well known 
that the interpretation of the f-potential values of ‘‘uncapped’’ particles, with sizes in 
the 5–100 nm range, represents a delicate challenge. 
Table 7. Zeta potential values of the nanoparticles. 
Au-ligand Zeta-potential, mV 
“Bare” Au NPs +11.04 
Au-adenine -25.29 
Au-adenosine -26.51 
Au-adenosine 5`-monophosphate -0.59 
Au-guanine -25.55 
Au-guanosine -21.56 
Au-guanosine 5`-monophosphate -47.56 
Au-thymine -40.63 
Au-thymidine -49.17 
Au-thymidine 5`-monophosphate -51.71 
Au-cytosine -21.47 
Au-cytidine -21.19 
Au-cytidine 5`-monophosphate -51.39 
Au-8-bromoguanosine -16.78 
Au-inosine -22.07 
Au- 1-methylguanosine -20.25 
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Therefore, the ligand-coated NPs provide further complexity, because the 
hydrodynamic size and surface-charge shielding depend on the ligand conformation 
[33]. 
In order to understand in which form (neutral or protonated) the molecules 
exist in the solution under given conditions, we measured pH values during the 
reaction progress: the pH of the starting solutions, before adding sodium 
borohydride, was quite acidic (pH 2.5-2.7), while the pH of the formed sols was close 
to 3.5-3.7 (likely due to traces of HAuCl4 present in the NaAuCl4 solution). 
Afterwards, we calculated the values of concentration fractions (α) as function of pH, 
using the acidity constant logarithms, pKa. From these, one can readily calculate an 
approximate ionization state of the species at any pH value in aqueous solution [34]. 
The summary of pKa and α values at pH 3.5 is reported in Table 8. 
 Concentration fraction α were calculated from the following equations: 
considering for the molecules with three different pKa values known: 
 
[H3B+] – mono-protonated form, 
[H2B+] – neutral form, 
[HB+] – mono-deprotonated form, 
[B] – fully deprotonated form 
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While for the molecules with two different pKa values known:  
[H2B+] – mono-protonated form, 
[HB+] - neutral form, 
[B] – mono-deprotonated form. 
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 The patterns of concentration fraction values (α) as function of pH are reported 
in Appendix. Table 8 reports the pKa values and corresponding 
protonation/deprotonation sites of each molecule, along with the percentage of 
protonated and neutral form existing at given conditions. The majority of the 
molecules exist both in mono-protonated and neutral state. Only adenosine 5’-
monophosphate exists in bi- and triprotonated state: both at N1, N3, N7 atoms and 
N1, N7 atoms, respectively. On the other hand, thymine, thymidine and 
corresponding nucleotide are mostly nonprotonated (neutral) at given conditions. The 
same is for guanosine derivatives, which exist mostly in neutral form. 
  
Chapter III  
 
 
85 
The protonation state of the molecules influences directly their spectroscopic 
characteristics and the way they interact with gold surface. Besides this, the variety 
of existing tautomeric forms of nucleic acid bases is believed to affect their 
spectroscopic data, such as infrared and NMR spectral line shapes. Moreover, 
tautomers of nucleic acid bases are believed to be involved in many different 
biochemical processes, including point mutations [35]. Their presence in 
biomolecules can alter cell functions and contribute to carcinogenic behaviour. In 
biological systems, nucleic acid bases are dominantly present in the stable canonical 
form. The adenine bases have been shown to exist in 14 different tautomeric forms 
by shifting one or two protons to a different nitrogen atom [35]. A recent  
 
Table 8. pKa values and estimated protonation states at pH 3.5. 
 
Ligand 
Protonatio/deprotonation 
site 
pKa Concentration fraction α, % 
Adenine N1 4.15 78% Ade N(1)H+ 
22% Ade N9 9.80 
Adenosine N1 3.3 50% Ado N(1)H+ 
50% Ado N9 12.5 
Adenosine 5’-
monophosphate 
N1 1.75 41% 5’-AMP N1(H)+ N3(H)+ 
N7(H)+ 
59% 5’-AMP N1(H)+ N7(H)+ 
N3 3.74 
Guanine N7 3.3 
40% Guo (N7)H+ 
60% Guo 
N1 9.2 
N9 12.3 
Guanosine 
N7 2.2 4% Gua (N7)H+ 
96 % Gua N1 9.5 
Guanosine 5’-
monophosphate 
N7 2.4 6% 5’-GMP (N7)H+ 
94 % 5’-GMP N1 9.4 
Cytosine 
N3 4.45 89% Cyt N3(H)+ 
11% Cyt N1 12.2 
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Cytidine 
N3 4.22 78% dCyt N3(H)+ 
22% dCyt N1 12.5 
Cytidine 5’-
monophosphate 
N3 4.5 90.9% 5’-CMP N3(H)+ 
9.9 % 5’-CMP 
Thymine 
O4 0.9 
100% Thy N3 9.8 
N1 13 
Thymidine N3 9.69 100% dThy 
Thymidine 5’-
monophosphate 
O4 1.6 1% 5’-TMP (O4)+ 
99% 5’-TMP N3 10 
Inosine 
N7 1.2 1% Ino (N7)H+ 
99% Ino N1 8.7 
M1G 
N7 2.44 6% M1G N(7)H+ 
94% M1G NH2 13.22 
8-Br-Gua 
N7 1.55 1% 8-Br-Gua N(7)H+ 
99% 8-Br-Gua N1 13.00 
 
 
theoretical study performed by Hobza et al. shows that the adenine tautomers may 
also exist in water [36]. Guanine also has several tautomeric forms, the stability of 
which is significantly influenced by the reaction medium. The reported IR studies 
reveal that both keto- and enol- guanine tautomers are present in equal proportions 
in solution, although the keto-N(9)-H form dominates in polar solvents [37].  
 Some structural investigations of the ligand shell surrounding gold 
nanoparticle have been already performed by infrared techniques to characterize the 
ligand-gold interactions. In particular, Mirkin and co-workers have used the 
temperature-programmed desorption method to study the interactions of DNA bases 
and nucleosides with a gold thin film, deposited on a flat support. The scientists have 
shown that nucleobases bind to the gold surface in a highly complex manner, with 
each base behaving differently.  
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However, a common behaviour has been found: none of the four nucleobases 
adsorb on gold in an orientation where the plane of the ring is perfectly parallel to the 
gold surface. Instead, all four molecules appear to be oriented with the molecular 
plane at an angle with respect to the gold surface [38]. Pergolese et al. have studied 
the adsorption of guanine, guanosine and 2′-deoxyguanosine on gold colloidal 
particles by SERS spectroscopy, suggesting that the molecules are tilted respect to 
the gold surface and the sugar moiety is not involved in the interaction [39]. Finally, 
Kryachko et al. have discovered that the bonding between DNA bases and Au3,4 
clusters occurs via Au-N or Au-O bonds. Moreover, a novel type of nonconventional 
N-H---Au hydrogen bonding formed between nucleic acid bases and gold clusters 
has been identified [24]. 
 Besides infrared studies, 1H and 31P NMR spectroscopies have been widely 
used to study metal complexes with nucleobases or other nucleic acid components. 
Here, we apply this coordinative metallorganic approach to explain the interaction of 
the compounds under investigation with gold surface, comparing 1H NMR spectra of 
free molecules, with 1H NMR spectra of capped AuNPs [40, 41]. Since spectra 
resolution highly depends on the concentration of the molecule under investigation, in 
order to scale up the amount of the ligands in the nanoparticle suspension, very 
concentrated colloidal solutions were synthesized, freeze-dried and re-dispersed in 
D2O just before the analyses.  
 In theory, the gold core can interact with the ligands in many ways: via 
phosphate oxygen atoms, sugar oxygen atoms, and (N, C, O) atoms of the 
heterocyclic base; or combinations thereof [40].  Here we discuss the binding of 
nucleobases, nucleosides and nucleotides to the gold nanoparticle surface.  
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The discussion is organized as follows: first, we concern guanine, corresponding 
nucleoside and nucleotide, along with guanine derivatives, comparing the NMR and 
FTIR results on the binding sites between these molecules and gold surface. Then, 
we consider adenine “family”, followed by thymine and cytosine compounds.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter III  
 
 
89 
3.1. Spectroscopic study of the binding between nucleobases, 
nucleoside and nucleotides and AuNPs 
 
3.1.1. Guanine and its derivatives.  
Guanine N(7) atom possesses a high basicity and a favourable electrostatic 
potential to be the target for the metal coordination. A large dipole moment of 
guanine and its orientation does allow the coordination of any positively charged 
metal entity to this site [40].  
 A comparison of 1H and 31P chemical shifts of the free guanine, guanosine, 
guanosine 5’-monophosphate, 1-methylguanosine, 8-bromoguanosine and inosine, 
and corresponding capped AuNPs, is reported in Table 9 (an expanded version of 
the Table 9 is reported in Appendix). At pH 3.5, H8 signal of free guanine moves 
downfield as the N7 atom protonation causes an electron density to be withdrawn 
from H8, in accordance with α data. The proton resonances of all the purine 
derivatives, except for guanine, are not much affected  
 
Table 9. 1H and 31P chemical shift values of the free ligands at pH 3.5 and after interaction with 
AuNPs. 
 Mult Δ Mult Δ 
 Ino Au-Ino 
H2 s 8.24 s 8.42-8.19 
H8 s 8.12 s 
H1’ d 6.00 d 6.20-6.07 
H2’ Burried under H2O signal 
H3’ dd 4.36 dd 4.41 
H4’ dd 4.20 dd 4.25 
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H5’ dd 
dd 
3.85 
3.77 
dd 
dd 
3.96 
3.81 
 Gua Au-Gua 
H8 s 7.98 s 8.28 
 Guo Au-Guo 
H8 s 7.96 s 7.90 
H1’ d 5.86 d 5.59 
H2’ Burried under H2O signal 
H3’ dd 4.35 dd 4.40| 
H4’ q 4.17 q 4.01 
H5’ dd 3.82 
3.76 
dd 3.82 
3.65 
 5’-GMP Au-5`-GMP 
H8 s 8.09 s 8.58 
H1’ d 5.85 d 5.86 
H2’ Burried under H2O signal 
H3’ dd 4.42 dd 4.42 
H4’ q 4.25 q 4.32 
H5’ dd 3.96 dd 4.11 
P s 2.87 s 0.34 
 M1G Au-M1G 
H8 s 7.92 s 7.99 
H1’ d 5.85 d 5.88 
H2’ Burried under H2O signal 
H3’ dd 4.35 dd 4.39 
H4’ q 4.17 q 4.24 
H5’ d 
d 
3.82 
3.76 
d 
d 
3.84 
3.82 
CH3 s 3.41 s 3.46 
 8-Br-Gua Au-8-Br-Gua 
H1` s 5.81 s --- 
H2` dd 4.91 dd --- 
H3` dd 4.28 dd 4.15 
H4` q 4.17 q 3.95 
H5` d 
d 
3.82 
3.75 
d 
d 
3.73 
3.68 
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Abbreviations: Ino-inosine, Gua-guanine, Guo-guanosine, 5’-GMP-guanosine 5’-monophosphate, 8-
Br-Guo-8-bromoguanosine, M1G-1-methylguanosine 
______________________________ 
by acidic pH and do not change considerably. On the contrary, the phosphate moiety 
suffers by the acidic medium and the value of 31P chemical shift of 5’-GMP did 
change from 3.96 to 2.87 ppm with pH moving from physiological to 3.5. The change 
can be attributed to the mono protonation of oxygen anion (pKa~6.3) [42]. Analysing 
1H NMR spectrum of Au-guanine NPs, we observed the H8 signal (8.28 ppm), 
shifted downfield more than that of free neutral molecule (7.65 ppm, δ = 0.63 ppm) 
and even more than that of free guanine in acidic conditions (7.98 ppm, δ = 0.3 ppm) 
(Figure 9).  
 
Figure 9. a) 1H NMR spectra of free guanine in D2O+CD3COOD in the 8.2-7.4 ppm region, b) 1H 
NMR spectra of Au-guanine NPs in the 8.5-7.1 ppm region. 
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The change is attributable to the electron density variation of the ring system, 
as a result of the gold interaction with the N7 lone pair of not-protonated guanine. 
The effect appears stronger than the deshielding effect observed upon protonation, 
suggesting an interaction of the basic guanine with a partially positive site on AuNPs 
(i.e. Au(+I) centres on gold surface). The protonated guanine species, if present, 
does not seem to interact with the particle, considering the presence of only one H8 
signal in the 1H NMR spectrum of Au-guanine NPs. 
 In 1H NMR spectrum of Au-guanosine NPs, H8 proton at 7.96 ppm is slightly 
upfield shifted (δ = 0.06 ppm, respect to acidic condition), indicating an interaction of 
N7 atom with Au less strong than in Au-guanine NPs. On the contrary, the H1’-H5’ 
sugar proton signals are broadened, with H1` and H4` signals being significantly 
upfield (δ H1`= 0.27 ppm; δ H4`= 0.16 ppm) compared with the values of guanosine 
at the same pH (Figure 10). The variations of ribose suggest eventual changes in its 
conformation upon interaction with Au. 
 1H NMR spectrum of Au-guanosine 5’-monophosphate NPs (Figure 11), 
shows a downfield shift of the H8 signal at 8.09 ppm (δ = 0.49 ppm, with respect to 
the acidic condition). The H1’-H4’ signals of ribose are broadened and slightly 
downfield, and only the H5’ signal undergoes a really significant change (δ = 0.15 
ppm), likely, due to its proximity to the phosphate group. Indeed, 31P NMR revealed a 
δ P value drastically upfield (from 2.87 to 0.34 ppm) upon formation of AuNPs, 
indicating a strong interaction with Au (Figure 12). The interactions of 5’-GMP and 
metal centres throughout purine N7 atom and oxygen atom(s) of the phosphate 
group has been already reported elsewhere in metal coordination complexes [40]. 
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Figure 10. 1H NMR spectra of free guanosine in D2O+CD3COOD: a) in the 8.5-5.5 ppm region; b) 
in the 5.0-3.0 ppm region; 1H NMR spectra of Au-guanosine NPs in c) 8.5-5.0 ppm region; d) 
4.45-3.65 ppm region. 
 
Chapter III  
 
 
94 
  
 
 
 
Figure 11.  1H NMR spectra of free guanosine 5`-monophosphate in D2O+CD3COOD: a) in the 
8.5-5.5 ppm region; b) in the 5.0-3.0 ppm region; 1H NMR spectra of Au-guanosine 5`-
monophosphate NPs: c) in the 8.5-5.5 ppm region; d) in the 4.5-3.7 ppm region. 
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Figure 12. 31P NMR spectra of a) free guanosine 5-monophosphate; b) Au-guanosine 5`-
monophosphate NPs. 
 
 Figure 13 shows 1H NMR spectra of Au-1-methylguanosine NPs. Only little 
changes and broadening of ribose signals are revealed under interaction with 
AuNPs. The presence of methyl substituent in N1 does not provide information on 
the coordination of M1G to AuNPs, but NMR data suggest that ribose conformation is 
not affected by the presence of gold. On the contrary, interesting information can be 
obtained from 1H NMR spectrum of Au-8-bromoguanosine NPs, in which strongly 
upfield shifted signals of H3’-H5’protons have been observed (δ = 0.1-0.28 ppm). The 
H1’and H2’ signals even disappear from the usual region (Figure 14). Taking into 
account that substituted nucleosides (nucleotides) exist mainly as syn conformations, 
the torsional angle of the glycosidic bond in 8-Br-Guo can induce different ribose 
conformations to fulfil the interaction with Au surface. 
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Figure 13.  1H NMR spectra of free 1-methylguanosine in D2O+CD3COOD: a) in the 8.5-5.5 ppm 
region; b) in the 5.0-2.5 ppm region; 1H NMR spectra of Au-1-methylguanosine NPs: c) in the 
8.0-5.5 ppm region; d) in the 5.0-3.0 ppm region. 
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Figure 14. a) 1H NMR spectrum of free 8-bromoguanosine in D2O+CD3COOD in the 6.5-4.0 
region; b) 1H NMR spectrum of Au-8-bromoguanosine NPs in the 7.0-3.0 ppm region. 
 
 Finally, Figure 15 shows 1H NMR spectrum of Au-inosine NPs. It is clearly 
seen that a large number of signals appeared in the 8.4-8.2 ppm region making it 
more complicated, probably because of oligomer species formation, and/or side 
products. In the case of inosine, the electron density on aromatic rings does not allow 
its (or its oligomers’) simple and univocal coordination to Au surface, being N1 and 
N7 both prone to a binding with gold.  
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Figure 15. 1H NMR spectra of free inosine in D2O+CD3COOD: a) in the 8.5-5.5 ppm region; b) in 
the 5.0-3.0 ppm region; 1H NMR spectra of Au-inosine NPs: c) in the 8.5-5.5 ppm region; d) in 
the 5.0-3.5 ppm region. 
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To summarize, we have established that guanine N7 atom is involved in the 
interaction with gold surface, while ribose moiety seems free from the binding, 
undergoing some conformational rearrangements (Scheme 1). 
 
 
Scheme 1. A representation of the binding sites between guanine, guanosine and guanosine 
5`-monophosphate and gold nanoparticles. 
 
 To have a clear view of the changes of the ribose puckering taking place 
under interaction with gold, as well as to understand if other groups are involved in 
the interaction, we performed ATR-FTIR analysis. In this context, bands of amino- 
and carbonyl stretching vibrations are of great interest, as well as ring breathing 
vibrations of guanine moiety, that are useful to diagnose the ribose conformation [43]. 
Further, the spectra of free compounds are reported with a black line, while those of 
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capped AuNPs are shown with a red line. The tables of the most important data for 
each spectrum, and the attributed vibration values are reported in Appendix. 
Moreover, being a few individual bands strongly overlapped, for their better resolution 
we used the second derivative spectra, having a maximum at the same position as 
the original band, but smaller bandwidth [44]. 
 In the spectrum of Au-guanine NPs (Figure 16), a strong band at 3202 cm-1, 
attributed to the stretching modes of the N2-H2 group, is redshifted of 119 cm-1, 
suggesting its vertical orientation towards Au. The C6=O stretching decreased in 
intensity and shifted at lower frequencies with respect to the free molecule, indicating 
an elongation of C6=O bond, therefore its interaction via the oxygen lone pair or 
double bond. The drastic weakness of C=O stretching vibration should suggest a 
nearly parallel disposition of guanine with respect to Au surface, while the enhanced 
out of plane C-H bending indicates that an edge-on orientation does not take place, 
suggesting its tilting towards gold. In addition, analyzing the second derivative 
spectrum of Au-guanine, broad and intense peak, comprising ν (N7-C8) and ν (C5-
N7) appears after interaction with Au (Figure A3.1, Appendix) [44, 45]. Correlating 
NMR and FTIR data, guanine interacts with gold via its N7 lone pair and C=O double 
bond, being arranged in a bent position towards Au surface, stabilizing the particles.  
 Mirkin et al. have performed a temperature-programmed study supported by 
infrared-reflection absorption spectroscopy using a flat gold support with an adsorbed 
guanine monolayer. It has been found that guanine adsorbs onto a single site 
represented by two peaks. From the study, the strong C=O stretching peak observed 
at 1745 cm-1 peak suggests the molecular plane of guanine to be nonparallel with the  
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metal surface, thus, ruling out the possibility of a flat “belly-down” conformation, that 
go in accordance with our findings. 
 The spectrum of Au-guanosine appears to be significantly different from that 
of free molecule, because of the nanoparticle-induced changes in the structure of 
guanosine (Figure 17). Notably, the N2-H2 stretching vibrations almost disappear, 
while a very weak band at 2923 cm-1 is detectable, tentatively attributed to a 
hydrogen bond between Au and a H-N group of guanosine. A strongly shifted and 
split band arises from the carbonyl group, confirming its participation in the 
interaction with Auδ+ gold sites. On the other hand, a sharp and intense signal, 
attributed to N-H bending, changes of 71-95 cm-1 compared to free molecule, due to 
the redistribution of electronic density in the aromatic part, involving the perturbations 
of N1-H and NH2 bonds, which can originate H-bindings with negatively charged gold 
centres. Interestingly, both the ribose C-C and guanine ring breathing vibration bands 
undergo a significant change, being shifted at lower wavenumbers upon interaction 
with Au, suggesting the changes in the ribose conformation: a C3’-endo-anti versus 
O4’ -endo-anti [43], according to the literature data [45] (Scheme 2, panel A). 
Guanosine binding to different gold surfaces has been discussed elsewhere, giving 
rise to different suggestions. Having performed SERS analysis, Jang has found that 
the coordination of guanosine to the gold surface is realized via the N1 atom and the 
oxygen of the C6=O group of the pyrimidine ring [46]. The geometrical configuration 
proposed indicates that the pyrimidine ring adopts preferably a perpendicular position 
on the gold surface through the nitrogen N1 atom. Another study performed by 
Pergolese et al. evidenced that guanosine adsorbs on gold nanoparticles through the 
guanine moiety being parallel to the gold surface, and expressing the oxygen of the 
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carbonylic group and the N7 atom as molecular sites involved in the interaction with 
the gold surface [45].  
 The FTIR spectrum of AuNPs capped by corresponding nucleotide (Figure 18) 
shows the guanine moiety of guanosine 5’-monophosphate involved in the 
interaction with gold in a similar way: a middle-intensity C(6)=O stretching band splits 
into two shoulders and shifts of 32 cm-1. Moreover, the shift of 16 cm-1 of the 
phosphate band is e related to its different spatial disposition after interaction with 
Au, being in a mono-anionic form, i.e. HO-P(=O)(-O-R)(-O-) (R = nucleoside). A sharp 
band at 3334 cm-1, assigned to ν(OH) of the ribose, suggests its proximity to the gold 
surface, while its puckering  
 
Figure 16. FTIR spectra of guanine (black line) and Au-guanine NPs (red line). 
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Figure 17. FTIR spectra of guanosine (black line) and Au-guanosine NPs (red line). 
 
changes assuming a C1’ exo-anti conformation [47] (Scheme 2, panel B), allowing an 
easy approach of phosphate group. The 31P NMR spectrum is in agreement with 
FTIR results (Figure 12).  
FTIR spectrum of Au-1-methylguanosine NPs (Figure 19) shows new 
vibrations with respect to the free compound. We observed a sharp band at 3214 cm-
1, arising from NH2 stretching, and a redistribution of intensities of the components in 
the 1700–1540 cm-1 region: C=O stretching band becomes less intense and shifts of 
42 cm-1, while the NH2 bending band takes part of a broad and intense peak, that 
includes also a two-shoulder band of N7-C8 and C5-N7 vibrations.  
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These evidences indicate the M1G to interact with Au via C=O double bond, besides 
the N7 lone pair (NMR evidence), and suggest that the plane of the molecule is 
slightly bent towards the gold surface, supporting the general tendency of interaction 
of these molecules with AuNPs. The ribose (C-O) stretching modes decrease in 
intensity, becoming hardly detectable, at the same time being well distinguishable in 
the second derivate spectrum. Interestingly, the band of guanine ring breathing 
remains centred at 670 cm-1, indicating the conservation of ribose C3’- endo-anti 
conformation in good agreement with NMR data [47]. 
 
 
 
Figure 18. FTIR spectra of guanosine 5’-monophosphate (black line) and Au-guanosine 5’-
monophosphate NPs (red line). 
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Figure 19. FTIR spectra of 1-methylguanosine (black line) and Au-M1G NPs (red line). 
 
FTIR spectrum of Au-inosine NPs shows large differences of the signals in 
comparison with the free inosine (Figure 20): a new weak band at 3425 cm-1 was 
assigned to OH stretching of ribose moiety, whereas N1-H stretching band is shifted 
of 80 cm-1 at lower frequencies. The C6=O band is split into two components of low 
intensity, while N1-H bending and N7-C8 ring stretching bands are stuck together 
forming an intense band. It probably means that inosine has nearly an edge-on 
disposition on the gold surface, being also able to get involved in C=O interaction and 
a hydrogen bond with N1-H. Considering ribose vibrations, we observed a sharp 
band at 1204 cm-1, slightly shifted in comparison with inosine, and C-C ribose ring 
vibrations decreased in intensity.  
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Figure 20. FTIR spectra of inosine (black line) and Au-inosine NPs (red line). 
 
 The position of ring breathing bands does mean a C3’,C4’ exo-syn 
conformation of ribose moiety becoming a C3’-endo- anti when bound to the gold 
[47]. The correlation of NMR and FTIR data of Au-inosine NPs suggests a different 
behaviour in D2O (1H NMR) and in the solid state (ATR-FTIR). In solution, the ligand 
shell is probably not stable with oligomer species being detached and free in D2O; 
while in the solid phase the interactions between inosine and gold can be detected, 
suggesting its edge-on disposition on the gold surface, involving an electronic 
donation of C6=O oxygen lone pair coupled with an hydrogen bond of N1-H. 
 Finally, the stretching vibrations of N1-H and NH2 of free 8-bromoguanosine 
become a large shapeless band in Au-8-Br-Gua NPs (Figure 21), composed of  
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several signals whereas the CH stretching decreases in intensity and shifts. 
Moreover, a strong peak appears in the 1700-1500 cm-1 region, including both C=O 
stretching and bending vibrations of N1-H and NH2. In particular, a two-shoulder 
band at 1696-1636 cm-1 attributed to ν(CO) and NH bending band at 1518 cm-1 are 
both shifted to lower wavenumbers (see the second derivative spectrum for a better 
examination). The ribose vibrations give rise to a new large band composed of two 
shoulders at 1079 and 1032 cm-1, and C-C ribose vibrations at 819 and 731 cm-1. 
Notably, the C2’-endo-syn ribose conformation in free 8-bromoguanosine changes to 
C3’-endo-syn [47]. Thus, the correlation of NMR and FTIR data indicates the 8-
bromoguanosine coordination to the gold particles via N7 lone pair is not favoured by 
the steric hindrance of Br substituent. The AuNPs are therefore stabilised by the 
electronic interactions of C=O double bond and NH2. Due to the Br atom, the ribose 
puckering assumes a C3’-endo-syn conformation, the same observed in the free 
ligand (Scheme 2, panel D).  
 
Figure 21. FTIR spectra of 8-bromoguanosine (black line) and Au-8-Br-Guo NPs (red line). 
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Scheme 2. An illustration of the conformational changes of the ribose moiety after binding to 
the AuNPs: A) guanosine, B) guanosine 5`-monophosphate, C) inosine, D) 8-bromoguanosine. 
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Table 3. Ribose puckering and ring breathing bands before and after interaction with gold 
nanoparticles. 
 
Guo Au-Guo 
C3`-endo-anti 
686 cm-1 
O4`-endo-anti 
665 cm-1 
5`-GMP Au-5`-GMP 
C2`-endo-anti 
699 cm-1 
C1`-exo-anti 
674 cm-1 
M1G Au-M1G 
C3`-endo-anti 
668 cm-1 
C3`-endo-anti 
670 cm-1 
Ino Au-Ino 
C3`-exo-syn 
692; 629 cm-1 
C3`-endo-anti 
662 cm-1 
8-Br-Guo Au-8-Br-Guo 
C2`-endo-syn 
681 cm-1 
C3`-endo-syn 
667 cm-1 
 
 
 Based on the above interpretation of NMR and FTIR results, we can conclude 
that most of “guanine family” compounds interact with the particles via N7 atom and 
C=O group, in their neutral form, as the H8 signal is shifts in 1H NMR and the C=O 
band significantly changes in ATR-FTIR spectra, in comparison with free compounds. 
On the other hand, 8-bromoguanosine differs in its binding, while inosine gives more 
than one product in the colloidal system. Moreover, guanosine and 8-
bromoguanosine derivatives showed to be able to form weak hydrogen bonds 
between N1-H group and gold surface, having observed changes of stretching and  
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bending NH bands after interaction with gold.  Kryachko and Remakle have found 
that guanine moiety interacts with gold clusters throughout an Au-O6 anchor bond 
along with nonconventional hydrogen bonds with N1-H center. The formation of the 
anchor bond “catalyzes” through charge redistribution the gold atoms to serve as a 
nonconventional proton acceptor and to form, via its lone pair 5d orbital, a 
nonconventional hydrogen bond with the conventional proton donor of guanine 
moiety [24]. 
 The substitution on C8 atom leads to a different constrain depending on bulky 
substituent, and different pathways of reaction can be possible for the building up of 
Au-purine NPs, as demonstrated for Au-8-bromoguanosine NPs. Novel results on the 
conformational changes of ribose puckering highlight that it can occur when purine 
derivatives interact with AuNPs. The need of conformational changes is strictly 
related to the electronic properties of guanine ring after contact with gold surface 
throughout N7 and C=O. Moreover, the phosphate group of guanosine nucleotide is 
strongly involved in a polar interaction with gold surface, being monoprotonated, 
HO(O)PO-R)(O-) due to the pH of colloids. 
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3.1.2. Thymine, thymidine and thymidine 5`-monophosphate 
Having pKa of N3 atom deprotonation ~ 10, all the three compounds exist in 
neutral (unprotonated) form at giving reaction conditions (pH 3.5) (Figures A3.10-12, 
Appendix). It has been already mentioned that thymine can spontaneously form 
platinum-nucleobase complexes, with bridging donor atom to be originated from 
pyrimidine entity (e.g. N3 and O4 atoms). Thymidine adsorption on Au(111) surface 
studied by photoemission spectroscopy revealed that the thymine moiety is lying 
nearly parallel to the Au(111) surface. Surface-enhanced Raman spectroscopy 
(SERS) study of Jang [46] shows that thymidine binds to the gold surface via the 
oxygen of the C4=O group of the pyrimidine ring. While Mirkin et al. have found from 
TPD-MS studies that thymine desorption occurs at the lowest temperature comparing 
with other nucleobases, giving rise to a single peak, suggesting the weakness of the 
bond between gold surface and thymine, and the binding via a single-site [38]. 
 NMR studies were carried out using the samples prepared by concentrating 
gold nanoparticles suspensions scaling up the amounts of all the components. 1H 
NMR spectra of thymine and Au-thymine NPs in D2O are reported in Figure 22. The 
signals at 7.31 and 1.79 ppm were assigned to H6 and CH3 of free thymine. The 
chemical shift has not changed significantly, but the peaks are broadened in the 
spectra of capped AuNPs, indicating a very weak interaction, that is in accordance 
with Mirkin`s observations. The same behavior is observed from the spectra of 
thymidine and Au-thymidine NPs (Figure 23). This may indicate both the weakness 
of the interaction between thymine ring, and uninvolvement of the ribose moiety in 
the binding. 
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Figure 22. 1H NMR spectra of thymine (a) and Au-thymine NPs (b) in D2O in the range from 1.9 
to 1.75 ppm and from 7.4 to 7.2 ppm. 
 
 
Figure 23. 1H NMR spectra of thymidine (a) and Au-thymidine NPs (b) in the 7.5 to 3.5 ppm 
range. 
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 On the other hand, the spectrum of Au-thymidine 5`-monophosphate NPs is 
considerably different from that of free compound (Figure 24-26). The signals 
corresponding to the thymine ring have not notably changed the position, while the 
H4`- H5` ribose signals drastically change upon interaction with gold (see Appendix). 
31P NMR spectra reveal an important shift of the phosphorous signal from 3.79 to 
0.27 ppm after interaction with AuNPs (Figure 27). These findings indicate that 
phosphate moiety and neighboring oxygen atoms are strongly affected by the 
proximity of the gold surface. 
 
 
 
 
Figure 24. 1H NMR spectra of thymidine 5’-monophosphate (a) and Au-thymidine 5’-
monophosphate NPs (b) in D2O in the 8 to 6.2 ppm range. 
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Figure 25. 1H NMR spectra of thymidine 5’-monophosphate (a) and Au-thymidine 5’-
monophosphate NPs (b) in D2O in the 4.7 to 3.7 ppm range. 
 
Figure 26. 1H NMR spectra of thymidine 5’-monophosphate (a) and Au-thymidine 5’-
monophosphate NPs (b) in D2O in the 2.5 to 1.5 ppm range. 
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Figure 27. 31P NMR spectra of thymidine 5’-monophosphate (a) and Au-thymidine 5’-
monophosphate NPs (b) in D2O in the 5 to 0 ppm range. 
 
 Due to the weakness of the changes observed for the hydrogen signals of 
thymine ring, we performed more detailed FTIR study in order to better analyze the 
binding sites. The plots in Figure 28 reveal that when thymine binds to gold, the 
infrared spectra change significantly compared to the isotropic spectrum of the 
compound in the crystalline state. Sharp characteristic bands of NH and C=O varies 
both in intensity and wavenumber after interaction. A weak band, found at 3201 cm-1 
in free thymine and assigned to the stretching of amino group, shifts of 16 cm-1 to 
longer wavenumbers and enhances in intensity, while CH and CH3 stretching bands 
become almost undetectable in the Au-thymine spectrum. A sharp and intense 
stretching band, attributed to C2=O and C4=O, shifts from 1736 to 1697 cm-1 under 
binding, most likely because of interactions with the gold nanoparticles. The band of 
NH bending (1431 cm-1) gives rise to two different bands at 1512 and 1415 cm-1 with 
Chapter III  
 
 
116 
a major intensity. It has been proved by Kryachko, that thymine can create 
nonconventional N–H---Au hydrogen bonds, similar to weak conventional H–bonds, 
that is in accordance with our data [24, 25]. Finally, the out-of-plane δ(C-H) provide a 
shifted very strong band at 726 cm-1. These observations suggest that thymine is 
affected by the proximity to the metal surface, interacting via the carbonyl oxygen, 
involving also amino N3-H group. Mirkin et al. suggest that both the C4=O and C2=O 
groups, along with amino group, are involved in the binding to the gold. A flat “belly-
down” orientation would allow thymine to interact simultaneously with gold in this 
way.  
  
 
 
Figure 28. ATR-FTIR spectra of thymine (red line) and Au-thymine NPs (black line). 
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 The spectrum of thymidine significantly changes under interaction with gold, 
as well. The band at 3296 cm-1 assigned to the stretching modes of N3-H group, 
shifts at lower frequencies giving rise to a large equal-intensity band at 3216 cm-1. On 
the other hand, an intense band at 1664 cm-1, comprising both C=O and C=C 
stretching vibrations, becomes very weak, while the bands in 1450-1000 cm-1 region, 
comprising ribose ring vibrations, originate a shapeless large set of bands decreased 
in intensity under interaction with gold. 
 
 
Figure 29. ATR-FTIR spectra of thymidine (red line) and Au-thymidine NPs (black line). 
 
 Finally, a weak band, centered at 731 cm-1 in free thymidine spectrum and 
assigned to the out-of-plane C-H bending modes, shifts of 43 cm-1 to the higher 
frequencies upon interaction, significantly increasing in intensity. Basing on these 
data, thymidine seems to bind to AuNPs in a similar way as corresponding 
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nucleobase, with the ribose moiety to be affected under interaction. 
 The spectra of thymidine 5`-monophosphate and capped AuNPs are shown 
in Figure 30. Due to the difficulty to accurately assign the position of the stretching 
modes of NH, OH and CH groups in the both spectra, caused by the broadness of 
the bands, we recur to the second derivative spectra. The data of the bands before 
and after interaction with gold are reported in Table A3.12, Appendix. All the bands of 
Au-5`-TMP NPs seem to be shifted comparing to the free ligand, indicating a 
perturbation caused by the proximity to the gold.  
 
 
 
Figure 30. ATR-FTIR spectra of thymidine 5’-monophosphate (red line) and Au-thymidine 5’-
monophosphate NPs (black line). 
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The C=O stretching band is slightly shifted from 1671 to 1688 cm-1, showing an 
intense band in AuNPs spectrum. Like in other cases, a significant up-shift was 
observed for the N3-H bending modes (from 1453 to 1522 cm-1), indicating the 
involvement of the amino group in the interaction. The phosphate R-OPO32- bands, 
normally appearing in the characteristic zone (1150–900 cm-1) [48, 49] for free 
nucleotides, is hardly recognized in the spectrum of the capped AuNPs, and can be 
seen only in the second derivative spectrum, suggesting P=O vibrations in a plane 
close to parallel to the gold surface. 
Thus, correlating the data obtained from NMR and FTIR, we can draw the 
following conclusions: thymine and thymidine weakly bind to the gold surface 
involving C=O4 and N3-H groups, with the latter able to form non-conventional 
hydrogen bonds with gold surface. Thymidine 5`-monophosphate seems to show a 
stronger interaction due to the presence of a phosphate group, which may participate 
in electrostatic stabilization of AuNPs. 
 
3.1.3. Adenine, adenosine and adenosine 5`-monophosphate 
Adenine provides three unprotonated endocyclic nitrogen atoms (N1, N3, N7) 
at physiological pH, all of which are potential metal binding sites. The basicity order is 
N1>N7>N3 [40]. While in duplex DNA the N7 site is preferred as a metal binding site, 
with isolated adenine base a pronounced dichotomy exists for metal binding at N1 
and N7. Only in strongly acidic pH, when N1 site is fully protonated, the metal binding 
is preferentially through N7. Under given reaction conditions (pH 3.5), adenine exists 
both in neutral form (78%) and protonated at N1 atom (22%) (Table 8). 
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Figure 31 shows the spectra of adenine at pH 3.5 (a) and Au-adenine NPs 
(b). The both H2 and H8 signals are upfield upon interaction with gold: H2 signal  
 
Figure 31.1H NMR spectra of a) adenine and b) Au-adenine NPs. 
 
moves from 8.21 to 8.14 ppm, while H8 signal changes from 8.16 to 8.10 ppm. Since 
the most part of the species are unprotonated at N7 and N1, the chemical shift of the 
neighboring hydrogen atoms may indicate the interaction via the two nitrogen atoms 
or the presence of two separate species on the gold surface. 
Adenosine does show significant changes in the chemical shift of all the 
signals after interaction with gold (Figure 32). The H2 and H8 signals shift upfield 
from 8.28 and 8.17 ppm to 7.94 and 7.68 ppm, respectively. The ribose signals are 
also affected by the interaction, in particular, the H1` and H3` signals drastically shift 
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from 6 and 4.23 ppm to 5.55 and 3.95 ppm, respectively. It is clearly seen that 
adenosine behaves in a similar way with the corresponding nucleobase: both N7 and  
 
 
Figure 32.1H NMR spectra of a) adenosine, b) Au-adenosine NPs in 8.5-5.0 ppm region, and c) 
Au-adenosine NPs in 4.5-3.4 ppm region. 
 
N1 atoms are probably involved in the binding, while the ribose moiety is strongly 
affected by the interaction. 
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The spectra of adenosine 5’-monophosphate and corresponding AuNPs are 
reported in Figure 33, 34. It is clearly seen that nanoparticles spectrum changes 
considerably and becomes more complicated. The H2, H8 and H1’ signals give rise 
to several signals, which may be due to the presence of different species in the 
sample. Ribose region also changes: all the signals broaden and shift indicating a 
perturbation of ribose moiety in the proximity with gold surface. Importantly, the 
phosphorous signal notably changes from 3.60 ppm to 0.23 ppm, pointing to a strong 
interaction between the phosphate group and gold surface. 
 
 
 
Figure 33.1H NMR spectra of a) adenosine 5’-monophosphate, and b) Au-adenosine 5’-
monophosphate NPs in 6- -1 ppm region. 
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Figure 34. 31P NMR spectra of a) adenosine 5’-monophosphate, and b) Au-adenosine 5’-
monophosphate NPs in 6- -1 ppm region. 
  
The FTIR spectra of adenine and Au-adenine NPs are reported in Figure 35. 
The spectrum of solid adenine shows clearly defined bands at 3273, 3092 and 2969 
cm-1 attributed to the stretching modes of NH2, C8-H and C2-H groups, respectively. 
Upon interaction with gold, the only band located at 3202 cm-1 is visible, suggesting a 
flat orientation of the NH2 onto the gold surface. The δ (NH2) scissoring, found at 
1663 cm-1 in solid adenine, significantly changes and splits in two bands at 1697 and 
1645 cm-1 in Au-adenine NPs, suggesting a possible slightly tilted orientation. The 
low intensities of the bands corresponding to the ring and located in the 1300-900 
cm-1 region in Au-adenine spectrum, support its flat orientation. Our findings are in 
accordance with Mirkin`s et al. which suggest that adenine coordinates to the gold 
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Figure 35. ATR-FTIR spectra of adenine (red line) and Au-adenine NPs (black line). 
 
flat surface through the amino group, thus changing the hybridization of the N10 
atom from sp2 (planar) to sp3 (pyramidal). This distorted, no planar geometry is 
compatible with appearance of NH2 scissoring.  
 The FTIR spectrum of free adenosine is quite similar to that of adenine and 
shows intense bands at 1644 and 1590 cm-1 due to the scissoring modes of NH2 and 
NH groups (Figure 36). The stretching NH2 modes give a band at 3147 cm-1 in free 
adenosine which increases in intensity and shifts a few wavenumbers to 3201 cm-1 
under interaction with AuNPs. On the other hand, the scissoring band significantly 
decreases in intensity and is hardly detectable at 1608 cm-1 in the AuNPs spectrum. 
Adenine ring vibrations found in free adenosine in 1470-1300 cm-1 region, now shift 
and take part of a single large sharp band and can be detected in the second 
derivative spectrum. 
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Figure 36. ATR-FTIR spectra of adenosine (red line) and Au-adenosine NPs (black line). 
 
A middle-intensity band at 1209 cm-1 assigned to C1`-N9 vibrations in free 
adenosine, is detected at 1184 cm-1 in Au-adenosine spectrum, indicating a 
nonplanar orientation of the glycosidic bond on the gold surface. Moreover, ribose 
breathing band is now shifted (from 759 to 708 cm-1) and increased in intensity 
confirming a nonplanar orientation of the ribose moiety. Thus, the FTIR results are in 
accordance with the NMR data, indicating a perturbation in the ribose moiety under 
interaction with AuNPs.  
 The spectrum of adenosine 5’-monophosphate (Figure 37) changes 
considerably after interaction with gold: all the stretching bands (-OH, -NH, -NH2) 
clearly seen in the 3400-3100 cm-1 region become a large shapeless band; the only 
band, found at 2924 cm-1, may be a result of a small shift of ν (CH) band centered at  
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2953 cm-1 in the spectrum of free compound. The scissoring vibrations of NH2 group 
give rise to a band at 1640 cm-1 in nucleotide spectrum, slightly shifted to 1645 cm-1 
under interaction. A set of the middle-intensity bands in the 1490-1240 cm-1 region 
may be assigned to the adenine ring modes, and becomes a large intense band 
containing several components. The possibility to observe both amino-group and 
adenine ring modes in the spectrum of AuNPs indicate a tilted disposition of the 
molecule on the gold surface. Importantly, phosphate moiety symmetrical vibrations 
band centered at 1074 cm-1 in free nucleotide spectrum, gives rise to a less intensive 
but still clearly observed band with two components, at 1097 and 1028 cm-1, 
indicating a strong electrostatic interaction with AuNPs. 
 
Figure 37. ATR-FTIR spectra of adenosine 5’-monophosphate (red line) and Au-adenosine 5’-
monophosphate NPs (black line). 
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Concluding NMR and FTIR results, adenine, adenosine and adenosine 5’-
monophosphate seem to interact with AuNPs via NH2 group of adenine ring, involving 
N7 lone pair of electrons. The ribose moiety is affected by the interaction, giving rise 
to a significant changes in NMR spectra, while the phosphate moiety may interact 
with gold surface electrostatically, providing the particle stabilization. 
 
3.1.4. Cytosine, cytidine and cytidine 5’-monophosphate 
Of all endocyclic N atoms of the four nucleobases, N3 of cytosine is the most basic 
one, hence has the highest pKa value and the highest affinity for H+. Thus, binding to 
either N3 or O2 is favored. At our reaction conditions, cytosine is protonated at 89% 
at N3 atom, and only 11 % of cytosine exists in neutral unprotonated form. The 
change of pH from neutral (pH 7) to acidic does not provoke a great change of H6 
and H5 chemical shifts in 1H NMR spectrum of free cytosine (Table 3, Appendix). On 
the other hand, the spectrum of Au-cytosine NPs becomes more complicated 
showing a group of new signals in the 8.2-7.4 ppm range (Figure 38). This may be 
due to the formation of side products soluble in water or the presence of different 
cytosine species (protonated and unprotonated). The H5 signal considerably shifts, 
from 5.93 ppm to 5.40 ppm, being affected by the interaction with gold. The binding 
to N1 blocked cytosine (e.g. cytidine and cytidine 5’-monophosphate) can occur in 
any of the following ways: through N3, O2, NH2, C5, or in π-fashion through C5 and 
C6 [40]. Cytidine, like corresponding nucleobase, exists both in protonated form at 
N3 atom (78%) and in neutral.  
 
 
Chapter III  
 
 
128 
 
 
Figure 38.1H NMR spectra of a) cytosine, and b) Au-cytosine NPs in the 8.2-7.4 and 6.0-5.4 ppm 
region. 
 
Similarly to cytosine, 1H NMR spectrum of cytidine is not affected by the acidic 
conditions, showing a minimal downfield change of the chemical shift values (Figure 
39). A similar picture is observed in the spectrum of Au-cytidine NPs: the 8.5-8.0 ppm 
region shows numerous signals, among which, however, it may be possible to detect 
the H6 and H5 proton signals. The two resonances shift downfield from 7.79 and 
5.99 ppm to 8.13 an 6.25 ppm, respectively. Nevertheless it is hard to track the exact 
position of the signals, it is clearly seen that ribose resonances are highly affected by 
the interaction, causing their broadening.  
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Figure 39.1H NMR spectra of a) cytidine, and b) Au-cytidine NPs. 
  
The spectrum of Au-cytidine 5’-monophosphateNPs (Figure 40) seems less 
complicated and the ring signals can be clearly detected: H6 and H5 resonances 
notably shift from 7.98 and 6.06 ppm to 8.17 and 6.24 ppm, respectively. The H1’ 
signal is less affected and moves from 5.94 to 5.90 ppm, while the ribose region 
strongly broadens comparing with free nucleotide.  
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Finally, the phosphate moiety is perturbed by the interaction, undergoing a 
considerable shift from 1.85 to 0.25 ppm (Figure 41).  
 
 
 
Figure 40.1H NMR spectra of a) cytidine 5’-monophosphate, and b) Au-cytidine 5’-
monophosphate NPs. 
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Figure 41. 31P NMR spectra of a) cytidine 5’-monophosphate, and b) Au-cytidine 5’-
monophosphate NPs. 
 
 The FTIR spectra of cytosine, cytidine and cytidine 5’-monophosphate and 
AuNPs are reported in Figures 42-44. The spectrum of free cytosine (Figure 42) 
shows two intense bands at 3368 and 3157 cm-1 responsible for symmetric and 
asymmetric stretching vibrations of NH2. In the Au-cytosine spectrum the only band 
appears in that region (3215 cm-1) assigned to the same NH2 vibrations. A middle-
intensity band is found at lower frequencies (2927 cm-1) in the AuNPs spectrum, 
which seems to be a result of a significant blue shift of the ν (CH) bands centered at 
2927 and 2851 cm-1. 
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Figure 42. ATR-FTIR spectra of cytosine (red line) and Au-cytosine NPs (black line). 
 
There are significant changes in the 2000-600 cm-1 region as well: the ν (C=O) band, 
centrered at 1647 cm-1 in free cytosine, gives a band with two components, at 1710 
and 1645 cm-1, that may correspond to the δ (NH2) and ν (C=O) modes of bound 
cytosine. The C-N stretching vibrations, showing two bands at 1520 and 1441 cm-1, 
shift at 1541 and 1449 cm-1, respectively. Finally, a group of the bands responsible 
for the ring stretching vibrations found in the 1216-974 cm-1 region in free cytosine 
spectrum, shifts to higher frequencies and decrease in intensity, while a very intense 
ring breathing band becomes weak and shifts from 773 to 811 cm-1 under interaction 
with gold. Mirkin et al. suggest a tilted orientation of cytosine on the gold surface, 
since the presence of x- and z-modes in the gold spectrum [38]. A clear observation 
of the NH2 and C=O bands in our Au-cytosine spectrum, suggests a non-parallel  
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orientation of the molecule on the particle surface, which is supported by the 
presence of ring vibrational bands. 
 The spectra of free cytidine and Au-cytidine NPs show a similar behaviour 
(Figure 43): OH ribose vibration, along with sym and asym stretching vibrations of 
NH2 group (3443, 3337 and 3220 cm-1) give rise to a large formless band including 
several components at 3442, 3350 and 3209 cm-1, which can be better observed in 
the second derivative spectrum (Figure A3.14, Appendix). The band at 1618 cm-1 in 
free cytidine may be due to both C=O hydrogen bonding with other molecules 
(normally, ν (C=O) is found in 1670 cm-1 region) or C=C vibrations. The Au-cytidine 
spectrum shows a band with two shoulders (1696 and 1642 cm-1), probably, due to 
both NH2 bending and C=O stretching vibrations. Another band with the components 
at 1556 and 1518 cm-1 is a result of the C-N (C=N) stretching vibrations. All the ring 
vibrations are broadened but still can be observed in the AuNPs spectrum, indicating 
a similar to cytosine non-parallel orientation.  
 
Figure 43. ATR-FTIR spectra of cytidine (red line) and Au-cytidine NPs (black line). 
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This is supported by the presence of a very strong band at 769 cm-1, at a lower 
frequency comparing to the free cytidine, assigned to the ring breathing vibrations of 
cytosine moiety.  
It can be clearly seen in the spectrum of Au-cytidine 5’-monophosphate 
NPs, that ribose moiety is highly perturbed by the interaction, showing a broad but 
intense band at 3415 cm-1, which is not observable in the spectrum of free molecule 
(Figure 44). On the other hand, the ν (C=O) band slightly shifts indicating a weak 
interaction (or its absence) with gold, while the cytosine ring vibrations give rise to a 
broad and intense multicomponent band confirming the above discussed non-parallel 
disposition of the ring. Importantly, the phosphate sym vibrations centered at 1066 
cm-1 in free nucleotide, give a weak band with two components (1094 and 1026 cm-
1), suggesting a strong interaction between the phosphate moiety and gold, thus, 
supporting 31P NMR data.  
 
Figure 44. ATR-FTIR spectra of cytidine 5’-monophosphate (red line) and Au-cytidine 5’-
monophosphate NPs (black line). 
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To summarize, “cytosine family” compounds interact with AuNPs involving N3 
atom of cytosine moiety, with the ribose moiety to be strongly perturbed under 
interaction. Likewise other nucleotides, the phosphate group of cytidine 5’-
monophosphate is involved in the interaction, showing a large chemical shift in 31P 
NMR spectrum. Cytosine moiety seems to has a non-parallel orientation onto the 
gold surface concerning the three molecules. 
 Based on the above interpretation of NMR and FTIR results, we conclude that 
guanine, adenine, thymine and cytosine “families” do interact with the gold in rather 
different ways. The most of “guanine family” compounds interact with the particles via 
N7 atom and C=O group of guanine moiety, in their neutral form. While guanosine 
and 8-bromoguanosine derivatives showed to be able to form weak hydrogen bonds 
between N1-H group and gold surface. The substitution on C8 atom leads to a 
different constrain depending on bulky substituent, and different pathways of reaction 
can be possible for the building up of Au-purine NPs, as demonstrated for Au-8-
bromoguanosine NPs. Novel results on the conformational changes of ribose 
puckering highlight that it can occur when purine derivatives interact with AuNPs. As 
for “thymine family”, thymine and thymidine weakly bind to the gold surface involving 
C=O4 and N3-H groups, with the latter able to form non-conventional hydrogen 
bonds with gold surface. Concerning “adenine family”, adenine and adenosine seem 
to interact with AuNPs via NH2 group of adenine ring, involving N7 lone pair of 
electrons. The ribose moiety is affected by the interaction, while the phosphate 
moiety interacts with gold surface electrostatically, providing the particle stabilization. 
Finally, cytosine interacts with AuNPs via N3 atom having a non-parallel orientation 
onto the gold surface.  
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Cytidine shows the same binding sites along with a strong perturbation of the ribose 
moiety. Notably, the phosphate group of the four nucleotides is strongly involved in a 
polar interaction with gold surface, being monoprotonated, HO(O)PO-R)(O-) due to 
the pH of colloids. The molecules interact with a different strength with AuNPs, likely 
due to the varying ability of the bases to coordinate to the substrate as a result of the 
different types of possible surface binding moieties (e.g., carbonyls and amides; 
mono- versus polydentate) [21]. 
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3.2. Biological experiments 
 
 Besides structural studies on AuNPs modified by nucleobases, nucleosides 
and nucleotides, we have also performed the cytotoxicity and cellular uptake 
experiments in order to evaluate their potential application in biology. Cytotoxicity 
experiments were performed using U-87 human glyoblastoma cell line. Glioblastoma 
is the highest dedifferentiated form of astrocytic brain tumours, and it is refractory to 
chemotherapy in most cases [50]. U-87 cells are used as in vitro model of human 
glioblastoma cells to investigate the cytotoxic effect of chemotherapeutic drugs 
towards cancer cells. The cells were incubated for 1 h with both conjugated AuNPs 
and Au-citrate NPs for comparison, using 6 nM AuNPs suspensions. The cell 
mortality was then studied by trypan blue exclusion test by determining the number of 
viable cells present in the cell suspension [51]. The assay is based on the principle 
that live cells possess intact cell membrane that exclude certain dyes, such as trypan 
blue, Eosin, or propidium, whereas dead cells do not. For this purpose, incubated 
with AuNPs cells, resuspended in PBS, were mixed with trypan blue 0.4% solution 
and then fixed. The plates with as-treated cells were visually examined to determine 
the number of cells which took up and exclude dye. Thus, viable cells have a clear 
cytoplasm whereas a nonviable ones have a blue cytoplasm. A few fields of every 
sample were analyzed by optical microscopy and cell mortality was calculated using 
the following equation:  
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 Figure 45 shows a histogram of cell mortality for different kinds of 
nanoparticles compared to Au-citrate NPs as a control. 
 
 
Figure 45. Cytotoxicity of AuNPs modified by nucleobases, nucleosides and nucleotides, 
compared to Au-citrate NPs. The U87 cells were incubated with 6nM AuNPs for 1 h. 
 
After one hour of incubation, the nanoparticles modified with nucleobases caused 12-
18% cell death, while nucleobases and nucleotides conjugates shown 8-23% of cell 
mortality. It is known that the kind of surface coating may play an important role in the 
cytotoxicity of AuNPs. Goodman et al. have studied the cytotoxicity of differently 
charged AuNPs and have found that cationic (ammonium-functionalized) AuNPs are 
clearly more toxic than the anionic (carboxylate-functionalized) ones [52]. Moreover, 
Connor et al. have found that the gold-salt (AuCl4-) is highly toxic for the cells (over 
90%) [53]. The light microscopy images of the incubated with trypan blue cells are 
reported in Figures A4.1-2, Appendix. 
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 The cellular uptake studies of several gold conjugates were performed both by 
confocal microscopy and TEM. Confocal laser microscopy is one of the most 
important cellular analysis techniques and has been used with considerable success 
in the real-time observation of cells [54]. In this technique, molecular fluorescent 
probes are employed to label the cells to be observed. Ren et al. studied AuNPs as a 
tool for confocal microscopy imaging of cancer cells. They observed that 
fluorescence of AuNPs possessed an excellent behaviour of antiphotobleaching 
under strong light illumination. On the basis of this AuNPs property and easy 
photobleaching of cellular autofluorescence, they developed a new method for 
imaging the cells using AuNPs as fluorescent probes. After photobleaching of cellular 
autofluorescence by illumination of strong light for several minutes, they were able to 
clearly observe AuNPs inside the cells [55]. The results of confocal microscopy 
studies are reported in Figures 46, 47. To note, the colour of the dots is chosen 
occasionally and does not represent the real colour of the nanoparticles. It can be 
clearly seen that all the tasted conjugates were taken up by the cells: the 
nanoparticles are distributed in different cellular compartments, and some of them 
even can be found inside the nucleus. Since the cells were post-fixed after incubation 
with nanoparticles, their form is not perfectly uniform and a few bubbles can be 
observed.  
 To further confirm the successful cellular uptake of the gold conjugates, TEM 
experiments were performed. Owing to electron density and capability of strong 
emission of secondary electrons, gold nanoparticles have been widely used as 
specific marker in microscopy both at the low and high resolution level. Since gold 
nanoparticles bind non-specifically to a very low extent, the technique has found  
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application in TEM for marking intracellular components on thin sections. 
 
 
 
Figure 46. Confocal microscopy images of U87 cells incubated with a) Au-thymine, b) Au-
thymidine and c) Au-thymidine 5’-monophosphate NPs. 
 
  
 
Chapter III  
 
 
141 
 
 
 
Figure 47. Confocal microscopy images of U87 cells incubated with a) Au-cytosine, b) Au-
adenine and c) Au-guanosine NPs. 
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Here, we focused our attention on the cellular uptake of Au-thymidine 5’-
monophosphate NPs. The results of these experiments are shown in Figure 48. After 
one hour of incubation, the nanoparticles are found approaching cellular membrane 
(a, b), and clustered together in cellular compartment that appear to be an endosome 
(b, c).  
 
 
Figure 48. TEM micrographs of U87 cells incubated with Au-thymidine 5’-monophosphate NPs 
for 1 h: a) AuNPs approaching cellular membrane, b) enclosed into an endosome, c) free into 
the cytoplasm and endosome, and d) roaming into different cellular compartments. 
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Moreover, the nanoparticles are observed free in the cytoplasm, which may indicate 
their ability to escape endosomal pathway. Infact, the nanoparticles are also found 
roaming into different cellular compartments, and, in particular, crossing nuclear 
membrane and even into the nucleus. Figure 41d shows the nanoparticles clustered 
in different parts of the nucleus.  
 Targeted nuclear delivery is a challenging task, however, as any cell-specific 
nuclear probe must satisfy the following requirements: it must be small enough to 
enter cells and cross the nuclear membrane (<100 nm for uptake by receptor-
mediated endocytosis and <30 nm for import through nuclear pores, penetrate 
cellular membranes or bind to cell-specific plasma membrane receptors, bypass or 
escape endosomal/lysosomal pathways, penetrate nuclear membranes or access 
importins to pass through the nuclear pore complex, and have low toxicity [56]. The 
Au-thymidine 5’-monophosphate nanoparticles seem to fulfil these conditions, being 
small enough (10 nm) to be able to penetrate nuclear membrane, and be probably 
taken up by the cells via passive uptake. This mechanism is still unclear and needs a 
more detailed study, by variation of cellular uptake conditions and using different cell 
lines. 
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4. Concluding remarks 
 We have synthesized small water-soluble gold nanoparticles using 
nucleobases (guanine, adenine, cytosine, thymine), nucleosides (guanosine, 
adenosine, cytidine, thymidine) and nucleotides (corresponding monophosphates) as 
stabilizing ligands. The nanoconjugates have been fully characterized by TEM, UV-
vis, DLS and zeta-potential methods, whereas the binding properties of the 
molecules towards gold nanoparticles have been studied by 1H, 31P NMR and ATR-
FTIR spectroscopy. The nanoconjugates have a 6-35 nm size and are negatively 
charged, as TEM and zeta-potential studies show. Basing on the previous studies on 
the binding of nucleobases to the gold, carried out by Mirkin, Pergolese and 
Kryachko, and our spectroscopic results, we have found out a behaviour of the 
nucleic acid components when bound to the gold surface. The binding of the 
molecules is shown to have a complex character involving different atoms of 
nucleobase ring. The ribose moiety does not seem to be involved in the binding, 
however, it does change the conformation under interaction with gold, in order to 
fulfill a better disposition of the binding atoms on the metal surface. Finally, 
phosphate group of the nucleotides is found to strongly interact with gold surface, 
likely, electrostatically, as shown by 31P NMR. Novel results have been obtained by 
FTIR spectroscopy on ribose conformation affected by the interaction with gold. 
Finally, cytotoxicity experiments carried out using U87 human glioblastoma cancer 
cell line have shown that as-prepared nanoconjugates possess a low toxicity with a 
maximum of 23%. Cellular uptake studies of several nanoconjugates have been 
performed both by confocal microscopy and TEM, revealing the ability of the 
nanoparticles to be taken up by the cells. Interestingly, thymidine 5’-monophosphate 
Chapter III  
 
 
146 
nanoparticles were also found roaming into different cellular compartments, including 
cytoplasm and cellular nucleus, as shown by TEM. This let us believe that 
endosomal escape mechanism takes place. Despite the encouraging results, the 
biological experiments on the nanoconjugates still need a deeper examination, in 
order to fully understand the mechanism driving the nanoparticles uptake. 
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1. Introduction 
 Tumors produce many angiogenic factors, which are able to activate 
endothelial cells in established blood vessels and induce endothelial proliferation, 
migration, and new vessel formation (angiogenesis) through a series of sequential 
but partially overlapping steps. Angiogenesis is a requirement for tumor growth and 
metastasis. Without the neovasculature to provide oxygen and nutrients, tumors 
cannot grow beyond 1-2 mm in size. Once vascularized, the tumors begin to grow 
rapidly. The angiogenic process depends on vascular endothelial cell migration and 
invasion and is regulated by cell adhesion receptors.  
 Integrins are a family of proteins that facilitate cellular adhesion and migration 
on extracellular matrix proteins in the intercellular spaces and basement membranes, 
and regulate cellular entry and withdraw from the cell cycle [1]. Integrins are divalent 
cation-dependent heterodimeric membrane glycoproteins composed of noncovalently 
associated α- and β-subunits. Eighteen α-subunits and 8 β-subunits can assemble 
into 24 different heterodimers. Each subunit is composed of an extracellular domain, 
a single transmembrane region, and a cytoplasmic region (Scheme 1).  
 Most integrins recognize their respective extracellular matrix proteins through 
short peptide sequences such as Arg-Gly-Asp (RGD) [2]. Integrin αVβ3 is expressed 
at low levels on epithelial cells and mature endothelial cells, but is overexpressed on 
the activated endothelial cells of tumor neovasculature, including osteosarcomas, 
neuroblastomas, glioblastomas, melanomas, lung carcinomas, and breast cancer [3]. 
The restricted expression of integrin αVβ3 during tumor growth, invasion, and  
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metastasis presents an interesting molecular target for both early detection and 
treatment of rapidly growing solid tumors. Most integrins can have “on” and “off” 
states. The extracellular domain of αVβ3 integrin is bent or folded, thereby hiding the 
RGD-binding site and preventing ligand binding. Conversely, RGD-bound αVβ3 
integrin has an unbent or straighter extracellular domain (Scheme 1). Although 
integrin cytoplasmic tails are much smaller than their extracellular domains, they can 
play pivotal roles in integrin signaling events, with separation, twisting, and hinging of 
the tails all considered mechanisms to allow activation [4]. 
 RGD-containing peptides compete in the binding of proteins to cell surface 
αVβ3, preventing cellular adhesion to the extracellular matrix, thwarting cell 
metastasis, and inducing apoptosis [5]. Linear and cyclic RGD peptide motifs have 
been employed as delivery agents for small molecular weight drugs, peptides, and 
proteins to the tumor endothelial cells [6]. RGD analogues have been also used for 
tumor imaging and targeting with chemotherapeutic drugs or radionuclides [7]. 
Radiolabeled RGD peptides were targeted to xenograft tumors expressing the 
integrins [8]. 
There is an increasing interest in nanocarriers such as inorganic and 
polymeric nanoparticles, liposomes, and quantum dots coated with RGD analogues 
as targeting and imaging agents. Graf et al. have synthesized polymeric nanoparticle 
construct that encapsulates a Pt(IV) complex in the core and is targeted to αVβ3 
integrin-expressing cells using the cyclic pentapeptide c(RGDfK) [2]. Nam et al. 
studied cyclic RGD-PEGylated AuNPs with directly labeled radioactive iodine as 
molecular imaging probes, having found their ability to specifically target integrin  
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Scheme 1. Structure of αVβ3 integrin receptor. An illustration of conformational changes in αVβ3 
integrin. Upon activation the extracellular domains extend and straighten, exposing the RGD-
binding domain (star). 
 
receptors and penetrate the cells via receptor-mediated endocytosis with almost no 
cytotoxicity. The authors pointed out the importance of RGD functionality for efficient 
and long-term tumor-targeted imaging in vivo [9]. 
 Cellular uptake of AuNPs conjugated both with the monocyclic RGDfK and 
linear RGD peptides into HUVEC cells was compared by Dowling et al. The 
researchers showed via MAIL (Multiphoton Absorption Induced Luminescence) 
imaging the importance both of the nanoparticle size and structure of the RGD 
analogue: cyclic RGD analogue was found to give a higher signal respect to the  
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linear control, while 16 nm particles exhibited significantly higher MAIL signal than 
those incubated with the smaller 4.5 nm AuNPs [10]. 99Tc-labeled AuNPs conjugated 
with HYNIC-GGC and c(RGDfK(C)) peptides were synthesized as a potential 
radiopharmaceutical for tumor integrin expression imaging and incubated with cancer 
cells and their distribution in different mice compartments was studied in vivo [11]. 
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2. Peptide design 
 Figure 1 shows a schematic illustration of both RGD-(GC)2 and (GC)2 
peptides. The RGD-(GC)2 peptide is a chimeric molecule of 12 amino acids 
containing two parts: encompassing an RGD-sequence and a (GC)2-motif for integrin 
targeting and nanoparticle stabilization, respectively. The RGD-containing part was 
derived from the c(RGDfK) peptide, an αvβ3 antagonist, where the lysine residue was 
replaced by glutamic acid to allow the conjugation to the (GC)2-motif by its γ-
carboxylic group. The (GC)2 portion contains a sequence of glycines and cysteines 
needed for the binding to the gold surface via Au-S covalent bond and providing 
nanoparticle stabilization against aggregation, allowing a parallel disposition towards 
gold surface.  
 
3. Peptide synthesis 
 The peptides were synthesized by Dr. Laura Zaccaro’s group at the Institute of 
Biostructures and Bioimages (Naples). A standard Fmoc 
(fluorenylmethyloxycarbonyl) solid-phase strategy was applied, using NovaSyn TGR 
resin (loading 0.28 mmol/g resin), and all the standard amino acids except for Fmoc-
Glu-OAll. The amino acids in 10-fold excess were preactivated with 2-(1H-
benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (HBTU) (9.8 
equiv)/1-hydroxybenzotriazole (HOBT) (9.8 equiv)/DIPEA (10 equiv) in DMF for 5 min 
and then added to the resin in the presence of DIPEA (10 equiv) in DMF.  
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The Cys residues were coupled in 5-fold excess with HBTU (5 equiv)/2,4,6-
trimethylpyridine (5 equiv) in DMF/DCM (1:1 v/v) for 90 min without preactivation to 
prevent racemisation [12]. The Fmoc deprotection step was performed with 30% 
piperidine in DMF for 10 min. Before the final Fmoc deprotection of the Arg1 in RGD-
(GC)2, a selective deprotection of the Glu residue from the allyl group was carried out 
by treatment of the peptidyl resins with PhSiH3 (24 equiv)/Pd(PPh3)4 (0.25 equiv) in 
DCM twice for 30 min. The cyclisation reaction was carried out on the resin with 
benzotriazole-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate (PyBop) (1.5 
eqiv)/HOBT (1.5 equiv)/DIPEA (2 equiv) in DMF for 3 h and monitored by Kaiser test. 
The peptides were cleaved off the resin by treatment with a mixture of trifluoroacetic 
acid/water/ethandithiol/triisopropylsilane (94:2.5:2.5:1 v/v/v/v) for 3 h at room 
temperature. The resins were filtered and the crude peptides were precipitated with 
diethyl ether, dissolved in a H2O/CH3CN solution and lyophilized. The products were 
purified by preparative RP-HPLC on a Shimadzu system equipped with a UV-visible 
detector SPD10A using a Phenomenex Jupiter Proteo column (21.2×250 mm; 4 µm; 
90 Å) and a linear gradient of H2 (0.1% TFA)/CH3CN (0.1% TFA) from 5 to 70% of 
CH3CN (0.1% TFA) in 30 min at flow rate of 20 mL/min. The collected fractions 
containing the peptides were lyophilized.  
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Figure 1. a) (GC)2 peptide; b) RGD-(GC)2 peptide. 
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The identity and purity of the compounds were assessed by ESI-LC-MS 
ThermoFinnigan instrument equipped with a diode array detector combined with an 
electrospray ion source and ion trap mass analyser on Phenomenex C18 column 
(250× 2 mm; 4µm; 90 Å) at flow rate of 200 µL/min. The peptide yield was 21% and 
95% for RGD-(GC)2 and (GC)2, respectively. Figure 2 shows RP-HPLC 
chromatograms and corresponding mass spectra of (GC)2 and RGD-(GC)2 pure 
peptides. 
 
 
Figure 2. RP-HPLC chromatograms and corresponding mass spectra of (a) (GC)2 and (b) RGD-
(GC)2. 
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4. Synthesis of gold nanoconjugates 
4.1. Au-RGD-(GC)2 nanoparticles preparation 
 In a typical reaction, to 0.06 mmol of NaAuCl4 (50.7 mM) in 60 mL of Milli-Q 
water 3·10-5 mmol of RGD-(GC)2 aqueous solution (3.95 mM) was added, under 
stirring. After 10 min, 0.12 mmol of sodiumborohydride aqueous solution (112 mM) 
was quickly added and left under vigorous stirring for further few hours. The particles 
were purified by dialysis for 48 h, by using Spectra/Por 6 dialysis tubing, 2K MWCO. 
 
4.2. Au-(GC)2 nanoparticles preparation 
 In a typical reaction, to 0.03 mmol of NaAuCl4  (34.1 mM) in 40 mL of Milli-Q 
water 21·10-5 mmol of (GC)2 aqueous solution (0.796 mM) was added, under stirring. 
After 10 min, 0.06 mmol of sodiumborohydride aqueous solution (100 mM) was 
quickly added  and left under vigorous stirring for further few hours. The particles 
were purified by dialysis for 48 h, by using Spectra/Por 6 dialysis tubing, 2K MWCO. 
 
 
 
 
 
 
 
 
 
Chapter IV  
 
 
162 
 
 
 
 
 
Scheme 2. Au-RGD-(GC)2 nanoparticles preparation. 
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5. Results and discussion 
 AuNPs were prepared using “one-pot” sodium borohydride reduction method 
in the presence of RGD-(GC)2 and (GC)2 peptides to give small nanoparticles of 10.2 
nm and 13.9 nm, respectively. The conjugation of AuNPs with peptides was 
confirmed by 1H NMR and ATR-FTIR spectroscopy, the stability of the conjugates 
was verified using both UV-vis spectroscopy and Zeta-potential studies, while their 
morphology analysed by TEM.  
 In order to match the conditions at which the nanoparticles were the most 
stable, the molar ratios between Au(III), peptides and sodium borohydride were 
varied. The reaction termination was detected by the constancy of SPR absorbance 
value, which, generally, stopped growing after 2 hours. The UV-vis spectra of 
conjugated AuNPs are reported in Figure 3.  
 
 
Figure 3. UV-vis spectra of Au-(GC)2 (a) and Au-RGD-(GC)2 (b) NPs prepared using various 
ratios between AuCl4- , peptides and sodium borohydride. 
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Having analyzed the SPR band position and its intensity for every sample, we 
choose 1:0.005:2 and 1:0.001:2 molar ratios for (GC)2 and (RGD)-(GC)2 peptides, 
respectively. All further experiments were carried out using the AuNPs prepared by 
the two conditions. The SPR band of as-prepared Au-(GC)2 NPs was found at 514 
nm, while Au-RGD-(GC)2 NPs shown the SPR band at 529 nm. 
 The as-prepared Au-(GC)2 and Au-RGD-(GC)2 NPs shown a shape close to 
spherical and mean diameter of 13.9 and 10.2 nm, respectively, as found by TEM 
analysis (Figure 4 (b, c). 
 
Figure 4. a) UV-vis spectra of: Au-RGD-(GC)2 NPs (black line, 529 nm); Au-(GC)2 NPs (red line, 
514 nm); b) TEM micrograph of Au-RGD-(GC)2 NPs (10.2 nm); c) TEM micrograph of Au-(GC)2 
NPs (13.9 nm). 
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Hydrodynamic diameter values, obtained by DLS, revealed the presence of 
small aggregates, also clearly observed by TEM, giving the fractions close to 45-46 
nm for both kinds of conjugates (Figure 5, a and b). 
 Zeta-potential measurements were run using the original sols diluted with Milli-
Q water. The particles were found negatively charged with Zeta-potential values of -
27.27 mV and -40.59 mV for Au-RGD-(GC)2 and Au-(GC)2, respectively. The 
difference between the Zeta-potential values can be due to a different local 
environment surrounding a single nanoparticle, and can depend on: surface 
concentration of the peptides on the particle, possible ionic dissociations or 
zwitterionic forms of the peptides, disposition of the peptide molecules on the particle 
surface, interactions of the two organic chains with water, and, most importantly, 
ionic strengths of the solutions [13]. 
 
Figure 5. DLS diagrams of particle hydrodynamic diameter distribution: a) Au-RGD-(GC)2 NPs, 
b) Au-(GC)2 NPs. 
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 In order to have an idea of coverage density on the nanoparticle surface, the 
number of peptide molecules per particle was determined by TGA analysis. For this 
purpose, the nanoparticles were lyophilized, purified from residual unbound peptides 
by repeated washing with Milli-Q water and centrifugation, and, finally, dried. The 
thermograms of both conjugates show a first weight loss between room temperature 
and 120°C due to the evaporation of residual and physisorbed water that can be 
neglected in our calculations (Figure 6). The weight losses of 1.609% and 1.058% 
were recorded in the 120-450°C heating range, and assigned to the combustion of 
the peptides bound to the particle surface. The number of peptide molecules residing 
on each gold particle was calculated, using a simple equation described by De Palma 
and co-workers [14], giving the numbers of 94 and 298 molecules for RGD-(GC)2 and 
(GC)2 peptides, respectively. 
 
, 
 
where N is the number of ligands on each particle, R is the mean radius of the 
AuNPs, ρ is the density of the nanoparticles (19.30 g/cm3), NA is Avogadro’s number, 
MM is the molar mass of the ligand molecules (g/mol) and ω is the mass loss in 
percent (%). 
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Figure 6. a) TGA curve of Au-RGD-(GC)2 NPs. Main weight loss of about 1.609 % from RGD-( 
GC)2 peptide occurs from 120 to 450 °C. (b) TGA curve of Au-(GC)2 NPs. Main weight loss of 
about 1.058 % from (GC)2 peptide occurs from 120 to 450 °C. Residual water is lost at 120 °C. 
 
In order to verify the binding of the peptides to nanoparticle surface and 
investigate the interactions in the ligand shell of the conjugates, ATR-FTIR and NMR 
spectroscopy were performed. A comparison between ATR-FTIR spectra of free 
peptides and gold conjugates are shown in Figures 7, 8. Pure RGD-(GC)2 and (GC)2 
peptides (solid line, Figures 7, 8) show similar FTIR spectra.  
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The only difference is in the amide I and II regions, where (GC)2 shows two peaks 
located at 1644 and1540 cm-1, while RGD-(GC)2 peaks fall at 1655 and 1534 cm-1. In 
the N-H stretching region (GC)2 has a sharper band located at 3292 cm-1, whereas 
RGD-(GC)2 shows a broader two component band with one component at 3301 and 
a shoulder at 3205 cm-1. The S-H stretching vibration falls around 2550 cm-1 for free 
cysteine, which vibration, unfortunately, was not clearly revealed in any of the 
recorded FTIR spectra. In pure (GC)2 peptide, a broad feeble band located at 2547 
cm-1 appears, but in the literature a feeble but sharp band of the S-H vibration is 
usually reported [15]. The whole spectrum of (GC)2 is strongly affected after 
interaction with gold surface (Figure 7): amide I and II bands undergo a significant 
splitting and the band located at 1644 cm-1 in the free peptide now shows a main 
component at 1652 cm-1 plus a shoulder at 1620 cm-1, and, in addition, two bands at 
1698 and 1687 cm-1 appear; the band at 1540 cm-1 is split in three components at 
1555, 1544 and 1513 cm-1, respectively. The N-H stretching band, which in the free 
peptide is located at 3264 cm-1, is almost absent when (GC)2 interacts with gold, 
probably, forbidden by surface selection rules. This result agrees with a flat and 
parallel disposition of (GC)2 over gold surface. 
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Figure 7. ATR-FTIR spectra of (GC)2 peptide (solid line) and Au-(GC)2 NPs (dashed line) in 3500-
2500 cm-1 (a) and 2000-600 cm-1 region. 
 
 
 
Figure 8. ATR-FTIR spectra of RGD-(GC)2 peptide (solid line) and Au-RGD-(GC)2 NPs (dashed 
line) in 3500-2500 cm-1 (a) and 2000-600 cm-1 region. 
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 The changes are also evident in the spectrum of RGD-(GC)2 peptide after 
conjugation with gold nanoparticles (dashed line, Figure 8): amide I band shows two 
feeble components at 1686 and 1646 cm-1, while amide II shows a broad band 
centered at 1455 cm-1. The N-H stretching vibrations are also affected: in the free 
peptide a strong absorption at 3301 cm-1 with 3195 and 3065 cm-1 less intense 
components are present, whereas the only strong band at 3221 cm-1 is evident upon 
interaction. These data suggest that both CO and NH groups of the amide bonds are 
affected by the interaction of the peptides with gold surface, and that the backbone 
conformation and the hydrogen bonding pattern of the conjugated peptides undergo 
significant changes. 
 FTIR results were correlated with NMR spectroscopy data to further validate 
the binding of the peptides to the gold nanoparticles and identify key organic residues 
involved in the interaction. First of all, 1H NMR spectra of the free peptides were 
recorded and proton resonance signals were attributed to the most important peptide 
components. 
 Due to the fast tumbling of these small peptides, no NOE contacts could be 
observed in 2D [1H, 1H] NOESY experiments [16], thus, we recorded 2D [1H, 1H] 
ROESY spectra [17]. By comparing 2D [1H, 1H] TOCSY and 2D [1H, 1H] ROESY we 
were able to identify all the different spin-systems and sequentially assign them 
(Figure 9). In particular, the presence of strong sequential ROE contacts of the HNi-
Hαi-1 type allowed us to clearly connect all the residues. 
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Figure 9. Comparison of 2D [1H, 1H] TOCSY (a,c) and 2D [1H, 1H] ROESY (b,d) spectra of the 
(GC)2 and RGD-(GC)2 peptides. Intra-residue HNi-Hαi and sequential HNi-Hαi-1 connectivities are 
indicated. 
 
 1D proton spectra of Au-(GC)2 NPs (Figure 10, b) shown an evident change of 
peptide resonances after interaction with gold, where a large broadening of all the 
signals was observed. Cysteine residues are highly influenced and their β-CH2 proton 
signals either move or totally disappear, with respect to the corresponding peak in 
the spectrum of the free (GC)2 peptide (Figure 10, a). Similarly, we compared 1D 
proton and 2D [1H, 1H] TOCSY spectra of the RGD-(GC)2 peptide with those of the  
 
Chapter IV  
 
 
172 
Au-RGD-(GC)2 nanoparticles (Figure 11, 12). In the spectrum of Au-RGD-(GC)2 NPs, 
the interaction between the peptide with large hydrophobic gold surface causes a 
severe enlargement of all the NMR lines (Figure 11, lower panel). The line 
broadening is, in fact, widespread in the 1D proton spectrum in the HN and aromatic 
region as well as in the side-chain region. It’s worth noting that the peak around 2.9 
ppm, corresponding to the β-CH2 groups of the cysteines in the free peptide, 
vanishes when the peptide is conjugated to the particles (Figure 11, b). 
 
 
 
Figure 10. Comparison of 1D proton spectra of the (GC)2 peptide (a) and Au-(GC)2 nanoparticles 
(b). Spectral regions containing signals from side-chain protons are shown. 
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This feature has been previously observed for resonances belonging to the protons 
that are located rather close to the gold surface [18]. The changes can be better seen 
in the 2D [1H, 1H] TOCSY spectra (Figure 12). Since the large broadening of the 
resonances causes the loss of many peaks and highly reduces the quality of the 2D 
spectrum, the use of a cold-probe allows us to partially overcome this problem. In 
fact, spin systems for Ala, Arg, Asp and Glu are easily recognised in the spectrum of 
the Au-RGD-(GC)2 NPs (Figure 12, b). 
 
 
Figure 11. Comparison of 1D proton spectra of the RGD-(GC)2 peptide (a, b, upper panels) and 
Au-RGD-(GC)2 nanoparticles (a, b, lower panels). An expansion of the HN and aromatic protons 
region is reported in (a) while signals from side-chain protons are shown in (b). 
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Correlations between HN and side chain protons disappear for the two Cys residues. 
Line broadening comes along with the small chemical shift changes mainly affecting 
the backbone HN group of the Arg (8.05 ppm in the apo-form and 8.16 ppm in the 
bound-form) as well as the β-CH2 protons of the Asp (2.75-2.61 ppm in the apo-form 
and 2.82-2.64 ppm in the bound-form), thus, indicating that only a small structural 
rearrangement takes place in the peptide-cyclic portion. 
 
 
Figure 12. Comparison of 2D [1H, 1H] TOCSY spectra of the RGD-(GC)2 peptide (a) and Au-RGD-
(GC)2 nanoparticles (b). The HN-aliphatic protons correlation region is reported and spin 
systems assignments indicated. 
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From the perusal of spectroscopic ATR-FTIR and NMR data a number of 
conclusions about the conjugation of the peptides to gold particle can be drawn: a 
strong interaction of the (GC)2 part with gold surface via the sulphur atom of cysteine 
residues results in a strong perturbation of CO and NH groups and disappearance of 
Cys β-CH2 proton signal. On the contrary, the rigid RGD ring seems to be almost 
unaffected upon interaction with gold: from NMR spectra only a minor structural 
rearrangement of the peptide-cyclic portion can be detected; in the FTIR spectrum, 
amide I and amide II bands show the patterns different from those found in the Au-
(GC)2 spectrum, likely, because of the amide I band to be forbidden by surface 
selection rules causing its low intensity. Summing-up, the interaction between (GC)2 
or RGD-(GC)2 and AuNPs mainly consists in the formation of S-Au bonds between 
the cysteine residues of (CG)2 part and gold surface, leaving the RGD moiety almost 
unaffected and free for the interaction with integrin receptor.  
 For cellular uptake studies, peptide conjugated nanoparticles were added to 
cultures of U87 cells, a human glioblastoma cell line, and the cellular uptake was 
compared after different incubation times, using confocal microscopy (Figure 13, a-
d). Importantly, the extent of cellular uptake in each case was vastly different: a large 
amount of Au-RGD-(GC)2 conjugates was found to be present into cellular body even 
after 5 min of incubation (Figure 13, b), while Au-(GC)2 particles were hardly taken up 
by the cells even after 30 min of incubation (Figure 13, c). The quantitative extent of 
cellular uptake was evaluated by measuring the pixel brightness of the confocal 
images. The cellular areas nearly equal to 780 µm2, containing conjugated gold 
nanoparticles, were examinated by using Leica Confocal Software.  
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The results of the experiments are reported in Table 1, showing a huge difference 
between the pixels related to the cells treated with RGD-containing nanoparticles and 
(GC)2 conjugated nanoparticles, respectively.  
 
Table 1. Comparison of Au-RGD-(GC)2 and Au-(GC)2 nanoparticles uptaken by U87 
glioblastoma cells. The brightness (pxl) of similar areas (780 µm2) measured by the images 
collected by confocal microscopy of Au-RGD-(GC)2 and Au-(GC)2 nanoparticles was calculated 
by the Leica Confocal Software. 
 
 
 
 
 
As expected, the amount of Au-RGD-(GC)2 particles taken up by the cells is 
growing along with incubation time, giving the pixel brightness of 0.87 and 13.3 after 
5 and 30 min of incubation, respectively. On the contrary, the cells incubated with the 
particles conjugated with peptide lacking RGD-moiety, shown the pixel brightness 
near to the zero.  
In order to better understand the uptake mechanism and discover the fate of 
the particles into the cellular body, TEM experiments were performed. For this 
purpose, the cells were incubated with the nanoconjugates for 1 hour. The results of 
these experiments are shown in Figures 14-15. The nanoparticles functionalized by 
linear (GC)2 peptide are approaching the cellular membrane after 1 h of incubation, 
however, are not able to cross it and be taken up by the cells (Figure 14).  
 
Peptide Pixel brightness (5 min) Pixel brightness (30 min) 
RGD-(GC)2 0.87 13.3 
(GC)2 0.07 0 
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Figure 13. Cellular uptake of conjugated gold nanoparticles into U87 cells recorded by confocal 
microscopy in the reflection mode: a) Au-(GC)2 after 5 min incubation, b) Au-RGD-(GC)2 after 5 
min incubation, c) Au-(GC)2 after 30 min incubation, d) Au-RGD-(GC)2 after 30 min incubation. 
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Figure 14. TEM image of Au-(GC)2 nanoparticles incubated with U87 cells for 1 hour. The 
AuNPs are located outside the cellular membrane (black arrows). 
 
 
 On the contrary, Au-RGD-(GC)2 NPs are found while crossing cellular 
membrane and enclosed into the endosomes (Figure 15, a, b, e). These findings are 
in accordance with confocal microscopy results, supporting an internalization 
mechanism via integrin-receptor mediated endocytosis [19]. Of extreme interest is 
that the RGD-conjugated nanoparticles were also found crossing nuclear pore 
complex, accumulated inside the nucleus and even into the nucleolus (Figure 15, c 
and d). 
 Nuclear delivery is known to be a challenging task, since the nanoparticles, 
once into the cell, must escape endosomal/lysosomal pathways, possess a nuclear 
localization sequence, and be small enough (<30 nm) to cross the nuclear membrane 
via nuclear pores [20]. 
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Figure 15. TEM images of internalization of Au-RGD-(GC)2 NPs into the U87 cells after 1 hour of 
incubation. Particles are found: a) crossing cellular membrane; b), e) enclosed into the 
endosomes; c), d) crossing nuclear pore complex and into the nucleus and nucleolus. 
 
 
In fact, the presence of nanoparticles free in the cytoplasm does suggest endosomal 
escape mechanism to take place, allowing the nanoparticles to get free to be ready 
to interact with nuclear pore complex (Figure 15, a). Even if RGD-peptide has not 
ever been recognized as nuclear localization signal (NLS) peptide, it appears to be 
able to perform this functionality. 
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Undoubtedly, the internalization mechanism and nanoparticle fate still need to be 
explored in details, performing more specific experiments, as the ability to direct the 
“cargo” nanoparticles into the nucleus has been a task of a great interest so far. 
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 6. Concluding remarks 
 The RGD sequence is currently the basic module for a variety of molecules 
designed for the preferential binding to αVβ3 integrin. The affinity of RGD peptides for 
their ligands may be affected by steric conformation of the peptide. Indeed, the 
cyclization is commonly employed to improve the binding properties of RGD 
peptides, conferring rigidity to the structure. The RGD peptide sequence is normally 
flanked by other amino acids to build a ring system, offering a possibility to present 
the RGD sequence in a specific conformation for a selected integrin [21]. Integrins 
are able to mediate adhesive events during various cancer stages such as malignant 
transformation, tumor growth and progression, invasion, and metastasis. Among all 
integrins, αVβ3 is probably the most strongly involved in the regulation of 
angiogenesis. Importantly, αVβ3 integrin is widely expressed on blood vessels of 
human tumors but not on the vessels in normal tissues. 
 Nanoparticles can be grafted at their surface with a targeting ligand such as an 
RGD-based sequence. Several advantages are attributable to these nanoconjugates: 
their size leads to the “passive targeting” of tumors via the so-called enhanced 
permeability and retention effect; because of their size, renal filtration is avoided, 
leading to prolonged blood circulation times and longer accessibility of the ligand to 
target receptors within the tissue; RGD-targeted nanoparticles may specifically 
address drugs to angiogenic endothelial cells or cancer cells by the binding of the 
RGD peptide to αVβ3 overexpressed by these cells, allowing the “active” targeting of 
the tumors; RGD-targeted nanoparticles can be internalized via receptor-mediated  
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endocytosis, which is not possible with single peptide construct or with nontargeted 
nanoparticles. Subsequently, intracellular drug cytosolic release occurs, followed by 
direct killing of endothelial cells. The destruction of the endothelium in solid tumors 
can result in the death of tumor cells induced by lack of oxygen and nutrients [4]. 
 Inspired by these facts, we designed and synthesized small (10-14 nm) gold 
nanoparticles covalently conjugated with an RGD-containing peptide. The 
nanoconjugates were fully characterized by a number of spectroscopic and 
microscopic methods, leading to the following findings: (GC)2 linear part of the RGD-
containing peptide was confirmed to be covalently bound to the gold surface via two 
Cys residues, while RGD-motif was free and ready to integrin receptor recognition. 
After incubation with U87 glioblastoma cells, the nanoparticles expressing RGD 
sequence where found taken up by the cells and distributed in different cellular 
compartments, while Au-(GC) 2 nanoparticles were not able to penetrate the cellular 
membrane. The internalization mechanism was studied by TEM, confirming the 
receptor-mediated endocytosis pathway followed by an endosomal escape, since the 
nanoparticles were found also free in the cytosol. Moreover, the nanoparticles were 
even able to cross nuclear membrane complex and were found into the nucleus and 
nucleolus. A further, more detailed understanding of the nanoparticle fate inside the 
cell is needed though. A quantitative analysis of the cellular uptake, carried out by 
pixel brightness measurements, confirmed the importance of RGD motif and the 
conservation of the conformation needed for the peptide to be active in integrin-
binding. 
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1. Introduction 
The specific labeling of proteins is a key to revealing their dynamics and 
functions in living cells [1]. However, many conventional methods used to generate 
fluorescently tagged proteins and image them in their native environment are time-
consuming and dificult, requiring expertise in protein chemistry, the successful 
microinjection of labeled products into cells, and specialized techniques [2]. Recently, 
a new modern approach, called Halo Tag technology, applied for cellular imaging, 
protein quantification and interaction analysis has been developed. It is designed to 
provide new options for rapid, side-specific labeling of proteins in living cells and in 
vitro, and based on the efficient formation of a covalent bond between the Halo Tag 
protein and synthetic ligands (Figure 1). The Halo Tag protein is a catalytically 
inactive, genetically modified derivative of a hydrolase protein [3]. This 33kDa 
monomeric protein can be used to generate N- or C-terminal fusions that can be 
efficiently expressed in a variety of cell types. The Halo Tag ligands are small 
chemical tags capable of covalently labeling the Halo Tag protein. These contain two 
crutial components: a common Halo Tag reactive linker that initiates formation of the 
covalent bond and a functional reporter such as a fluorescent dye or affinity handles 
such biotin. The rate of the ligand-protein binding is remarkably fast. The stability of 
the covalent bond easily allows fixed-cell imaging. The covalent bond forms rapidly 
under physiological conditions, is highly specific and essentially irreversible yielding a 
stable complex even under denaturing conditions. The flexibility to create labeled 
Halo Tag fusion proteins with a wide range of optical properties and functions allows  
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to image and localize labeled Halo Tag protein fusions in live- or fixed-cell  
populations as well as isolate and analyze Halo Tag protein fusions and protein 
complexes [3]. 
Several requirements are needed for specific ligand to be active for interaction 
with Halo Tag protein: the linker between halide and functional group should be 14 
atoms long and contain 6 carbon atoms proximal to the terminal chloride (Figure 2) 
[4]. Normally, nanoparticle bioconjugates are prepared via formation of new chemical 
bonds between functional groups associated with a nanoparticle and a biomolecule 
or small molecule of interest. In general, the structure of a nanoparticle bioconjugate 
affects its function, and the controlled display of biomolecules on NPs is paramount 
in obtaining conjugates with well-defined and reproducible properties [5].  
 
 
Figure 1. A schematic representation of Halo Tag Technology: a) Halo Tag protein is fused with 
a protein of interest, and a Halo Tag specific ligand is added; b) Halo Tag ligand is recognized 
by Halo Tag-containing protein. 
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Figure 2. Halo Tag ligand building blocks: a) Halo Tag Thiol (O4); b) Halo Tag Amino (O4). 
 
For creating a continuous passivation layer around AuNPs thiol compounds 
have been widely used, allowing efficiently improve their stability and dispersity in 
aqueous solution. This is mainly attributed to the fact that the thiol groups can bind 
covalently to the surface of AuNPs via an Au−S bond. Currently used thiol 
compounds mainly include glutathione (GSH), mercaptopropionic acid (MPA), 
cysteine, cystamine, dihydrolipoic acid (DHLA), thiol-ending polyethylene glycol 
(PEG-SH) etc [6-17]. As found by Ren et al., PEG-SH-modified AuNPs are most 
stable in aqueous solution compared to other thiol compounds [18]. Conjugation of 
appropriately chosen functional molecules is then used to control the interaction of 
the nanoparticles with a desired target, affording functional AuNPs that specifically 
interacts with the proteins [19], nucleic acids [20], or other nanoparticles [21]. These 
few examples clearly show that the ligand shell surrounding the gold core is of 
paramount importance for its functionality. Conjugation of peptides, proteins and 
other biologically active molecules to the ligand shell of AuNPs, and not directly to 
the Au surface through the Au-S bond, is an appealing strategy to preserve their 
biological activity. For this purpose the AuNPs need to be capped by a mixed ligand  
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shell displaying some functionalizable groups, and an efficient coupling reaction for 
attachment of the peptide to these reactive groups is established [22]. We have 
already had an experience in attaching biologically active thiol-containing peptides 
and proteins directly to the gold surface, observing a successful preservation of their 
biological functionality [23, 24].  
The goal of this work was to design and synthesize gold nanoparticles 
conjugated with Halo Tag functional ligands, in order to obtain bioactive conjugates 
with a number of properties, such as stability in a wide pH range and physiological 
media, certain size and functionality. These particles should be able to be recognised 
by Halo Tag protein expressed in different cellular compartments of interest.  
From a wide range of available Halo Tag ligands, we have chosen a thiol- and 
an amino-containing molecules (Figure 2). Different techniques have been used to 
obtain the conjugates, and their properties have been compared on the basis of the 
synthesis method used. To stabilize the nanoparticles, a mixture of short PEGs, 
containing –OH, -COOH and –NHS functional groups, has been used. The choice of 
a modified PEG provides the functionality to coordinate to the Au surface while 
providing a well-ordered packing layer near the NP surface. This PEG layer provides 
a shield between the biological target and AuNP surface, thus reducing nonspecific 
interactions between the two [25]. 
The Halo Tag Thiol ligand has been used both for direct conjugation to the 
gold surface and conjugation via a spacer separating the PEG layer and Halo Tag 
ligand. The spacer allows to expose the active chlorine atom from the particle surface 
to be coupled to the Halo Tag protein in the cells.  
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Figure 3. An overview of cellular imaging using Halo Tag conjugation: A) cells are transfected 
with a vector containing Halo Tag fusion protein; B) the cells expressing Halo Tag protein 
fused with a protein of interest are incubated with a Halo Tag functional ligand; C) the cells are 
visualised by confocal microscopy. 
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The Halo Tag Amino ligand has been conjugated via two different ways in order to 
campare their impact on the conjugates` properties: a EDC/sulfo-NHS coupling 
reaction involving –COOH groups of the PEG, and a direct conjugation to the PEG 
containing –NHS reactive groups [26].  
A detailed characterization of the conjugates has been performed, using a 
number of up-to-date techniques. Biological studies including internalization 
experiments are now in progress and are going to be continued during my post-doc 
research. 
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2. Synthesis of monolayer-protected AuNPs 
As a basis, gold nanoparticles stabilized by citrate ions have been used. 
Citrate molecules can be readily exchanged with thiol-containing ligands in a very 
short period of time, followed by a formation of a self-assembly monolayer (SAM) 
[27]. For this purpose, citrate nanoparticles have been prepared by a modified 
Turkevich-Frens method [28,29] and subsequently stabilized and functionalized by a 
shell of thiolated PEG molecules [30, 31].  
 
2.1. Au-citrate nanoparticles (GNP) 
Gold nanoparticles of 16±1.28 nm diameter have been prepared by quickly 
mixing a boiling solution of HAuCl4 trihydrate(15 mg, 40 µmol) in 150 mL of Milli-Q 
water with 4.5 mL of warm (60-80 °C) 1 % (wt) aqueous solution of trisodium citrate, 
followed by reflux for 60 min. The resulted nanoparticle suspension was then allowed 
to cool down to room temperature and stirred overnight. The nanoparticles were 
filtered using a 0.45 µm Millipore filter before use, and characterized by UV-vis 
spectroscopy, TEM and analytical centrifugation (DSC). 
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2.2. Conjugation of Halo Tag Thiol ligand 
2.2.1. Direct conjugation of Halo Tag Thiol (O4) ligand to GNP: GNP@PEG-OH-
Halo Tag Thiol (O4) nanoparticles 
For direct conjugation, a mixture containing Halo Tag Thiol ligand and 
thiolated PEG with terminal hydroxyl groups was used (Scheme 1). Due to the 
presence of a thiol goup, Halo Tag Thiol molecule is able to make a covalent bond 
with the gold surface contributing to the SAM layer surrounding nanoparticle [32], 
while PEG-OH layer protects against nonspecific interaction between AuNP surface 
and biological target. 
As prepared GNP were conjugated with PEG-OH and Halo Tag Thiol (O4) 
ligands via citrate exchange method introducing in the ligand shell both 3% and 10 % 
of the latter ligand. The modification of AuNPs with PEG and Halo Tag Thiol (O4) 
ligands was carried out as follows. PEG HS-C11(EG)4-OH was dissolved in methanol 
to give 0.156 M stock solution. Halo Tag Thiol (O4) ligand was dissolved in DMSO to 
give 0.0152 M stock solution, which was stored at -20 °C. The ligands were pre-
mixed in desired proportions in methanol in order to obtain the final volume of 200 
µL. The total number of ligands to cover gold particle surface was considered 20500. 
Subsequently, the methanol-ligand mixture was added quickly under vigorous stirring 
to 30 mL of 2.58 nM GNP dispersion. The ligands were allowed to attach to the 
particles overnight, followed by washing by repeated centrifugation at 13500 rpm for 
20 min at 10 °C. 
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The amount of Halo Tag Thiol ligand in the ligand shell was varied from 3% to 
10% in order to compare both the properties of the conjugates and their colloidal 
stability, and their biological behaviour. UV-vis spectra of GNPs before conjugation 
(Figure 4, a, b; black line) show a SPR band at 522 nm, which shifts to 524 nm after 
exchange of citrate ions by Halo Tag Thiol molecules. Moreover, the absorbance of 
the SPR band increases in both cases confirming a change of the local extinction 
coefficient of the medium surrounding the particle [33]. The results of analytical 
centrifugation performed on a disc sedimintation centrifuge shown a considerable 
shift: diameter of citrate nanoparticles obtained by this method is 13.5 nm, while it 
undergoes a significant change to 12.1 nm and even 11.9 nm with increasing content 
of Halo Tag Thiol molecule in the ligand shell from 3% to 10%, respectively (Figure 5, 
a, b). 
 
Scheme 1. Representation of direct conjugation of Halo Tag Thiol ligand to citrate-stabilized 
gold nanoparticles. 
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Figure 4. UV-vis spectra of AuNPs: a) GNP-522 nm (black line); GNP@PEG-OH(97%)-Halo Tag 
Thiol (O4) (3%)- 524 nm (red line); b) GNP-522 nm (black line); b) GNP@PEG-OH(90%)-Halo Tag 
Thiol (O4) (10%)- 524 nm (red line). 
 
 
 
Figure 5. Analytical centrifugation patterns of AuNPs: a) GNPs-13.5 nm (black line); Au@PEG-
OH(97%)-Halo Tag Thiol (O4) (3%)-12.1 nm (red line); b) GNP-13.5 nm (black line); b) Au@PEG-
OH(90%)-Halo Tag Thiol (O4) (10%)- 11.9 nm (red line). 
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TEM results illustrated the presence of very monodispersed well separated 
particles with similar mean diameters of 15.91±1.13 nm (Figure 5) and 15.28±0.83 
nm (Figure 6). Interestingly, the particles were able to form a kind of self-assembled 
2D structures under natural dewetting process by slow evaporation of nanoparticle-
containing solvent on the TEM grid [34].  
 
 
Figure 6a. TEM micrograph of GNP@PEG-OH(97%)- Halo Tag Thiol (O4) (3%): a) scale bar 200 
nm; b) scale bar 500 nm; c) size distribution histogram (15.91±1.13 nm mean particle diameter). 
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Figure 6b. TEM micrograph of GNP@PEG-OH(90%)-Halo Tag Thiol (O4) (10%): a) scale bar 500 
nm; b) scale bar 200 nm; c) size distribution histogram (15.28±0.83 nm mean particle diameter). 
 
To confirm the successful modification of GNPs with PEG and Halo Tag 
ligands, we measured the zeta-potentials of unmodified and modified particles. The 
results indicated the zeta-potentials of conjugated particles were significantly different 
from those of unmodified citrate GNPs: -14.3 and -15.2 mV versus -32.7 mV for 
citrate GNPs. The zeta-potential values considerably increased for functionalized 
nanoparticles due to the contribution of a great number of “neutral” PEG-OH 
molecules. However, the chlorine atom of the Halo Tag Thiol ligand is responsible for 
a negative particle charge. Infact, the zeta-potential of the particles containing 10% of 
Halo Tag Thiol ligand resulted slightly more negative (Figure 7).  
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Figure 7. Zeta-potential of gold nanoparticles: black line- GNP, -32.7 mV; red line-Au@PEG-OH-
Halo Tag Thiol (O4): a) 3%, -14.3 mV; b) 10%, -15.2 mV. 
 
To be useful for biological applications or for building nanostructures using 
biological interactions, gold nanoparticles have to be stable over a wide range ionic 
strength and pH in the absence of an excess of capping ligand [35]. Halo Tag-
capped nanoparticles were first separated from the excess of the ligand and citrate 
by repeated centrifugation and re-dispersion in PBS. 
As an empirical measurement of the aggregation process, an aggregation 
parameter, which measures the variation of the integrated absorbance between 600 
and 700 nm, was used. The aggregation parameter AP is defined as follows: AP=(A-
A0)/A0, where A is the integrated absorbance between 600 and 700 nm of the sample 
at a given moment and A0 is the integrated absorbance between 600 and 700 nm of 
the initial, fully dispersed solution of nanoparticles [36]. Figure 8 (a-c) shows the pH-
induced aggregation patterns of Halo Tag Thiol-capped nanoparticles, prepared by 
direct conjugation, with 3% and 10% of bioactive molecule in the ligand shell (black 
and red line, respectively). 
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Figure 8. UV-vis spectra of Au@PEG-OH (97%)-Halo Tag Thiol (O4) (3%) (a) and Au@PEG-
OH(90%)-Halo Tag Thiol (O4) (10%) (b) in PBS and different pH solutions. The pH values were 1, 
3, 5, 7, 9, 11 and 13. (c) Stability against pH-induced aggregation of Au@PEG-OH (97%)-Halo 
Tag Thiol (O4) (3%) (black line) and Au@PEG-OH(90%)-Halo Tag Thiol (O4) (10%) (red line). 
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It is clear that the particles with major content of the ligand show a better 
stability both in PBS and at acidic pH, with aggregation parameter maximum less 
than 0.2. While PEGylated nanoparticles are subjected to a slight aggregation at 
acidic pH, probably due to protonation of terminal –OH groups.  
The most of the bioassays are performed in the presence of buffers and salts 
up to the concentration of 300 mM NaCl. To be properly used in cellular uptake 
studies, the nanoconjugates must be as much as possible stable in presence of salts. 
Figure 9 represents the results on the stability of the conjugates in high concentrated 
NaCl solutions. No aggregation of the nanoparticles was detected even in extremely 
high salt conditions: incubated with NaCl, both particles were stable up to 3M 
concentration. The same behaviour is observed in this case: the particles containing 
10% of Halo Thiol ligand appear more stable with a very low aggregation parameter 
less than 0.1. 
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Figure 9. UV-vis spectra of Au@PEG-OH (97%)-Halo Tag Thiol (O4) (3%) (a) and Au@PEG-
OH(90%)-Halo Tag Thiol (O4) (10%) (b) in mQ water and different NaCl solutions. The NaCl 
concentrations were 1M, 2M and 3M. (c) Stability against NaCl-induced aggregation of 
Au@PEG-OH (97%)-Halo Tag Thiol (O4) (3%) (black line) and Au@PEG-OH(90%)-Halo Tag Thiol 
(O4) (10%) (red line). 
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2.2.2. Conjugation of Halo Tag Thiol (O4) ligand via cystamine spacer 
An alternative and valuable approach to conjugate Halo Tag molecules 
requires a deliberate separation of the functionalization process from the passivation: 
first the particles are covered by a mixture of PEGs with different functional groups 
aiming to protect the particle, and serves as a loading platform for the bioactive Halo 
Tag ligands. 
To realise this, a siutable linker between the passivation layer and biomolecule 
should be used. Using a mixture of PEGs, where a hydroxyl PEG-SH used in access 
is responsible for colloidal stabilization, while a small amount of a carboxyl PEG-SH 
is introduced for covalent functionalization with cystamine linker. Cystamine is 
decarboxylated cystine, a small disulfide-containing molecule with primary amines at 
both ends. Here, cystamine is used as an activating reagent for disulfide exchange 
reaction [37-39]. The cystamine-modified nanoparticles then are mixed with the Halo 
Tag Thiol ligand, where the latter cleaves the disulfide of cystamine-modified 
particles, releasing 2-mercaptoehylamine and forming a disulfide crosslink (Scheme 
2). This method is supposed to improve the accessibility of the Halo Tag ligand and, 
subsequently, of the chlorine atom to be recognized by the Halo Tag protein. 
In practice, as prepared citrate GNP were conjugated with PEG-OH and Halo 
Tag Thiol (O4) ligands via citrate exchange method introducing in the ligand shell 
both 5% and 10 % of the latter ligand. First, GNP were covered by PEG-OH and 
PEG-COOH molecules, loading in the passivation layer both 5% and 10% of –COOH 
groups. In brief, the modification of GNP with PEG ligands was carried out as follows.  
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PEG HS-C11(EG)4-OH and PEG HS-C11(EG)6-CH2-COOH were dissolved in 
methanol to give 0.101 M and 0.00148 M stock solutions, respectively. The ligands 
were pre-mixed in desired proportions in methanol in order to obtain the final volume 
of 200 µL. The total number of PEG to cover gold particle surface was considered 
20500. Subsequently, the methanol PEG mixture was added quickly under vigorous 
stirring to 30 mL of 3.1 nM GNP dispersion. The ligands were allowed to attach to the 
particles overnight, followed by washing by repeated centrifugation at 13500 rpm for 
20 min at 10 °C. Purified PEGylated nanoparticles were resuspended in 12 mL of 
PBS to give 7.5 nM (5% PEG-COOH) and 8.14 nM (10% PEG-COOH) concentration. 
Cystamine dihydrochloride was dissolved in PBS to give 4.8 mM stock solution. EDC 
was dissolved in Milli-Q water to give a 6mM stock solution which was kept freezed at 
-20 °C. An aliquot of cystamine solution to obtain a 20-fold molar excess over the 
amount of –COOH groups present was added: 32 µL and 69.5 µL corresponding to 
5% and 10% of –COOH groups, respectively. Subsequently, an aliquot of EDC 
solution (128 µL for 5% -COOH and 278 µL for 10%-COOH) in order to obtain a 5-
fold molar excess over the amount of cystamine present was added. The 
nanoparticles were allowed to react for 2 hours at room temperature. Afterwards, the 
excess of cystamine and EDC was eliminated by repeated centrifugation at 13500 
rpm for 20 min at 10 °C. The purified nanoparticles were resuspended in Milli-Q 
water to give final concentrations of 7.96 nM (5%) and 8.07 nM (10%). As prepared 
gold nanoparticle dispersion was loaded between 12 protein lo-bind eppendorf tubes 
(1.0 mL each). Finally, an aliquot of Halo Tag Thiol (O4) ligand (1 µL for 5% -COOH 
and 2.2 µL for 10%-COOH) in order to obtain a 2-fold molar excess over the amount  
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of activated –COOH groups present was added. The reaction was allowed to 
proceed overnight. Excess Halo Tag Thiol ligand was removed by repeated 
centrifugation and resuspension in PBS. 
A red-shift from 520 to 522 nm occured when citrate ions stabilising GNPs 
were substituted by PEG-OH and PEG-COOH molecules. An increase of SPR band 
absorbance was indicative of a change of the environment surrounding the particles 
– the density of PEG molecules is different from that of citrate. Importantly, the 
particles remained stable and no change in SPR band was found after repeated 
centrifufìgation and final re-dispersion in PBS for further coupling. After cystamine 
conjugation, a further shift of 2 nm occured for the particles containig 10% PEG-
COOH.  
Finally, when functionalized by Halo Tag Thiol ligand attached to the 
cystamine spacer, the SPR band mooves from 522 to 524 nm in both cases, 
indicating a successful coupling reaction. 
Analytical centrifugation data show a considerable shift of 0.7 nm (from 12.4 
nm to 11.7 nm) when the GNPs are covered by the mixture of PEG and 5% of 
cystamine. While increasing the content of cystamine linker to 10%, the shift 
becomes larger (0.8 nm) indicating the presence of a greater number of cystamine 
molecules sticking out. When functionalized by Halo Tag Thiol, the ligand shell 
becomes thicker resulting in a subsequent shift of 0.1 nm (Figure 12). These data are 
in accordance with those obtained for the GNPs functionalized by direct conjugation 
of the Halo Tag Thiol ligand.  
 
Chapter V  
 
 
206 
 
Figure 10. UV-vis spectra of AuNPs: a) GNP-520 nm (black line); GNP@PEG-OH(95%)-PEG-
COOH(5%)- 522 nm (red line); b) GNP@PEG-OH(95%)-PEG-COOH(5%) redispersed in PBS- 522 
nm (black line); GNP@PEG-OH(95%)-PEG-COOH-cystamine(5%)- 522 nm (red line); GNP@PEG-
OH(95%)-PEG-COOH-cystamine-Halo Tag Thiol (O4)(5%)-524 nm (blue line). 
 
 
Figure 11. UV-vis spectra of AuNPs: a) GNP-520 nm (black line); GNP@PEG-OH(90%)-PEG-
COOH(10%)- 522 nm (red line); b) GNP@PEG-OH(90%)-PEG-COOH(10%) redispersed in PBS- 
522 nm (black line); GNP@PEG-OH(90%)-PEG-COOH-cystamine(10%)- 524 nm (red line); 
GNP@PEG-OH(90%)-PEG-COOH-cystamine-Halo Tag Thiol (O4)(10%)- 524 nm (blue line). 
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Scheme 2. Representation of Halo Tag Thiol conjugation to citrate-stabilized gold 
nanoparticles via PEG –SH passivation and functionalization using cystamine linker. 
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Figure 12. Analytical centrifugation patterns of AuNPs: a) GNPs-12.4 nm (black line); Au@PEG-
OH(95%)-PEG-COOH-cyst (5%)-11.7 nm (red line); Au@PEG-OH(95%)-PEG-COOH-cyst-Halo 
Tag Thiol (O4) (5%)-11.6 nm (green line); b) GNP-12.4 nm (black line); Au@PEG-OH(90%)-PEG-
COOH-cyst (10%)- 11.6 nm (red line); Au@PEG-OH(90%)-PEG-COOH-cyst-Halo Tag Thiol (O4) 
(10%)-11.5 nm (green line). 
 
Figure 13. Zeta-potential of gold nanoparticles: black line- GNP, -22.5 mV; a) red line-Au@PEG-
OH (95%)-PEG-COOH-cystamine (5%), -14.2 mV; blue line-Au@PEG-OH (95%)-PEG-COOH-
cystamine-Halo Tag Thiol (O4) (5%), -11.2 mV; b) red line-Au@PEG-OH (90%)-PEG-COOH-
cystamine (10%), -18.7 mV; blue line-Au@PEG-OH (90%)-PEG-COOH-cystamine-Halo Tag Thiol 
(O4) (10%), -11.4 mV. 
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Like nanoparticles prepared via direct Halo Tag Thiol conjugation, those 
containing cystamine linker result to have a negative zeta-potential. The particles 
containing 95% of PEG molecules in the ligand shell are less negative (-14.2 mV) in 
comparison with their analogues containing 90% of PEG (-18.7 mV), that is explained 
by the “neutral nature” of the PEG-OH used. The zeta-potential moves in more 
positive region after conjugation of Halo Tag Thiol to the cystamine, becoming -11.2 
mV and -11.4 mV, respectively (Figure 13), as chlorine groups are now present on 
the particle surface. 
TEM results indicate the as-prepared particles to have a spherical shape and 
a narrow distribution with mean diameters of 16.59±1.25 and 16.19±1.2 nm for the 
conjugates containig 5%- and 10%-Halo Tag Thiol, respectively (Figures 14, 15). The 
particles are found to be able to form a lattice-like structures via self-assembly on the 
carbon coated copper grid. It seems that the assembly of the particles takes place 
only when deposited on a surface, as no secondary SPR band at longer wavelengths 
is detected by UV-vis spectroscopy. 
Theorically, hydrogen atoms of PEG-OH molecule may electrostatically 
interact with chlorine of Halo Tag Thiol ligand, leading to a self-assembly. However, 
at the same time, the stabilisation capacity of PEG is high enougth to keep the 
assembled clasters stable. As shown in Figure 13, at a lower Halo Tag Thiol 
concentration (5%), the particles are unevenly distributed and form patch-like 
structures with depletion particles. While at a higher Halo Tag Thiol concentration 
(10%), the nanoparticles seem to be more evenly distributed (Figure 15) [40]. 
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Figure 14. Figure X. TEM micrograph of GNP@PEG-OH(95%)-PEG-COOH-Cyst-Halo Tag Thiol 
(O4) (5%): a) scale bar 500 nm; b) scale bar 200 nm; c) size distribution histogram ( 16.59±1.25 
nm mean diameter). 
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Figure 15. Figure X. TEM micrograph of GNP@PEG-OH(90%)-PEG-COOH-Cyst-Halo Tag Thiol 
(O4) (10%): a) scale bar 100 nm; b) scale bar 200 nm; c) size distribution histogram ( 16.19±1.2 
nm mean diameter). 
 
Stability experiments were carried out incubating both cystamine-modified 
PEGylate nanoparticles and Halo Thiol-conjugates. The cystamine-containig 
PEGylated particles appeared to be stable both in PBS and at the basic and neutral 
pH (Figure 16). Aggregation parameter values vary from 0 to 0.23 for the particles 
containing 5% cystamine. Those containing 10% of cystamine seem to be less stable 
in highly acidic pH (pH 1) showing aggregation parameter value around 0.55 (Figure 
17). Nevertheless, both particles demonstrate no pH-induced aggregation and colour 
change even at extreme pH values.  
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The conjugation of Halo Thiol ligand allowes to improve pH-induced aggregation 
stability, as the aggregation parameter values significantly decreases in whole pH 
interval concerned. Salt-induced aggregation resistance was estimated incubating 
Halo Thiol-conjugated nanoparticles in 1-3M NaCl solutions, and comparing 
aggregation parameter values with those obtained for nanoparticles re-dispersed in 
mQ water.  
 
Figure 16. UV-vis spectra of Au@PEG-OH (95%)-cystamine (5%) (a), Au@PEG-OH(95%)-cyst-
Halo Tag Thiol (O4) (5%) (b), Au@PEG-OH (90%)-cystamine (10%) (c), Au@PEG-OH(90%)-cyst-
Halo Tag Thiol (O4) (10%) (d) in PBS and different pH solutions. The pH values were 1, 3, 5, 7, 9, 
11 and 13. 
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We were interested in testing only Halo Thiol-conjugated nanoparticles, since these 
were going to be used in internalization experiments with cells, and compare their 
stability depending on the amount of Halo Thiol legand used. Figure 18 shows UV-vis 
spectra of the particles containing 5% (a) and 10% (b) of Halo Tag Thiol molecule in 
the ligand shell. No change of the SPR band profile is detected when the 
nanoparticles are exposed to the high salt concentrations indicating an excellent 
colloidal stability even in extreme conditions. However, the particles containig major 
amount (10%) of Halo Tag Thiol ligand possess a better stability, being the 
aggregation parameter a little lower (Figure 18, red line).  
In conclusion, a comparison of the two conjugation methods indicates that 
gold nanoparticles synthesised via cystamine linker show better colloidal stability 
both against pH- and NaCl-induced aggregation. Moreover, the cystamine-containing 
nanoparticles loaded with 10% of Halo Tag Thiol ligand demonstrate the lowest 
aggregation parameter, and, thus, are the most stable among the studied samples 
(Figure 19). In order to understand the efficacy of the both conjugation methods form 
biological piont of view, internalization experiments with Halo Tag protein transfected 
cells are needed, providing more data on the exposition of the chlorine atom to be 
specifically recognized by the protein. 
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Figure 17. Stability against pH-induced aggregation of Au@PEG-OH (95%)-cystamine (5%) (a) 
(black line), Au@PEG-OH(95%)-cyst-Halo Tag Thiol (O4) (5%) (a) (red line), Au@PEG-OH (90%)-
cystamine (10%) (b) (black line), and Au@PEG-OH(90%)-cyst-Halo Tag Thiol (O4) (10%) (b) (red 
line). 
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Figure 18. UV-vis spectra of Au@PEG-OH (95%)-cyst-Halo Tag Thiol (O4) (5%) (a) and 
Au@PEG-OH(90%)-cyst-Halo Tag Thiol (O4) (10%) (b) in mQ water and different NaCl solutions. 
The NaCl concentrations were 1M, 2M and 3M. (c) Stability against NaCl-induced aggregation of 
Au@PEG-OH (95%)-cyst-Halo Tag Thiol (O4) (5%) (black line) and Au@PEG-OH(90%)-cyst-Halo 
Tag Thiol (O4) (10%) (red line). 
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Figure 19. Comparison of the stability against (a) pH-induced aggregation of Au@PEG-
OH(97%)-Halo Tag Thiol (O4)(3%) (black line), Au@PEG-OH(90%)-Halo Tag Thiol (O4)(10%) (red 
line), Au@PEG-OH(95%)-cyst-Halo Tag Thiol (O4)(5%) (blue line), and Au@PEG-OH(90%)-cyst-
Halo Tag Thiol (O4)(10%) (green line); (b) Stability against NaCl-induced aggregation of 
Au@PEG-OH(97%)-Halo Tag Thiol (O4)(3%) (black line), Au@PEG-OH(90%)-Halo Tag Thiol 
(O4)(10%) (red line), Au@PEG-OH(95%)-cyst-Halo Tag Thiol (O4)(5%) (blue line), and Au@PEG-
OH(90%)-cyst-Halo Tag Thiol (O4)(10%) (green line). 
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2.3. Conjugation of Halo Tag Amino (O4) ligand 
The approach applied to conjugate amino-containing Halo Tag ligand to the 
particles involves the using of a zero-length cross-linking agent, mediating the 
conjugation of two molecules by forming a bond containing no additional atoms. 
Carbodiimides are used to mediate the formation of amide linkage between 
carboxylates and amines [41-43]. They are probably the most popular type of zero-
length crosslinker in use, being efficient in forming conjugates between two protein 
molecules, between a peptide and a protein, between an oligonucleotide and a 
protein, between a biomolecule and a particle, or any combination of these with small 
molecules. EDC (or EDAC, 1-ethyl-3-)3-dimethylaminopropyl)carbodiimide 
hydrochloride) is the most frequently used crosslinking agent in order to conjugate 
biological substances containing carboxylates and amines. Its application in particle 
conjugation procedures along with sulfo-NHS (N-hydroxysulfosuccinimide) is nearly 
universal and commonly used nowadays. EDC is water-soluble, which allows for its 
direct addition to a reaction without prior organic solvent dissolution. 
Both the reagent itself and the isourea formed as the by-product of the 
crosslinking reaction are water-soluble and may be removed easily by dialysis or 
centrifugation. Most references to the use of EDC describe the optimal reaction 
medium to be at a pH from 4.7 to 6.0 [44]. However, the carbodiimide reaction occurs 
effectively up to at least pH 7.5 without significant loss of yield. Given the reactivity of 
EDC, a more stable active intermediate can be formed, using sulfo-NHS (N-
hydroxysulfosuccinimide).  
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Formed sulfo-NHS esters are hydrophilic reactive groups that coulpe rapidly with 
amines on target molecules [44]. In the presence of amine nucleophiles that can 
attack at the carbonyl group of the ester, the sulfo-NHS group rapidly leaves, creating 
a stable amide linkage with the amine. Thus, amino-containing Halo Tag ligand is 
subsequently added to the active intermediate and a stable peptidic bond between -
COOH group of PEG molecule and -NH2-group of Halo Tag is formed. 
Rao et al. used this strategy to conjugate a bioluminescent protein genetically 
fused with Halo Tag protein via its N-terminus to carboxilated quantum dots [4]. They 
shown this method to be straightforward enougth, since covalent bond formation 
between the protein and targeting ligand was successfully occured just mixing them 
under physiological conditions. In another research work, Rao and co-workers 
genetically fused the Halo Tag protein to a cell membrane anchoring domain to 
present Halo Tag protein extracellularlly for the quantum dots labelling. By live cell 
fluorescent imaging they confirmed that the labelling was specific and took place at 
the cell surface [4]. 
 
2.3.1. Conjugation of Halo Tag Amino (O4) ligand by EDC/sulfo-NHS coupling 
reaction 
As prepared citrate GNPs were conjugated with PEG-OH and Halo Tag Amino 
(O4) ligands via citrate exchange method introducing in the ligand shell both 5% and 
10 % of the latter ligand. First, GNPs were covered by PEG-OH and PEG-COOH 
molecules, loading in the passivation layer both 5% and 10% of –COOH groups. 
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The modification of the GNPs with PEG ligands was carried out as follows. PEG HS-
C11(EG)4-OH and PEG HS-C11(EG)6-CH2-COOH were dissolved in methanol to give 
0.101 M and 0.00148 M stock solutions, respectively. The ligands were pre-mixed in 
methanol in desired proportions in order to obtain the final volume of 200 µL. The 
total number of PEG to cover gold particle surface was considered 20500. 
Subsequently, the methanol PEG mixture was added quickly under vigorous stirring 
to 30 mL of 3 nM GNP dispersion. The ligands were allowed to attach to the particles 
overnight, followed by washing by repeated centrifugation at 13500 rpm for 20 min at 
10 °C. Purified PEGylated nanoparticles were resuspended in 10 mL of PBS to give 
6.88 nM (5% PEG-COOH) and 7.49 nM (10% PEG-COOH) concentration. To 
activate the –COOH groups on the particle surface for covalent conjugation, 5 µL of 
both freshly prepared EDC (6 mM) and 5 sulfo-NHS solutions (6 mM) were added to 
the nanoparticles’ dispersion and mixed vigorously at 25 °C for 15 min [ref 45]. 
Excess EDC and sulfo-NHS were separated from the activated nanoparticles by 
three rounds of centrifugation at 13500 rpm for 20 min at 10°C and resuspension in 
PBS. The purified activated particles were finally resuspended in 1 mL (5%-COOH) 
and 1.3 mL (10%-COOH) of PBS. Subsequently, the particles were reacted with the 
Halo Tag Amino ligand (0.0014 mM, 5 µL and 14.2 µL for 5%- and 10%-COOH 
containing particles, respectively) at 25°C overnight. Excess Halo Tag Amino ligand 
was removed by repeated centrifugation and resuspension in PBS. A schematic 
representation of the conjugation steps is shown in Scheme 3. 
The starting citrate GNPs show a characteristic SPR band at 520 nm, which 
significantly shifts to longer wavelengths at 526 nm after passivation by PEG mixture 
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Scheme 3. Representation of Halo Tag Amino conjugation to citrate-stabilized gold 
nanoparticles via PEG –SH passivation and functionalization using EDC/sulfo-NHS coupling 
reaction.
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(Figure 20, 21). When the particles are washed and redispersed in PBS the SPR 
band moves at 528 nm, probably, because of concentration of the dispersion used 
for further coupling. When conjugated with Halo Tag Amino ligand, a little blue-shift of 
the SPR band takes place, however, its intensity is maintained, indicating good 
resistance to the coupling reaction. Figure 22a shows the results of analytical 
centrifugation analysis. A large shift takes place after exchange between citrate ions 
and PEG molecules: initial value of 12.4 nm now becomes 11.5 nm. Further shift is 
hardly detectable, however, the peak becomes more narrow after coupling reaction, 
indicating a narrower particle distribution and better stability (Figure 22b). 
 
 
Figure 20. UV-vis spectra of AuNPs: a) GNP-520 nm (black line); GNP@PEG-OH(95%)-PEG-
COOH(5%)- 526 nm (red line); b) GNP@PEG-OH(95%)-PEG-COOH(5%) in PBS-528 nm (blue 
line); GNP@PEG-OH(95%)-PEG-COOH-Halo Tag Amino (O4) (5%)-526 nm (magenta line). 
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Figure 21. UV-vis spectra of AuNPs: a) GNP-520 nm (black line); GNP@PEG-OH(90%)-PEG-
COOH(10%)- 526 nm (red line); b) GNP@PEG-OH(95%)-PEG-COOH(5%) in PBS-528 nm (black 
line); GNP@PEG-OH(95%)-PEG-COOH-Halo Tag Amino (O4) (5%)-526 nm (red line). 
 
 
Figure 22. Analytical centrifugation patterns of AuNPs: a) GNPs-12.4 nm (black line); Au@PEG-
OH(95%)-PEG-COOH(5%)-11.5 nm (red line); Au@PEG-OH(95%)-PEG-COO-Halo Tag Thiol 
(O4)(5%)-11.5 nm (green line); b) GNP-12.4 nm (black line); Au@PEG-OH(90%)-PEG-
COOH(10%)- 11.5 nm (red line); Au@PEG-OH(90%)-PEG-COO-Halo Tag Thiol(O4)(10%)-11.5 nm 
(green line).
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Zeta-potential studies confirmed the nanoparticles to be negatively charged 
with zeta-potential value changing after every conjugation step: citrate GNPs show 
the value of -22.5 mV, which becomes less negative after exchange reaction 
between citrate ions and PEG molecules, due to domination of “neutral” PEG-OH in 
the ligand shell. Infact, particles containing 95% PEG-OH show less negative zeta-
potential (-11.3 mV) comparing to those containing 90% PEG-OH (-16.9 mV) (Figure 
23, red line). After coupling reaction, Halo Amino-conjugated nanoparticles have a 
more negative zeta-potential of -15.7 mV and -22.2 mV for 5%- and 10%-loading, 
respectively (Figure 23, blue line). This confirms the successful coupling reaction and 
presence of a negatively charged molecules in the ligand shell [46-47]. 
 
 
Figure 23. Zeta-potential of gold nanoparticles: black line- GNP; red line-Au@PEG-OH-PEG-
COOH, and blue line-Au@PEG-OH-PEG-COOH-Halo Tag Amino (O4): a) 5%, b)10%. 
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TEM results are shown in Figures 24, 25. The particles slightly differ in 
diameter, being of 16.12±1.25 and 14.77±1.26 nm for 5%- and 10%-Halo Tag Amino 
content, respectively. The disagreement in the mean diameter is due to the using of 
two different batches of starting citrate GNP. The disposition of nanoparticles looks 
different from the previously discussed conjugates prepared by different methods 
(Figure 7, 15). In particular, the nanoparticles loaded with 5% Halo Tag Amino ligand 
are evenly distributed on the copper grid, creating a mass of long wires side by side. 
On the other hand, 10%-loaded nanoparticles show a different picture, forming short 
and long clastered wires.  
 
Figure 24. Figure X. TEM micrograph of GNP@PEG-OH(95%)-PEG-COOH-Halo Tag Amino (O4) 
(5%): a) scale bar 200 nm; b) scale bar 500 nm; c) size distribution histogram ( 16.12±1.25 nm 
mean diameter). 
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Figure 25. Figure X. TEM micrograph of GNP@PEG-OH(90%)-PEG-COOH-Halo Tag Amino (O4) 
(10%): a) scale bar 500 nm; b) scale bar 200 nm; c) size distribution histogram ( 14.77±1.26 nm 
mean diameter). 
 
Both PEGylated and Halo Tag Amino-conjugated nanoparticles maintain the 
stability in PBS and against pH-induced aggregation in basic, acidic and neutral 
medium. UV-vis spectra are reported in Figure 26 and indicate a preservation of the 
SPR band shape and position even at extreme pH. Aggregation parameter refered to 
a value of the area (600-700 nm) of the nanoparticles incubated in neutral pH 7 has a 
linear trend, characterizing a good stability. Independently of Halo Tag Amio loading, 
the stability of both systems improves comparing with PEGylated nanoparticles 
(Figure 27). 
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Figure 26. UV-vis spectra of Au@PEG-OH (95%)-PEG-COOH (5%) (a), Au@PEG-OH (95%)-PEG-
COOH-Halo Tag Amino (O4) (5%) (b), Au@PEG-OH (90%)-PEG-COOH (10%) (c), Au@PEG-OH 
(90%)-PEG-COOH-Halo Tag Amino (O4) (10%) (d) in PBS and different pH solutions. The pH 
values were 1, 3, 5, 7, 9, 11 and 13. 
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Figure 27. Stability against pH-induced aggregation of (a) Au@PEG-OH (95%)-PEG-COOH (5%) 
(black line), Au@PEG-OH (95%)-PEG-COOH-Halo Tag Amino (O4) (5%) (red line), and (b) 
Au@PEG-OH (90%)-PEG-COOH (10%) (black line), Au@PEG-OH (90%)-PEG-COOH-Halo Tag 
Amino (O4) (10%) (red line). 
 
A similar trend is observed when the nanoparticles are incubated with the 
solutions containig different salt concentration. The SPR band does not change the 
shape and position, as well as the colour of the dispersions remains unchanged. Like 
in other cases, major loading of the ligand (10%) improves stability against NaCl-
induced aggregation (Figure 28).  
Mixed alkanethiols layers, typically with a ratio of 10-30% of carboxyl-
functionalized molecules vs. nonfunctionalized ones, have been successfully used to 
avoid aggregation of small nanoparticles such as quantum dots upon carbodiimide-
based protein coupling [48]. 
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Figure 28. UV-vis spectra of Au@PEG-OH(95%)-PEG-COO-Halo Tag Amino (O4) (5%) (a) and 
Au@PEG-OH(90%)- PEG-COO-Halo Tag Amino (O4)(10%) (b) in mQ water and different NaCl 
solutions. The NaCl concentrations were 1M, 2M and 3M. (c) Stability against NaCl-induced 
aggregation of Au@PEG-OH(95%)-PEG-COO-Halo Tag Amino (O4) (5%) (black line) and 
Au@PEG-OH(90%)- PEG-COO-Halo Tag Amino (O4)(10%) (red line). 
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2.3.2. Direct conjugation of Halo Tag Amino (O4) ligand to the PEG-NHS 
containing layer 
Another way to conjugate Halo Tag Amino ligand with PEG shell is to use a 
PEG containig functional NHS group. In this case, no EDC/sulfo-NHS coupling 
reaction is needed being PEG molecule already activated and ready to be 
conjugated. The conjugates were prepared as follows (Scheme 4). 
As prepared citrate GNPs were conjugated with PEG-COOH and Halo Tag 
Amino (O4) ligands introducing in the ligand shell 5%, 10% and 15 % of the latter 
ligand. First, GNPs were covered by PEG-COOH and PEG-COONHS molecules via 
citrate exchange method, using the above amounts of –COONHS groups. The 
modification of the GNP with PEG ligands was carried out as follows. PEG HS-
C11(EG)4-COOH and PEG HS-C11(EG)6-OCH2-COONHS were dissolved in methanol 
to give 0.101 M and 0.023 M stock solutions, respectively. The ligands were pre-
mixed in methanol in desired proportions in order to obtain the final volume of 200 
µL. The total number of PEG to cover gold particle surface was considered 20500. 
Subsequently, the methanol PEG mixture was added quickly under vigorous stirring 
to 20 mL of 2.58 nM GNPs dispersion. The ligands were allowed to attach to the 
particles overnight, followed by washing by repeated centrifugation at 14000 rpm for 
12 min at 10 °C. The purified PEGylated nanoparticles were resuspended in 8 mL, 3 
mL and 3 mL of PBS to give 3.7 nM, 5.11 nM and 4.02 nM particle concentration for 
5%, 10% and 15% -COONHS content, respectively. These particles do not need to 
be activated, originally having –COONHS groups.  
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Thus, the resuspended particles were reacted with the Halo Tag Amino ligand 
(0.000143 mM, 212 µL, 219 µL and 259 µL for 5%-, 10%-, and 15%-COONHS 
containing particles, respectively) at 25°C overnight. Excess Halo Tag Amino ligand 
was removed by repeated centrifugation and resuspension in PBS. 
 UV-vis spectra of GNPs before conjugation, covered by PEG molecules and 
after coupling reaction with different amounts of Halo Tag Amino ligand are reported 
in Figures 29-31. When GNPs are passivated by PEG molecules, independently of 
the ratio between the components in the “passivation” mixture, SPR band shifts of 4 
nm towards longer wavelengths and its intensity rises in absorbance, indicating the 
exchange between citrate and PEG molecules and formation of a monolayer. After 
redispersion of washed and concentrated PEGylated particles in PBS, the SPR band 
is unchanged, giving a first indication of a good colloidal stability.  
 
Figure 29. UV-vis spectra of AuNPs: a) GNP-518 nm (black line); GNP@PEG-COOH(95%)-PEG-
COONHS(5%)- 522 nm (red line); b) GNP@PEG-COOH(95%)-PEG-COONHS(5%) in PBS-522 nm 
(blue line); GNP@PEG-COOH(95%)-PEG-CO-NH-Halo(5%)-524 nm (magenta line). 
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Scheme 4. Representation of Halo Tag Amino conjugation to citrate-stabilized gold 
nanoparticles via HS-PEG–COOH and NHS-containing PEG-SH passivation. 
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Figure 30. UV-vis spectra of AuNPs: a) GNP-520 nm (black line); GNP@PEG-COOH(90%)-PEG-
COONHS(10%)- 524 nm (red line); b) GNP@PEG-COOH(90%)-PEG-COONHS(10%) in PBS-524 
nm (blue line); GNP@PEG-COOH(90%)-PEG-CO-NH-Halo(10%)-524 nm (magenta line). 
 
Figure 31. UV-vis spectra of AuNPs: a) GNP-520 nm (black line); GNP@PEG-COOH(85%)-PEG-
COONHS(15%)- 524 nm (red line); b) GNP@PEG-COOH(85%)-PEG-COONHS(15%) in PBS-524 
nm (blue line); GNP@PEG-COOH(85%)-PEG-CO-NH-Halo(15%)-524 nm (magenta line). 
 
While Halo Amino-conjugated nanoparticles show a slight (2 nm) shift of the SPR 
band to 524 nm and a decrease in intensity, confirming the changes in the ligand 
shell. 
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Analytical centrifugation results are shown in Figure 32. A large shift of the 
particle diameter values takes place when GNPs are covered by PEG layer: diameter 
of citrate GNPs of 13.4 nm changes to give 12.1 nm for the particles with a 5% 
amount of active NHS groups, while for the particles containing 10 and 15% of PEG-
NHS the shift is even larger being 11.9 nm.This confirms UV-vis preliminary results 
on the successful ligand exchange between citrate ions and PEG. A further shift from 
11.9 to 11.7 nm can be clearly observed when the particles are conjugated with 15% 
Halo Tag Amino ligand, while in the case of minor ligand amounts the shift is hardly 
seen due to the increase of ligand shell diameter (Figure 32, c). 
Zeta-potential results shown the change of the values after each 
functionalization step: initial zeta-potential value of -32.7 mV corresponding to citrate 
GNPs becomes less negative after passivation by PEG mixture because of the 
contribution of sulfo-NHS neutral groups, while it turnes to be more negative after 
conjugation with Halo Tag Amino ligand, due to the negative chlorine terminal groups 
(Figure 33). 
TEM images of final conjugated nanoparticles are reported in Figures 34-
36.The mean particle diameter obtained by TEM is around 17 nm and has a narrow 
distribution. Like in the case of the particles conjugated with Halo Tag Amino ligand 
via EDC/sulfo-NHS, the as-prepared particles are able to form chain-like structures 
via self-assembly. It is likely due to the presence of a large amount of carboxylic 
groups in the PEG shell, which can form intermolecular hydrogen bonds. However, a 
more detailed study of all the systems is needed to better understand the origin of  
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Figure 32. Analytical centrifugation patterns of AuNPs: a) GNPs-13.4 nm (black line); Au@PEG-
COOH(95%)-PEG-COONHS (5%)-12.1 nm (red line); Au@PEG-COOH(95%)-PEG-COO-Halo Tag 
Amino (O4) (5%)-12.1 nm (green line); b) GNP-13.4 nm (black line); Au@PEG-COOH(90%)-PEG-
COONHS (10%)- 11.9 nm (red line); Au@PEG-COOH(90%)-PEG-COO-Halo Tag Amino (O4) 
(10%)-11.9 nm (green line), c) GNP-13.4 nm (black line); Au@PEG-COOH(85%)-PEG-COONHS 
(15%)- 11.9 nm (red line); Au@PEG-COOH(85%)-PEG-COO-Halo Tag Amino (O4) (15%)-11.7 nm 
(green line). 
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Figure 33. Zeta-potential of gold nanoparticles: black line- GNP, -32.7 mV; a) red line-Au@PEG-
COOH (95%)-PEG-COONHS (5%), -20.7 mV; blue line-Au@PEG-COOH (95%)-PEG-COO-Halo 
Tag Amino (O4) (5%), -24.8 mV; b) red line-Au@PEG-COOH (90%)-PEG-COONHS (10%), -23.6 
mV; blue line-Au@PEG-COOH (90%)-PEG-COO-Halo Tag Amino (O4) (10%), -24.5 mV; c) red 
line-Au@PEG-COOH (85%)-PEG-COONHS (15%), -16.7 mV; blue line-Au@PEG-COOH (85%)-
PEG-COO-Halo Tag Amino (O4) (15%), -22.1 mV. 
 
these assembly fenomena and, probably, find them a future application. 
The stability of both PEGylated and Halo Amino-conjugated particles against 
pH- and NaCl-aggregation was examined in the above range of pH (1-13) and salt 
concentrations (1-3 M). The results slightly differ from those obtained for other kinds 
of particles. Figure 37 represents a set of UV-vis spectra showing the change in the 
SPR band both of PEGylated GNP and those conjugated using sulfo-NHS containing 
PEG incorporated in the ligand shell. These results clearly indicate that in the pH 
range 13-5 the particles form a well dispersed suspension in water exhibiting a 
characteristic SPR band at 524 nm. We did not observe any change in the spectra or 
suspension colour in the whole pH range. However, on further decreasing of pH to 3, 
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a large shift of the SPR band along with a colour change from red to violet took 
place. At pH<3 the spectra did not change further and became almost saturated 
without any shifting of SPR band. 
 
 
Figure 34. TEM micrograph of GNP@PEG-COOH(95%)-PEG-COONHS-Halo Tag Amino (O4) 
(5%): a) scale bar 500 nm; b) scale bar 200 nm; c) size distribution histogram ( 17.17±1.02 nm 
mean diameter). 
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Figure 35. TEM micrograph of GNP@PEG-COOH(90%)-PEG-COONHS-Halo Tag Amino (O4) 
(10%): a) scale bar 500 nm; b) scale bar 200 nm; c) size distribution histogram ( 16.96±1.28 nm 
mean diameter). 
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Figure 36. TEM micrograph of GNP@PEG-COOH(85%)-PEG-COONHS-Halo Tag Amino (O4) 
(15%): a) scale bar 500 nm; b) scale bar 200 nm; c) size distribution histogram ( 16.96±1.28 nm 
mean diameter). 
 
These observations can be explained as follows. In general, pKa values of carboxylic 
acids vary slightly depending on the chemical environment. The –COOH groups are 
completely acidified below their pKa value and usually form an intermolecular H-
bonds as shown in Scheme 5 [49]. The H-bonding between two –COOH groups of 
surface-bound PEG molecules brings the nanoparticles into close proximity to form 
an assembled structure and results in the development of another SPR band in a 
higher-wavelength region as a result of the coupling of interparticle plasmon 
resonance of GNPs.  
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Scheme 5. An overview of reversible pH-induced aggregation of gold nanoparticles covered by 
PEG-COOH: protonation of –COO- groups under pH<4; intermolecular H-bonding; nanoparticle 
aggregates formation and reversible disaggregation under basic conditions. 
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Figure 37. UV-vis spectra of Au@PEG-COOH (95%)-PEG-NHS (5%) (a), Au@PEG-COOH (95%)-
PEG-NHS-Halo Tag Amino (O4) (5%) (b), Au@PEG-COOH (90%)-PEG-NHS (10%) (c), Au@PEG-
COOH (90%)-PEG-NHS-Halo Tag Amino (O4) (10%) (d), Au@PEG-COOH (85%)-PEG-NHS (15%) 
(e) and u@PEG-COOH (85%)-PEG-NHS-Halo Tag Amino (O4) (15%) (f) in PBS and different pH 
solutions. The pH values were 1, 3, 5, 7, 9, 11 and 13.
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In order to understand if the assembly process was reversible, 0.1M NaOH 
solution was added to the assembly medium in order to increase the pH to 10, 
resulting in a colour change from violet to initial red, indicating a disassembly process 
(Figure 38). It is clear that the assembly process is driven by hydrogen-bonding 
interactions, as no red shift of SPR band was observed in the case of Halo Tag Thiol 
conjugation where the –COOH groups were lacking.  
 
 
 
 
 
    
 A                                  B 
Figure 38. Reversible aggregation of AuNPs: A) After addition of NaOH solution, AuNPs turn 
back red; B) aggregated AuNPs. 
 
Figure 39 describes the change of aggregation parameter calculated from UV-
vis spectra as function of pH. The patterns are very similar in the basic and neutral 
pH, indicating that Halo Tag Amino conjugation does not improve the stability of 
nanoparticles respect to PEGylated ones nor influences the stability against pH-
induced aggregation.  
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Figure 39. Stability against pH-induced aggregation of (a) Au@PEG-COOH (95%)-PEG-NHS 
(5%) (black line) and Halo Tag Amino (O4)-conjugated (5%) (red line), (b) Au@PEG-COOH 
(90%)-PEG-NHS (10%) (black line) and Halo Tag Amino (O4)-conjugated (10%) (red line), and (c) 
Au@PEG-COOH (85%)-PEG-NHS (15%) (black line) and Halo Tag Amino (O4)-conjugated (15%) 
(red line). 
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Figure 40. UV-vis spectra of Au@PEG-COOH (95%)-PEG-NHS-Halo Tag Amino (O4) (5%) (a), 
Au@PEG-COOH (90%)-PEG-NHS-Halo Tag Amino (O4) (10%) (b) and Au@PEG-COOH (85%)-
PEG-NHS-Halo Tag Amino (O4) (15%) (c) in mQ water and different NaCl solutions. The NaCl 
concentrations were 1M, 2M and 3M. (d) Stability against NaCl-induced aggregation of 
Au@PEG-COOH (95%)-PEG-NHS-Halo Tag Amino (O4) (5%) (black line), Au@PEG-COOH (90%)-
PEG-NHS-Halo Tag Amino (O4) (10%) (red line) and Au@PEG-COOH (85%)-PEG-NHS-Halo Tag 
Amino (O4) (15%) (green line). 
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On the contrary, the stability against NaCl-induced aggregation slightly 
decreases with increasing loading of Halo Tag Amino ligand on the particle surface 
(Figure 40, c). 
In conclusion, aggregation parameter patterns for all the systems based on 
Halo Tag Amino ligand and obtained by two different conjugation techniques are 
reported in Figure 41. It is clearly seen that conjugation via EDC/sulfo-NHS coupling 
reaction with 10% loading of Halo Tag Amino ligand gives the best results in terms of 
stability even in extreme conditions like very acidic or basic pH, or high salt 
concentrations.  
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Figure 41. Comparison of the stability against (a) pH-induced aggregation of Au@PEG-
COOH(95%)-PEG-NHS-Halo Tag Amino(5%) (black line), Au@PEG-COOH(90%)- PEG-NHS-Halo 
Tag Amino(10%) (red line), Au@PEG-COOH(85%)-PEG-NHS-Halo Tag Amino(15%) (green line), 
Au@PEG-OH(95%)-PEG-COO-Halo Tag Amino(5%) (brown line), and Au@PEG-OH(90%)-PEG-
COO-Halo Tag Amino(10%) (blue line); (b) Stability against NaCl-induced aggregation of 
Au@PEG-COOH(95%)-PEG-NHS-Halo Tag Amino(5%) (black line), Au@PEG-COOH(90%)- PEG-
NHS-Halo Tag Amino(10%) (red line), Au@PEG-COOH(85%)-PEG-NHS-Halo Tag Amino(15%) 
(green line), Au@PEG-OH(95%)-PEG-COO-Halo Tag Amino(5%) (blue line), and Au@PEG-
OH(90%)-PEG-COO-Halo Tag Amino(10%) (cyan line). 
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3. Concluding remarks 
Bioconjugation technology has affected nearly every discipline in the life 
sciences. The appication of the available crosslinking reactions and reagents for 
creating novel conjugates with peculiar activities has facilitated a significant number 
biological assays, the in vivo and in vitro targeting of molecules and cells, and the 
modulation of specific biological processes. To successfully design a nanoconjugate 
that will meet the requirements to be used in biological experiments, one should keep 
in mind a number of factors: a molecule with certain biological activity should be used 
for functionalization of nanoparticles which readily interacts with a biological target, 
such as antibody, receptor, or specifiv protein;  a proper coupling approach should be 
used in order to obtain the active site of the molecule well exposed from the ligand 
shell for interaction with the target; and, finally, the nanoconjugate must be stable in 
phisiological solutions, containing high salt concentrations and PBS, as well in a wide 
pH-range to be succesfully used in biologhical experiments.  
In this Chapter, we have focused our attention on the design, synthesis and 
characterization of gold nanoparticles functionalized with both amino- and thiol-
containing Halo Tag ligands. A number of bioconjugation techniques have been 
illustrated and the characteristics of the conjugates have been compared in order to 
select a system meeting the requirements for a successful application in biological 
experiments. The nanoparticles have been characterized by TEM, UV-vis, analytical 
centrifugation and zeta-potential measurements. Their stability have been tested both 
in a wide pH range (pH 1-13) and in extreme salt concentrations (1-3 M NaCl).  
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Being based on the stability results, we can conclude that the conjugates synthesized 
via EDC/sulfo-NHS coupling reaction using Halo Tag Amino ligand have shown the 
best stability compared to the other candidates both against pH- and salt-induced 
aggregation. Further biological experiments will be carried out in order to compare 
the conjugates’ behaviour in the living cells and study internalization mechanism 
which will drive the nanoparticles in different cellular compartments where Halo Tag 
fusion protein will be expressed for specific biorecognition. 
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Appendix:  
Concentration fraction patterns as function of pH: 
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Figure A1. Concentration fraction α patterns as function of pH, where Ade N(1)H+ is adenine 
protonated at N(1) atom, Ade-neutral form, and Ade N(9)- -deprotonated at N(9) atom. 
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Figure A2. Concentration fraction α patterns as function of pH, where Ado N(1)H+ is adenosine 
protonated at N(1) atom, Ado-neutral form, and Ado N(9)- -deprotonated at N(9) atom. 
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Figure A3. Concentration fraction α patterns as function of pH, where 5’-AMP N(1)H+ N(3)H+ 
N(7)H+ is adenosine 5’-monophosphate protonated at N(1), N(3) and N(7) atoms, 5’-AMP N(1)H+ 
N(7)H+ - protonated at N(1) ans N(7) atoms, and 5’-AMP N(7)H+ - protonated at N(7) atom. 
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Figure A4. Concentration fractions α patterns as function of pH, where Guo N(7)+ is guanine 
protonated at N(7) atom, Guo-neutral form, Guo N(1)—deprotonated at N(1) atom and Guo N(1)-
N(9)—deptotonated both at N(1) and N(9) atoms. 
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Figure A5. Concentration fractions α patterns as function of pH, where Gua N(7)+ is guanosine 
protonated at N(7) atom, Gua-neutral form, Gua N(1)—deprotonated at N(1) atom. 
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Figure A6. Concentration fractions α patterns as function of pH, where 5’-GMP N(7)H+ is 
guanosine 5’-monophosphate protonated at N(7) atom, 5’-GMP -neutral form, 5’-GMP N(1)—
deprotonated at N(1) atom. 
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Figure A7. Concentration fractions α patterns as function of pH, where Cyt N(3)H+ is cytosine 
protonated at N(3) atom, Cyt-neutral form, and Cyt N(1)- -deprotonated at N(1) atom. 
 
0
0,1
0,2
0,3
0,4
0,5
0,6
0,7
0,8
0,9
1
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14
pH
a
dCyt N(3)H+ dCyt N(3)H dCyt N(1)-
 
 
Figure A8. Concentration fractions α patterns as function of pH, where dCyt N(3)H+ is cytidine 
protonated at N(3) atom, Cyt-neutral form, and Cyt N(1)- -deprotonated at N(1) atom. 
Appendix  
 
 
259 
0
0,1
0,2
0,3
0,4
0,5
0,6
0,7
0,8
0,9
1
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14
pH
α
5`-CMP N(3)H+ 5`-CMP
 
Figure A8. Concentration fractions α patterns as function of pH, where 5’-CMP N(3)H+ is 
cytidine 5’-monophosphate protonated at N(3) atom and 5’-CMP -neutral form. 
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Figure A9. Concentration fractions α patterns as function of pH, where Thy (O4) H+ is thymine 
protonated at O(4) atom, Thy – neutral form, Thy (N3)- -deprotonated at N(3) atom, and Thy (N3)- 
N(1) - -deprotonated at N(3) and N(1) atoms. 
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Figure A10. Concentration fractions α patterns as function of pH, where dThy – neutral form, 
and dThy (N3)- -deprotonated at N(3) atom. 
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Figure A11. Concentration fractions α patterns as function of pH, where 5’-TMP (O4)H+ is 
thymidine 5’-monophosphate protonated at O(4) atom, 5’-TMP – neutral form, and 5’-TMP (N3)- -
deprotonated at N(3) atom. 
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Figure A12. Concentration fractions α patterns as function of pH, where Ino N(7)H+ is inosine 
protonated at N(7) atom, Ino -neutral form, Ino N(1)—deprotonated at N(1) atom. 
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Figure A13. Concentration fractions α patterns as function of pH, where M1G N(7)H+ is 1-
methylguanosine protonated at N(7) atom, M1G -neutral form, M1G NH-—deprotonated at NH2 
group. 
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Figure A14. Concentration fractions α patterns as function of pH, where 8-Br-Gua N(7)H+ is 8-
bromoguanosine protonated at N(7) atom, 8-Br-Gua -neutral form, 8-Br-Gua N(1)—
deprotonated at N(1) atom. 
 
2. Chemical shift values from 1H and 31P NMR: 
 
Table 1. 1H NMR chemical shifts of free ligands at pH 7, pH 3.5 and after interaction with Au 
NPs. 
 Ino pH 7 Ino pH 3.5 Au-Ino 
H2 s 8.26 s 8.24 s 
8.42-8.19 
H8 s 8.15 s 8.12 s 
H1’ d 6.02 d 6.00 d 6.20-6.07 
H2` Burried under H20 signal 
H3’ dd 4.36 dd 4.36 dd 4.41 
H4’ dd 4.21 dd 4.20 dd 4.25 
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H5’ dd 
dd 
3.84 
3.79 
dd 
dd 
3.85 
3.77 
dd 
dd 
3.96 
3.81 
 Guo pH 7 Guo pH 3.5 Au-Guo 
H8 s 7.65 s 7.98 s 8.28 
 Gua pH 7 Gua pH 3.5 Au-Gua 
H8 s 7.95 s 7.96 s 5.59 
H1’ d 5.85 d 5.86 d 5.59 
H2` Burried under H20 signal 
H3’ dd 4.34 dd 4.35 dd 4.40| 
H4’ q 4.17 q 4.17 q 4.01 
H5’ d 
d 
3.82 
3.76 
d 
d 
3.82 
3.76 
dd 3.82 
3.65 
 5’-GMP pH 7 5’-GMP pH 3.5 Au-5`-GMP 
H8 s 8.13 s 8.09 s 8.58 
H1’ d 5.86 d 5.85 d 5.86 
H2` Burried under H20 signal 
H3’ dd 4.43 dd 4.42 dd 4.42 
H4’ q 4.25 q 4.25 q 4.32 
H5’ dd 3.93 dd 3.96 dd 4.11 
P S 3.96 s 2.87 s 0.34 
 M1G pH 7 M1G pH 3.5 Au- M1G 
H8 S 7.92 s 7.93 s 7.99 
H1’ D 5.85 d 5.84 d 5.88 
H2` Burreid under H20 signal 
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H3’ dd 4.35 dd 4.35 dd 4.39 
H4’ q 4.17 q 4.17 q 4.24 
H5’ d 
d 
3.82 
3.76 
d 
d 
3.81 
3.77 
d 
d 
3.84 
3.82 
CH3 s 3.41 s 3.40 s 3.46 
 8-Br-Gua pH 8-Br-Guo pH 3.5 Au-8-Br-Guo 
H1` s 5.81 s 5.93 s --- 
H2` dd 4.91 dd 5.01 dd --- 
H3` dd 4.28 dd 4.43 dd 4.15 
H4` q 4.17 q 4.15 q 3.95 
H5` d 
d 
3.82 
3.75 
d 
d 
3.83 
3.78 
d 
d 
3.73 
3.68 
 
 
Table 2. 1H NMR chemical shifts of free adenine (Ade), adenosine (Ado) and adenosine 5’-
monophosphate (5’-AMP) at pH 7, pH 3.5 and after interaction with Au NPs. 
 Ade pH 7 Ade pH 3.5 Au-Ade 
H2 s 8.04 s 8.21 s 8.14 
H8 s 7.89 s 8.16 s 8.10 
 Ado pH 7 Ado pH 3.5 Au-Ado 
H2 s 8.23 s 8.28 s 7.94 
H8 s 8.13 s 8.17 s 7.68 
H1’ d 5.85 d 6.0 d 5.55 
H2`  4.69  4.36  4.35 
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H3’ dd 4.21 dd 4.22 dd 3.95 
H4’ q 4.16 q 4.17 q 3.95 
H5’ d 
d 
3.83 
3.74 
d 
d 
3.86 
3.77 
dd 
3.61 
 5’-AMP pH 7 5’-AMP pH 3.5 Au-5`-AMP 
H2 s 8.53 s 8.46 s 8.41 
H8 s 8.14 s 8.05 s 8.07 
H1’ d 6.06 d 6.01 d 6.03 
H2` Burried under H20 signal 
H3’ dd 4.45 dd 4.43 dd 
4.31-3.89 H4’ q 4.30 q 4.29 q 
H5’ dd 3.95 dd 3.96 dd 
P s 3.95 s 3.60 s 0.23 
 
Table 3. 1H NMR chemical shifts of free thymine (Thy), thymidine (dThy) and thymidine 5’-
monophosphate (5’-TMP) at pH 7, pH 3.5 and after interaction with Au NPs. 
 
 Thy pH 7 Thy pH 3.5 Au-Thy 
H6 s 7.31 s 7.30 s 7.31 
CH3 s 1.79 s 1.80 s 1.81 
 dThy pH 7 dThy pH 3.5 Au-dThy 
H6 s 7.59 s 7.59 s 7.60 
CH3 s 1.83 s 1.83 s 1.86 
H1’ d 6.22 d 6.22 d 6.25 
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H2` t 2.31 t 2.31 t 2.34 
H3’ d 4.41 d 4.41 d 4.43 
H4’ dd 3.96 dd 3.96 dd 3.98 
H5’ ddd 3.74 ddd 3.74 ddd 3.76 
 5’-TMP pH 7 5’-TMP pH 3.5 Au-5`-TMP 
H6 s 7.76 s 7.71 s 8.41 
CH3 s 1.87 s 1.86 s 1.83 
H1’ d 6.28 d 6.30 d 6.31 
H2` m 2.31 m 2.31 m 2.33 
H3’ m 4.52 m 4.52 m 4.53 
H4’ m 4.08 m 4.12 m 4.14 
H5’ m 3.89 m 4.01 m 4.03 
P s 3.79 s 3.79 s 0.27 
 
Table 3. 1H NMR chemical shifts of free cytosine (Cyt), cytidine (dCyt) and cytidine 5’-
monophosphate (5’-CMP) at pH 7, pH 3.5 and after interaction with Au NPs. 
 Cyt pH 7 Cyt pH 3.5 Au-Cyt 
H6 d 7.53 d 7.47 d 8.2-7.4 
H5 d 5.83 d 5.93 d 5.40 
 dCyt pH 7 dCyt pH 3.5 Au-dCyt 
H6 d 7.77 d 7.79 s 8.13 
H5 d 5.97 d 5.99 d 6.25 
H1’ d 5.83 d 5.83 d --- 
H2` m 4.23 m 4.24 m 4.5-3.5 
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H3’ m 4.13 m 4.13 m 
H4’ dd 4.06 dd 4.06 dd 
H5’ ddd 3.86 
3.73 
ddd 3.86 
3.74 
ddd 
 5’-CMP pH 7 5’-CMP pH 3.5 Au-5`-CMP 
H6 d 8.16 d 7.98 d 8.17 
H5 d 6.22 d 6.06 s 6.24 
H1’ d 5.89 d 5.94 d 5.90 
H2` m 4.27 m 4.28 m 
4.3-3.75 
H3’ m 4.20 m 4.23 m 
H4’ m 4.15 m 4.05 m 
H5’ m 4.03 m 3.97 m 
P s 3.79 s 1.85 s 0.25 
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3. FTIR data: the secon derivative patterns and main vibrational modes: 
 
 
 
 
 
 
 
 
 
Figure A3.1. The second derivative spectra of guanine (black line) and Au-guanine NPs (red 
line). 
 
 
 
Figure A3.2. The second derivative spectra of guanosine (black line) and Au-guanosine NPs 
(red line). 
 
Modes Guanine Au-Guanine 
ν (NH2)asym 3321 (s) 3202 (s) 
ν (NH2)sym 3103 (s) 
ν (CH) 2990 (m)  
2897 (m) 
--- 
ν (C=O) 1653 (vs) 1608 (w) 
δ (NH2) 1545 (w) 1485 (vw) 
ν (C-N) 1360 (m) 1374 (w) 
Ring breathing 765 (s) 710 (s) 
Modes Guo Au-Guo 
ν (NH2)asym 3315 (m) ---- 
ν (N(1)-H) 3200 (s) 2923 (vw) 
ν (C=O) 1723 (w) 1693 (s) 
1637 (s) 
δ (NH2) 1621 (s) 1550 (s) 
1526 (s) 
ν (C(2)-NH2) 1405 
1331 (m) 
1453 
1399 (m) 
Ribose vibr. 894 (s) 769 (w) 
Ring breath. 686 (s) 665 (s) 
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Figure A3.3. The second derivative spectra of guanosine 5’-monophosphate (black line) 
and Au-guanosine 5’-monophosphate NPs (red line) 
Modes 5`-GMP Au-5`-GMP 
ν (OH) 3443 (vs) 3448 
3334 (vw) 
ν (NH2)sym 3283 (m) 3224 (v) 
ν (N(1)-H) 3117 (m) 3129 (s) 
ν (N(1)-H) b 2934 (vw) 2924 (s) 
ν (C=O) 1669 
1606 (s) 
1698 
1637 (s) 
δ (NH2) 1543 (s) 1518 (vw) 
ν (C(2)-NH2) 1362 (m) 1450 (w) 
ν (P=O) sym 1071 (vs) 1087 (m) 
Ribose vibr. 814 (s) 791 (w) 
Ring breath. 699 (s) 674 (m) 
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Figure A3.4. The second derivative spectra of 1-methylguanosine (black line) and Au-1-
methylguanosine NPs (red line). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Modes M1G Au-M1G 
ν (OH) 3439 
(w) 
--- 
ν (NH2)asym 3351 
(w) 
--- 
ν (NH2)sym 3248 
(s) 
3214 (s) 
ν (N(1)-H) bound 2938 
(w) 
2929 (w) 
ν (C=O) 1686 
(s) 
1644 (m) 
δ (NH2) 1528 
(s) 
1545 
(vw) 
Ribose vibr. 899 
842 (m) 
789 (m) 
Ring breath. 668 
(vs) 
670 (vs) 
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Figure A3.5. The second derivative spectra of 8-bromoguanosine (black line) and Au-8-
bromoguanosine NPs (red line). 
 
 
 
 
Modes 8-Br-Gua Au-8-Br-Gua 
ν (NH2) 3100 (vs) 3444-3120 (s) 
ν (NH) bound 2931 (m) 2922 (vw) 
ν (C=O) 1683 
1623 (vs) 
1696 
1636 (m) 
δ (NH) 1569 
1519 (m) 
1518 (vs) 
ν (C-N) 1459 
1346 (s) 
1450 
1394 (s) 
Ribose vibr. 845 
752 (s) 
819 
731 (vw) 
Ring breath. 681 (s) 667 (m) 
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Figure A3.6. The second derivative spectra of inosine (black line) and Au-8-inosine NPs (red 
line). 
 
 
Modes Ino Au-Ino 
ν (OH) --- 3425 (m) 
ν (NH) 3297 (m) 3217 (vs) 
ν (C=O) 1687 (vs) 1698 
1636 (m) 
δ (NH) 1588 
1530 (m) 
1507 (vs) 
ν (C-N) 1420 (m) 1453 (vs) 
Ribose vibr. 890 
816 (m) 
878 
818 (vw) 
Ring breath. 692 
629 (vs) 
662 (vs) 
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Figure A3.7. The second derivative spectra of adenine (black line) and Au-adenine NPs (red 
line). 
 
 
 
 
 
 
 
 
 
 
Modes Ade Au-Ade 
ν (NH) 3273 (m) 3202 (vs) 
ν (CH) 3092 (vs) 
2969 (m) 
--- 
δ (NH)scis 1663 (s) 1697 (s) 
1645(s) 
Ring breath. 698 (w) 680 (w) 
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Figure A3.8. The second derivative spectra of adenosine (black line) and Au-adenosine NPs 
(red line). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Modes Ado Au-Ado 
ν (NH) 3147 (s) 3201 (vs) 
δ (NH)scis 1644 (s) 
1590 (s) 
1608 (w) 
ν (C-N) 1209 (m) 1184 (vs) 
Ribose vibr. --- 788 (vs) 
Ring breath. 759 (m) 708 (vs) 
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Figure A3.9. The second derivative spectra of adenosine 5’-monophosphate (black line) and 
Au-adenosine 5’-monophosphate NPs (red line). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Modes 5’-AMP Au-5’-AMP 
ν (OH) 3433 (vw) 3443 (v) 
ν (NH) 3213 (w) 
3096 (w) 
--- 
ν (CH) 2953 (v) 2924 (vw) 
δ (NH)scis 1640 (s) 1645 (m) 
ν (P=O) 1074 (s) 1097 (vw) 
1028 (vw) 
Ring breath. 790 (m) 770 (s) 
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Figure A3.10. The second derivative spectra of thymine (black line) and Au-thymine NPs (red 
line). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Modes 5’-AMP Au-5’-AMP 
ν (NH) 3201 (w) 3217 (s) 
ν (CH) 
ν (CH3) 
3030 (s) 
2902 (s) 
3008 (vw) 
2907 (vw) 
ν (C=O) 1736 (vs) 1697 (s) 
δ (NH)scis 1431 (s) 1512 (s) 
1415 (s) 
δ (CH)oop 735 (vs) 726 (s) 
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Figure A3.11. The second derivative spectra of thymidine (black line) and Au-thymidine 
 NPs (red line). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A3.11. The second derivative spectra of thymidine 5’-monophosphate (black line) and 
Au-thymidine 5’-monophosphate NPs (red line). 
 
Modes 5’-AMP Au-5’-AMP 
ν (NH) 3296 (s) 3216 (s) 
ν (C=O) 
ν (C=C) 
1664 
(s) 
1704 (w) 
1640 (w) 
δ (CH)oop 731 (w) 774 (vs) 
Modes 5’-AMP Au-5’-AMP 
ν (OH) 3402 (vw) 3379 (vw) 
ν (NH) 3175 (vw) 3231 
ν (CH) 2941 (v) 3018 (vw) 
Ν (C=O) 1671 (s) 1688 (s) 
δ (NH)scis 1453 (m) 1522 (s) 
ν (P=O) 1080 (s) 1084 (vw) 
Ribose vibr. 949 (s) 983 (vw) 
δ (CH) oop 771 (s) 791 (vs) 
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Figure A3.12. The second derivative spectra of cytosine (black line) and Au-cytosine NPs (red 
line). 
 
 
 
 
 
 
 
 
 
 
Modes 5’-AMP Au-5’-AMP 
ν (NH) 3368 (vs) 
3157 (vs) 
3215 
ν (CH) 2927 (m) 2927 (vw) 
2851 
ν (C=O) 1647 (vs) 1710 
1645 (s) 
ν (C-N) 1520 (s) 
1441 (vs) 
1541 (vs) 
1449 (m) 
Ring breath. 773 (vs) 811 (w) 
δ (CH) oop 673 (m) 675 (m) 
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Figure A3.13. The second derivative spectra of cytidine (black line) and Au-cytidine NPs (red 
line). 
 
 
Modes 5’-AMP Au-5’-AMP 
ν (OH) 3443 (w) 3442 (vw) 
ν (NH) 3337 (vs) 
3220 (vs) 
3350 
3209 (vw) 
ν (CH) 3072 (w) 
2909 (m) 
2926 (vw) 
2854 
ν (C=O) 1618 (s) 1696 (ms) 
1642 (s) 
Ring breath. 799 (w) 769 (vs) 
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Figure A3.14. The second derivative spectra of cytidine 5’-monophosphate (black line) and Au-
cytidine 5’-monophosphate NPs (red line). 
 
 
 
 
 
Modes 5’-AMP Au-5’-AMP 
ν (OH) 3427 (vw) 3415 (vs) 
ν (NH) 3292 (vw) 3212 
ν (CH) 3072 (vs) 
3028 
2926 (m) 
3095 (vw) 
 
2932 (m) 
ν (C=O) 1646 (m) 1702 (m) 
1641 (m) 
δ (NH)scis 1584 (w) 1554 (b) 
ν (P=O) 1066 (vs) 1094 (vw) 
1026 (vw) 
Ring breath. 799 (s) 729 (vs) 
δ (CH) oop 664 (s) 672 (vs) 
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4. Biological experiments 
 
 
 
Figure A4.1. Light microscopy image of U87 cells incubated with a) Au-thymine, b) Au-
thymidine, c) Au-thymidine 5’-monophosphate, d) Au-citrate, e) Au-cytosine, f) Au-cytidine and 
g) Au-cytidine 5’-monophosphate NPs. 
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Figure A4.2. Light microscopy image of U87 cells incubated with a) Au-guanine, b) Au-
guanosine, c) Au-guanosine 5’-monophosphate, d) Au-adenine, e) Au-adenosine and f) Au-
adenosine 5’-monophosphate NPs. 
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Introduction 
 The aim of my PhD research project has been the study of gold nanoparticles 
(AuNPs) functionalized by different biologically active molecules and their 
applications in biological systems. Biological studies on cells have been 
accomplished in collaboration with Dr. Giorgio Scarì from the Department of Biology 
of Milan University.  
 During the first two years, my research was focused on the following topics:  
• Synthesis and characterization of AuNPs stabilized by nucleic acid 
components, such as nucleobases (adenine, guanine, thymine and cytosine), 
corresponding nucleosides and mononucleotides. 
• Spectroscopic study of the binding between nucleic acid components and gold 
surface; 
• Cytotoxicity and cellular uptake studies of the conjugates into human 
glioblastoma cancer cells; 
• Synthesis and characterisation of AuNPs functionalized by an RGD-containing 
peptide for integrin receptor targeting. 
 The 3rd year of my PhD studies I partly spent working in Prof. Mathias Brust’s 
lab at The University of Liverpool. My research was dedicated to design, synthesis 
and characterisation of AuNPs conjugated with Halo Tag specific ligands for Halo 
Tag protein targeting. 
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AuNPs modified by nucleic acid components: synthesis, spectroscopic study 
and potential application in biology 
 The interaction of DNA with gold nanoparticles has found diverse applications 
in the recent advancements of nanobiotechnology, including diagnostics involving 
DNA detection employing such techniques as surface plasmon resonance 
spectroscopy, electrochemical, colorimetric detection, as well as electronics, sensors, 
drug delivery, chips, imaging, etc [1-19]. In this PhD project, purine and pyrimidine 
bases, along with corresponding nucleosides and nucleotides are used as stabilizing 
agents for AuNPs. Moreover, several guanosine derivatives (1-methylguanosine, 8-
bromoguanosine and inosine) are used to better understand the binding between the 
molecules and gold surface. 
Small water-soluble AuNPs are prepared following “one-pot” approach, where 
a gold salt aqueous solution is reduced by sodium borohydride in the presence of 
stabilizing ligands. The molar ratios between the components are varied in the 
preliminary experiments in order to find out the reaction conditions at which the 
resulting AuNPs possess a number of characteristics, such as small particle size and 
stability. The reaction progress is continuously followed by UV-vis spectroscopy, 
tracing both shape and position of SPR band along with the colour of resulting 
colloidal solutions as an indication of stability and certain particle size. As-prepared 
AuNPs are characterized by TEM, dynamic light scattering (DLS) and zeta-potential 
techniques. TEM results indicate the diameter of the particles to vary from 6 to 35 
nm: the largest nanoparticles of 35 nm were obtained using adenosine 5`-
monophosphate as capping agent, while the smallest ones of 6 nm were produced 
both with guanosine 5`-monophosphate and cytidine and corresponding nucleotide,  
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which indicates a dependence of the size from the ligand nature and its amount per 
nanoparticles. DLS studies show an increase of particle diameter comparing to that 
obtained by TEM (of 3-6 nm), being a good indication of a successful particle 
modification and presence of a “shell” around the particle. Moreover, it shows the 
presence of fractions with larger mean diameters (34-95 nm), arising from the 
formation of small particle agglomerates, however, without bringing about any 
nanoparticle aggregation. 
Electrokinetic studies show that all the nanoconjugates are negatively charged 
showing negative zeta-potential values. Notably, the particles capped by 
nucleobases and nucleosides show similar zeta-potential values around -20-23 mV, 
indicating that sugar does not greatly contribute to the particle charge. On the other 
hand, the particles capped by nucleotides show very negative values close to -50 
mV, indicating a contribution of the phosphate moiety in the stabilization of the 
AuNPs. Zeta-potential values have been compared to a value of “bare” nanoparticles 
(+11.04 mV), supporting the results of DLS and a successful modification of the 
nanoparticles. 
 Ionization state does have a great impact both on the spectroscopic 
characteristics of a molecule and on its binding to a surface. In order to understand in 
which form (neutral or protonated) the molecules exist in the solution under given 
conditions, we calculated the values of concentration fractions (α) as function of pH, 
using the acidity constant logarithms, pKa. We have found that the majority of the 
molecules exist both in mono-protonated and neutral state. Only adenosine 5’-
monophosphate exists in bi- and tri-protonated state: both at N1, N3, N7 atoms and 
N1, N7 atoms, respectively. On the other hand, thymine, thymidine and  
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corresponding nucleotide are mostly nonprotonated (neutral) at given conditions. The 
same is for guanosine derivatives, which exist mostly in neutral form. 
Some structural investigations on the interactions between the nucleobases 
and gold nanoparticle have been already performed by infrared techniques [20-22]. 
However, the data on NMR studies are still lacking in the literature. Since NMR 
spectroscopy have been widely used to study metal complexes with nucleobases or 
other nucleic acid components, we apply this coordinative metallorganic approach to 
explain the interaction of the compounds under investigation with gold surface, 
comparing 1H NMR spectra of free compounds, with 1H NMR spectra of capped 
AuNPs [23, 24]. In theory, the gold core can interact with the ligands in many ways: 
via phosphate oxygen atoms, sugar oxygen atoms, and (N, C, O) atoms of the 
heterocyclic base; or combinations thereof [23]. 
Based on the interpretation of NMR and FTIR results, we conclude that most 
of “guanine family” compounds interact with the particles via N7 atom and C=O 
group, in their neutral form, as the H8 signal shifts in 1H NMR and the C=O band 
significantly changes in FTIR spectra, in comparison with free compounds. On the 
other hand, 8-bromoguanosine differs in its binding, while inosine gives more than 
one product in the colloidal system, as indicated by the complexity of NMR spectrum. 
Moreover, guanosine and 8-bromoguanosine derivatives seem to be able to form 
weak hydrogen bonds between N1-H group and gold surface (or other molecules, 
creating a multilayered corona)), having observed changes of stretching and bending 
NH bands after interaction with gold.  
The substitution on C8 atom leads to a different constrain depending on bulky 
substituent and different pathways of reaction can be possible for the building up of  
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Au-purine NPs, as demonstrated for Au-8-bromoguanosine NPs. Novel results on the 
conformational changes of ribose puckering highlight that it can occur when purine 
derivatives interact with AuNPs. The need of conformational changes is strictly 
related to the electronic properties of guanine ring after contact with gold surface 
throughout N7 and C=O. Moreover, the phosphate group of guanosine nucleotide is 
strongly involved in a polar interaction with gold surface, being monoprotonated, 
HO(O)PO-R)(O-) due to the pH of colloids. 
 Thymine and thymidine weakly bind to the gold surface involving C=O4 and 
N3-H groups, with the latter able to form non-conventional hydrogen bonds with gold 
surface. Thymidine 5`-monophosphate seems to show a stronger interaction due to 
the presence of a phosphate group, which may participate in electrostatic 
stabilization of AuNPs. On the other hand, adenine, adenosine and adenosine 5’-
monophosphate seem to interact with AuNPs via NH2 group of adenine ring, involving 
N7 lone pair of electrons. The ribose moiety is affected by the interaction, giving rise 
to significant changes in NMR spectra, while the phosphate moiety may interact with 
gold surface electrostatically, providing the particle stabilization. Finally, “cytosine 
family” compounds interact with AuNPs involving N3 atom of cytosine moiety, with 
the ribose moiety to be strongly perturbed under interaction. Likewise other 
nucleotides, the phosphate group of cytidine 5’-monophosphate is involved in the 
interaction, showing a large chemical shift in 31P NMR spectrum. 
Besides structural studies on AuNPs, we have also performed the cytotoxicity 
and cellular uptake experiments in order to evaluate their potential application in 
biology. All the experiments have been performed using U87 human glyoblastoma 
cell line, used as an in vitro model of human glioblastoma cells to investigate the  
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cytotoxic effect of chemotherapeutic drugs towards cancer cells. The cell mortality 
has been studied by trypan blue exclusion test by determining the number of viable 
cells present in the cell suspension, basing on the principle that live cells possess 
intact cell membrane that exclude certain dyes, whereas dead cells do not [25]. After 
one hour of incubation, the nanoparticles modified with nucleobases caused 12-18% 
cell death, while nucleobases and nucleotides conjugates shown 8-23% of cell 
mortality. It is known that the kind of surface coating may play an important role in the 
cytotoxicity of AuNPs. 
 The cellular uptake studies of several gold conjugates have been performed 
both by confocal microscopy and TEM. All the tested conjugates are taken up by the 
cells: the nanoparticles are distributed in different cellular compartments, and some 
of them even can be found inside the nucleus. The cellular uptake of Au-thymidine 5’-
monophosphate NPs has been studied by TEM. After one hour of incubation, the 
nanoparticles are found approaching cellular membrane and clustered together in 
cellular compartment that appear to be an endosome. Moreover, the nanoparticles 
are observed free in the cytoplasm, which may indicate their ability to escape 
endosomal pathway. In fact, the nanoparticles are also found roaming into different 
cellular compartments, and, in particular, crossing nuclear membrane and even into 
the nucleus. The Au-thymidine 5’-monophosphate NPs seem to fulfil the necessary 
conditions to enter the nucleus, being small enough (10 nm) to be able to penetrate 
nuclear membrane, and be probably taken up by the cells via passive uptake. This 
mechanism is still unclear and needs a more detailed study, by variation of cellular 
uptake conditions and using different cell lines. 
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AuNPs functionalized by RGD-containing peptide for integrin targeting 
 Integrins are a family of proteins that facilitate cellular adhesion and migration 
on extracellular matrix proteins in the intercellular spaces and basement membranes, 
and regulate cellular entry and withdraw from the cell cycle [26]. Integrin αVβ3 is 
expressed at low levels on epithelial cells and mature endothelial cells, but is 
overexpressed on the activated endothelial cells of tumor neovasculature, including 
osteosarcomas, neuroblastomas, glioblastomas, melanomas, lung carcinomas, and 
breast cancer [27]. 
Most integrins recognize their respective extracellular matrix proteins through short 
peptide sequences such as Arg-Gly-Asp (RGD) [28]. RGD-containing peptides 
compete in the binding of proteins to cell surface αVβ3, preventing cellular adhesion 
to the extracellular matrix, thwarting cell metastasis, and inducing apoptosis [29]. 
 In this PhD research, both cyclic RGD-(GC)2 and linear (GC)2 peptides are 
used. The RGD-(GC)2 peptide is a chimeric molecule of 12 amino acids containing 
two parts: an RGD-sequence and a (GC)2-motif for integrin targeting and 
nanoparticle stabilization, respectively. The RGD-containing part was derived from 
the c(RGDfK) peptide, an αvβ3 antagonist, where the lysine residue was replaced by 
glutamic acid to allow the conjugation to the (GC)2-motif by its γ-carboxylic group.  
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Figure 1. a) (GC)2 peptide; b) RGD-(GC)2 peptide. 
 
The (GC)2 portion contains a sequence of glycines and cysteines needed for the 
binding to the gold surface via Au-S covalent bond and providing nanoparticle 
stabilization against aggregation, allowing a parallel disposition towards gold surface. 
The peptides were synthesized by Dr. Laura Zaccaro’s group at the Institute of 
Biostructures and Bioimages (Naples). A standard Fmoc solid-phase strategy was 
applied. The products were purified by preparative RP-HPLC and the collected 
fractions containing the peptides were lyophilized. 
 AuNPs were prepared using “one-pot” sodium borohydride reduction method 
in the presence of RGD-(GC)2 and (GC)2 peptides to give small nanoparticles of 10.2 
nm and 13.9 nm, respectively. The conjugation of AuNPs with peptides was 
confirmed by 1H NMR and ATR-FTIR spectroscopy, the stability of the conjugates 
was verified using both UV-vis spectroscopy and Zeta-potential studies, while their 
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morphology analysed by TEM. Varying the molar ratios between the reagents 
(Au:peptide:sodium borohydride), the conditions corresponding to the most stable 
nanoconjugates have been matched: the 1:0.005:2 and 1:0.001:2 ratios for (GC)2 
and (RGD)-(GC)2 peptides, showing 514 and 529 nm SPR band, respectively.  
 Zeta-potential studies show the AuNPs to be negatively charged with zeta-
potential values of -27.27 mV and -40.59 mV for Au-RGD-(GC)2 and Au-(GC)2, 
respectively. The difference between the zeta-potential values can be due to a 
different local environment surrounding a single nanoparticle, and can depend on: 
surface concentration of the peptides on the particle, possible ionic dissociations or 
zwitterionic forms of the peptides, disposition of the peptide molecules on the particle 
surface, interactions of the two organic chains with water, and, most importantly, 
ionic strengths of the solutions [30]. 
 In order to have an idea of coverage density on the nanoparticle surface, the 
number of peptide molecules per particle was determined by TGA analysis. The 
weight losses of 1.609% and 1.058% were recorded in the 120-450°C heating range, 
and assigned to the combustion of the peptides bound to the particle surface. The 
number of peptide molecules residing on each gold particle was calculated, using a 
simple equation described by De Palma and co-workers [31], giving the numbers of 
94 and 298 molecules for RGD-(GC)2 and (GC)2 peptides, respectively. 
 In order to verify the binding of the peptides to nanoparticle surface and 
investigate the interactions in the ligand shell of the conjugates, ATR-FTIR and NMR 
spectroscopy have been performed. From the perusal of the spectroscopic data the 
following conclusions about the conjugation of the peptides to the gold particle are  
drawn: a strong interaction of the (GC)2 part with gold surface via the sulphur atom of  
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cysteine residues results in a strong perturbation of CO and NH groups and 
disappearance of Cys β-CH2 proton signal. On the contrary, the rigid RGD ring 
seems to be almost unaffected upon interaction with gold: from NMR spectra only a 
minor structural rearrangement of the peptide-cyclic portion can be detected; in the 
FTIR spectrum, amide I and amide II bands show the patterns different from those 
found in the Au-(GC)2 spectrum, likely, because of the amide I band to be forbidden 
by surface selection rules causing its low intensity. Summing up, the interaction 
between (GC)2 or RGD-(GC)2 and AuNPs mainly consists in the formation of S-Au 
bonds between the cysteine residues of (CG)2 part and gold surface, leaving the 
RGD moiety almost unaffected and free for the interaction with integrin receptor.  
 For cellular uptake studies, peptide conjugated nanoparticles are added to 
cultures of U87 cells, a human glioblastoma cell line, and the cellular uptake is 
compared after different incubation times, using confocal microscopy. Importantly, 
the extent of cellular uptake in each case seems vastly different: a large amount of 
Au-RGD-(GC)2 conjugates is found to be present into cellular body even after 5 min 
of incubation, while Au-(GC)2 particles are hardly taken up by the cells even after 30 
min of incubation.  
 The quantitative analysis of cellular uptake is evaluated by measuring the pixel 
brightness of the confocal images taking into consideration the cellular areas nearly 
equal to 780 µm2. As expected, the amount of Au-RGD-(GC)2 particles taken up by 
the cells is growing along with incubation time, giving the pixel brightness of 0.87 and 
13.3 after 5 and 30 min of incubation, respectively. On the contrary, the cells 
incubated with the particles conjugated with peptide lacking RGD-moiety, show the 
pixel brightness near to the zero.  
  
Summary  
 
 
296 
TEM results support confocal microscopy data: the nanoparticles 
functionalized by (GC)2 peptide are approaching the cellular membrane after 1 h of 
incubation, however, are not able to cross it and be taken up by the cells, whereas 
Au-RGD-(GC)2 NPs are found while crossing cellular membrane and enclosed into 
the endosomes. The results suggest an internalization mechanism via integrin-
receptor mediated endocytosis [19]. Of extreme interest is that the RGD-conjugated 
nanoparticles are also found crossing nuclear pore complex, accumulated inside the 
nucleus and even into the nucleolus. The presence of nanoparticles free in the 
cytoplasm does suggest endosomal escape mechanism to take place, allowing the 
nanoparticles to get free to be ready to interact with nuclear pore complex. Even 
though RGD-peptide has not ever been recognized as nuclear localization signal 
(NLS) peptide, it appears to be able to perform this functionality. Undoubtedly, the 
internalization mechanism and nanoparticle fate still need to be explored in details, 
performing more specific experiments, as the ability to direct the “cargo” 
nanoparticles into the nucleus has been a task of a great interest so far. 
 
Design and synthesis of AuNPs conjugated with Halo Tag specific ligands for 
cellular targeting 
 The goal of this project was to design and synthesize gold nanoparticles 
conjugated with Halo Tag functional ligands, in order to obtain bioactive conjugates 
with a number of properties, such as stability in a wide pH range and physiological 
media, certain size and functionality. These particles should be able to be recognised 
by Halo Tag protein expressed in different cellular compartments of interest.  
A new modern approach, called Halo Tag technology, is being widely applied  
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for cellular imaging, protein quantification and interaction analysis. It is designed for 
rapid, side-specific labelling of proteins in living cells and in vitro, and based on the 
efficient formation of a covalent bond between the Halo Tag protein and synthetic 
ligands (Figure 2). The Halo Tag protein is a catalytically inactive, genetically 
modified derivative of a hydrolase protein [32]. This protein is used to generate N- or 
C-terminal fusions that can be efficiently expressed in a variety of cell types. The 
Halo Tag ligands are small chemical tags, containing two crucial components: a 
common Halo Tag reactive linker that initiates formation of the covalent bond 
(chlorine) and a functional reporter such as a thiol or amino-group. The rate of the 
ligand-protein binding is remarkably fast and the covalent bond formed is highly 
specific and irreversible.  
 
 
Figure 2. Halo Tag ligand building blocks: a) Halo Tag Thiol (O4); b) Halo Tag Amino (O4). 
 
 Normally, nanoparticle bioconjugates are prepared via formation of new 
chemical bonds between functional groups associated with a nanoparticle and a 
biomolecule or small molecule of interest. For creating a continuous passivation layer 
around AuNPs thiol compounds have been widely used, allowing efficiently improve 
their stability and dispersity in aqueous solution. In this project several bifunctional 
PEGs (-SH/NH2-, or –SH/ -COOH, or –SH/-OH) have been used for nanoparticle 
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stabilization. Thiol groups can bind covalently to the surface of AuNPs via an Au−S 
bond, while reactive groups can be readily coupled with Halo Tag reactive sites. 
As a basis, gold nanoparticles stabilized by citrate ions have been used. For 
this purpose, citrate nanoparticles have been prepared by a modified Turkevich-
Frens method [33, 34] and subsequently stabilized and functionalized by a shell of 
thiolated PEG molecules [35, 36].  
 The Halo Tag Thiol ligand has been used both for direct conjugation to 
the citrate nanoparticles and conjugation via a spacer separating a PEG layer and 
Halo Tag ligand. The spacer allows to expose the active chlorine atom from the 
particle surface to be coupled to the Halo Tag protein in the cells. The Halo Tag 
Amino ligand has been conjugated via two different ways with the aim to compare 
their impact on the conjugates` properties: an EDC/sulfo-NHS coupling reaction 
involving –COOH groups of the PEG, and a direct conjugation to the PEG containing 
–NHS reactive groups [37]. As-prepared nanoparticles were purified by repeated 
centrifugation in order to eliminate the excess of the ligands. The clear 
nanoconjugates were characterized by UV-vis, analytical centrifugation, TEM, and 
Zeta-potential studies. Moreover, stability against salt- and pH-induced aggregation 
was compared. As an empirical measurement of the aggregation process, an 
aggregation parameter, which measures the variation of the integrated absorbance 
between 600 and 700 nm, was used. 
For direct conjugation, a mixture containing Halo Tag Thiol ligand and 
thiolated PEG with terminal -OH groups was used. Both 3% and 10 % of the Halo 
Tag molecules were introduced into the shell. The successful conjugation was 
confirmed by a shift of SPR band from 522 to 524 nm and an increase in intensity.  
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Analytical centrifugation shows a large shift as well: diameter of citrate NPs obtained 
by this method is 13.5 nm, while it undergoes a significant change to 12.1 nm and 
even 11.9 nm with increasing content of Halo Tag Thiol molecule in the ligand shell 
from 3% to 10%, respectively. TEM results illustrated the presence of very 
monodispersed well separated particles with similar mean diameters of 15.91±1.13 
nm and 15.28±0.83 nm. Interestingly, the particles were able to form a kind of self-
assembled 2D structures under natural dewetting process by slow evaporation of 
nanoparticle-containing solvent on the TEM grid [38]. The zeta-potentials of 
conjugated particles were significantly different from those of unmodified citrate 
GNPs: -14.3 and -15.2 mV versus -32.7 mV for citrate GNPs, supporting the 
occurred conjugation. Stability studies show that the particles with major content of 
the ligand have a better stability both in PBS and at acidic pH, with aggregation 
parameter maximum less than 0.2. While PEGylated nanoparticles are subjected to a 
slight aggregation at acidic pH, probably due to protonation of terminal –OH groups. 
On the other hand, no aggregation of the nanoparticles was detected even in 
extremely high salt conditions: incubated with NaCl, both particles were stable up to 
3M concentration. The same behaviour is observed in this case: the particles 
containing 10% of Halo Thiol ligand appear more stable with a very low aggregation 
parameter less than 0.1. 
An alternative and valuable approach to conjugate Halo Tag Thiol molecule is 
to use the cystamine linker. To realise this, a mixture of PEGs (-SH/-OH and –SH/-
COOH), with 5% and 10% of the latter PEG, is used. Cystamine is decarboxylated  
cystine, a small disulfide-containing molecule with primary amines at both ends. 
Here, cystamine is used as an activating reagent for disulfide exchange reaction [39- 
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41]. The cystamine-modified nanoparticles then are mixed with the Halo Tag Thiol 
ligand, where the latter cleaves the disulfide of cystamine-modified particles, 
releasing 2-mercaptoehylamine and forming a disulfide crosslink. A red-shift from 
520 to 522 nm occurred when citrate GNPs were substituted by PEG-OH and PEG-
COOH molecules. After cystamine conjugation, a further shift of 2 nm occurred for 
the particles containing 10% PEG-COOH. Finally, when functionalized by Halo Tag 
Thiol ligand attached to the cystamine spacer, the SPR band moves from 522 to 524 
nm in both cases, indicating a successful coupling reaction. Analytical centrifugation 
data show a considerable shift of 0.7 nm (from 12.4 nm to 11.7 nm) when the GNPs 
are covered by the mixture of PEG and 5% of cystamine. While increasing the 
content of cystamine linker to 10%, the shift becomes larger (0.8 nm), and a 
subsequent shift of 0.1 nm is occurred when functionalized by Halo Tag Thiol. Like 
nanoparticles prepared via direct Halo Tag Thiol conjugation, those containing 
cystamine linker result to have a negative zeta-potential, which changes after each 
conjugation step. TEM shows a similar behaviour of the as-prepared NPs with those 
directly conjugated, with particle diameters to be 16.59±1.25 and 16.19±1.2 nm for 
the conjugates containing 5%- and 10%-Halo Tag Thiol, respectively. Stability 
experiments were carried out incubating both cystamine-modified PEGylated 
nanoparticles and Halo Thiol-conjugates.  
The cystamine-containing PEGylated particles appeared to be stable both in 
PBS and at the basic and neutral pH. The conjugation of Halo Thiol ligand allows 
improving pH-induced aggregation stability, as the aggregation parameter values 
significantly decreases in whole pH interval concerned. Concerning salt-induced 
aggregation, no change of the SPR band profile is detected when the nanoparticles  
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are exposed to the high salt concentrations indicating an excellent colloidal stability 
even in extreme conditions. However, the particles containing major amount (10%) of 
Halo Tag Thiol ligand possess a better stability, being the aggregation parameter a 
little lower. 
The approach applied to conjugate amino-containing Halo Tag ligand to the 
particles involves the using of a zero-length cross-linking agent, mediating the 
conjugation of two molecules by forming a bond containing no additional atoms. EDC 
(or EDAC, 1-ethyl-3-)3-dimethylaminopropyl)carbodiimide hydrochloride) along with 
sulfo-NHS (N-hydroxysulfosuccinimide) are the most frequently used crosslinking 
agents in order to conjugate biological substances containing carboxylates and 
amines [42-44]. 
First, GNPs were covered by PEG-OH and PEG-COOH, loading in the 
passivation layer both 5% and 10% of –COOH groups. Afterwards, Halo Tag Amino 
(O4) ligand was coupled to the –COOH functionality. The starting citrate NPs show a 
characteristic SPR band at 520 nm, which significantly shifts to longer wavelengths at 
526 nm after passivation by PEG mixture. When conjugated with Halo Tag Amino 
ligand, a further blue-shift of the SPR band takes place, however, its intensity is 
maintained, indicating good resistance to the coupling reaction. A large shift of 
analytical centrifugation spectra takes place after exchange between citrate ions and  
PEG: initial value of 12.4 nm now becomes 11.5 nm. Further shift is hardly 
detectable; however, the peak becomes narrower after coupling reaction, indicating a 
narrower particle distribution and better stability.  
Zeta-potential studies confirmed the nanoparticles to be negatively charged 
with zeta-potential value changing after every conjugation step. TEM indicates the  
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disposition of the nanoparticles to look different from the previously discussed 
conjugates prepared by different methods. In particular, the nanoparticles loaded with 
5% Halo Tag Amino ligand are evenly distributed on the copper grid, creating a mass 
of long wires side by side. On the other hand, 10%-loaded nanoparticles show a 
different picture, forming short and long clustered wires. Finally, both PEGylated and 
Halo Tag Amino-conjugated nanoparticles maintain the stability in PBS and against 
pH-induced aggregation in basic, acidic and neutral medium. 
Another way to conjugate Halo Tag Amino ligand with PEG shell is to use a 
PEG containing functional NHS group. In this case, no EDC/sulfo-NHS coupling 
reaction is needed being PEG molecule already activated and ready to be 
conjugated. For this purpose, citrate NPs were covered by PEG-COOH and PEG-
COONHS molecules via citrate exchange method, using 5%, 10% and 15 % of the 
latter ligand, followed by the coupling with Halo Tag Amino molecule. As indicated by 
UV-vis, when citrate NPs are passivated by PEG, independently of the ratio between 
the components in the “passivation” mixture, SPR band shifts of 4 nm towards longer 
wavelengths and its intensity rises in absorbance. While Halo Amino-conjugated 
nanoparticles show a slight (2 nm) further shift to 524 nm and a decrease in intensity, 
confirming the changes in the ligand shell. Analytical centrifugation results show a 
large shift from 13.4 nm to 12.1 nm when citrate NPs are covered by PEG layer 
containing 5% of active NHS-groups, while for the particles containing 10 and 15% of 
PEG-NHS the shift is even larger being 11.9 nm. A further shift from 11.9 to 11.7 nm 
can be clearly observed when the particles are conjugated with 15% Halo Tag Amino 
ligand, while in the case of minor ligand amounts the shift is hardly seen due to the 
increase of ligand shell diameter.  
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Zeta-potential results have shown the change of the values after each 
functionalization step: initial zeta-potential value of -32.7 mV corresponding to citrate 
GNPs becomes less negative after passivation by PEG mixture because of the 
contribution of sulfo-NHS neutral groups, while it turns to be more negative after 
conjugation with Halo Tag Amino ligand, due to the negative chlorine terminal 
groups. TEM indicates that like in the case of the particles conjugated with Halo Tag 
Amino ligand via EDC/sulfo-NHS, the as-prepared particles are able to form chain-
like structures via self-assembly. It is likely due to the presence of a large amount of 
carboxylic groups in the PEG shell, which can form intermolecular hydrogen bonds. 
The results of stability studies slightly differ from those obtained for other kinds of 
particles: in the 13-5 pH range the particles form a well dispersed suspension in 
water exhibiting a characteristic SPR band at 524 nm. However, on further 
decreasing of pH to 3, a large shift of the SPR band along with a colour change from 
red to violet take place. At pH<3 the spectra do not change further and become 
almost saturated without any shifting of SPR band. These observations can be 
explained as follows: the H-bonding between two –COOH groups of surface-bound 
PEG molecules brings the nanoparticles into close proximity to form an assembled 
structure and results in the development of another SPR band in a higher-wavelength 
region as a result of the coupling of interparticle plasmon resonance of GNPs [45].  
In order to understand if the assembly process is reversible, 0.1M NaOH solution is 
added to the assembly medium in order to increase the pH to 10, resulting in a colour 
change from violet to initial red, indicating a disassembly process. It is clear that the 
assembly process is driven by hydrogen-bonding interactions, as no red shift of SPR 
band was observed in the case of Halo Tag Thiol conjugation where  
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the –COOH groups were lacking. Regarding salt-induced aggregation, Halo Tag 
Amino conjugation does not improve the stability of nanoparticles respect to 
PEGylated ones nor influences the stability against pH-induced aggregation. On the 
contrary, the stability against NaCl-induced aggregation slightly decreases with 
increasing loading of Halo Tag Amino ligand on the particle surface. 
In conclusion, several bioconjugation techniques have been illustrated and the 
characteristics of the conjugates have been compared in order to select a system 
meeting the requirements for successful application in biological experiments. Being 
based on the stability results, we can conclude that the conjugates synthesized via 
EDC/sulfo-NHS coupling reaction using Halo Tag Amino ligand have shown the best 
stability compared to the other candidates both against pH- and salt-induced 
aggregation. Further biological experiments are being carried out in order to compare 
the conjugates’ behaviour in the living cells and study internalization mechanism 
which will drive the nanoparticles in different cellular compartments where Halo Tag 
fusion protein will be expressed for specific biorecognition. 
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